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ABSTRACT 
Recent advances in computational modelling of biological networks have helped researchers 
study the cellular metabolism of organisms. In this project, these approaches were used to 
analyze Trypanosoma brucei metabolism. This protozoan parasite is the causative agent of 
African trypanosomiasis, a lethal disease which has been responsible for huge loss of lives 
and livestock in Sub-Saharan Africa since ancient times. Information on T. brucei metabolism 
was gathered from published studies, databases and from personal communication with 
experts studying different areas of Trypanosomatid research. This information has been 
presented to the public through the TrypanoCyc Database, a community annotated T. brucei 
database. The database was published in November 2014 and has had over 4200 visitors 
from more than 100 countries as of November 2015. A manually curated genome-scale 
metabolic model for T. brucei was also built based on the gathered information to facilitate 
the study of T. brucei metabolism using systems biology approaches. Flux balance analysis 
based algorithms were designed to optimize visualization and study interesting metabolic 
properties. Blood-stream form specific metabolic models were generated using information 
available from published studies and the TrypanoCyc annotations with the help of the iMAT 
algorithm. Finally, an algorithm was designed to further optimize these stage specific models 
to improve the consistency of their predictions with results published in previous studies. 
These stage-specific models were observed to have a clear advantage over the genome-scale 
model when predicting stage-specific behaviour of T. brucei, particularly when predicting 
mutant behaviour.  
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1.1 METABOLISM 
Metabolism is the set of physical and chemical processes that an organism is capable of 
performing in order to survive and reproduce [1]. The word ‘Metabolism’ was coined from 
the Greek term μεταβολή (metabolē - change) and ism (a suffix used to convert a verb as a 
noun) [2]  
1.1.1 History of metabolism 
Since the dawn of time man has been trying to understand the world around him. We made 
observations on the living and non living elements that interact with us and developed 
conclusions on why things happen the way they do. The rise of interest in agriculture and 
cattle breeding practices inevitably led to observations of the effect of food and other 
elements from the environment on cattle and crops. With the development of interest in the 
physiology of living beings, the effects of food and air on fellow humans and cattle were 
observed by physicians such as Claudius Gaven. In the 1st century ,Gaven proposed that 
pnuema, the fundamental principle of life according to Gaven, entered the body through air 
and from food into the blood [3]. However, the earliest recorded observations on 
metabolism have been credited to Ibn al-Nafis who stated in 13th century in his theological 
novel, ‘Al-Risalah al-Kamiliyyah fil Siera al-Nabawiyyah’ that "Both the body and its parts are 
in a continuous state of dissolution and nourishment, so they are inevitably undergoing 
permanent change" [4]. Later in the 16th century, Sanctorio sanctorius performed studies on 
himself and subjects by monitoring the weight of food, water, excrement and the human 
body before and after performing everyday activities and contributed to the study of an 
‘insensible perspiration’ which tried to explain the disappearance of most of the food 
ingested [5].  
Until Louis Pasteur’s revolutionary studies with fermentation in the 19th century, metabolic 
processes were thought to be spontaneous. Pasteur observed that there was specific 
substances inside yeast, which he called “ferments”, that was responsible for fermentation 
[6][7]. However, it was believed that living matter possessed a vital force and was somehow 
different from non-living matter (the vitalist theory) [8]. In 1828, Friedrich Wöhler 
synthesized urea from ammonium cyanate and later in the century, Eduard Buchner was 
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capable of demonstrating the fermentation process using enzymes alone and without any 
live yeast [9]. This revelation opened up the field of biochemistry and fuelled the study of 
metabolic processes; and Buchner was awarded the Nobel prize in 1907 for his work [10]. 
With the development of powerful techniques in biochemistry, molecular biology and 
genetic engineering such as DNA sequencing (Fred Sanger), polymerase chain reaction or 
PCR (Kary Mullis), northern blotting (Alvin, Kemp and Stark), southern blotting (Edwin 
Southern), western blotting (Harry Towbin), X-ray crystallography (Max von Laue), mass 
spectrometry (J.J. Thompson), Nuclear magnetic resonance (NMR) spectrometry (Purcell and 
Bloch), electron microscopy (Ruska and Knoll), Gene knockout and RNA interference or RNAi 
(Fire and Mello) by the 21st century, huge leaps in understanding metabolism were made.  
1.1.2 Types of Metabolic processes 
Through evolution, living beings have developed and optimized their metabolism to survive 
in their respective environments. Resources are procured from the surrounding by various 
means. These nutrients are then used directly or broken into smaller simpler compounds 
which are then used to build new larger biomolecules such as proteins, lipids, DNA, RNA, etc 
which are essential for growth and survival. Metabolism hence can be broadly classified into 
two major processes – anabolism and catabolism 
a) Anabolism 
Anabolism is the set of processes responsible for the synthesis of large biomolecules from 
their smaller precursors [1]. Starch and glycogen synthesis from glucose, lipid synthesis from 
acetyl-CoA, synthesis of proteins from amino acids, DNA and RNA synthesis from its 
precursors are some examples of anabolism. The word anabolism was coined in the late 19th 
century from the Greek word ἀναβολή (anabolē – throwing up) [11]. 
b) Catabolism 
Catabolism on the other hand, refers to the biochemical breakdown of larger biomolecules 
into simpler compounds, which can later be used in anabolic processes or excreted into the 
environment. The release of energy associated with catabolism is very important for the 
growth and survival [1]. Protein degradation to amino acids, lipid breakdown into precursors 
12 
 
and glycolysis that generates energy (ATP) are some examples of catabolism. The word 
catabolism was derived from the Greek word καταβολή (katabolē – throwing down) [12] 
1.1.3 Enzymes and regulation of Metabolism 
Enzymes are large biomolecules responsible for catalyzing chemical reactions in cells. Most 
enzymes are proteins or protein complexes. The metabolic capabilities of a cell are directly 
related to the enzymes it is capable of expressing. 
The first enzyme to be discovered was a diastase, the enzyme responsible for the breakdown 
of starch into maltose. It was discovered by the French chemists Payen and Persoz in 1833 
[13]. Later in the same century, based on his observations, Louis Pasteur called the 
substance in yeast he believed to be responsible for fermentation as ‘ferments’[7]. Pasteur 
however proposed that the ferments would be active only in living cells and so it was not 
until 1877, that the word ‘enzyme’ was coined by Wilhelm Kühne to represent biomolecules 
responsible in catalyzing reactions even outside living cells [14].  
Enzyme functioning is best explained by looking at the thermodynamics of their chemical 
Figure 1 - The effects of enzyme catalysis in an endergonic reaction 
The reaction for which the free energy (G) levels are illustrated in the figure was determined to an endergonic 
reaction owing to the a positive ΔG ( ΔG > 0 ). ΔG
‡
 is the activation energy required to initiate the reaction. 
Involvement of the enzyme reduces the free energy of the transition state and hence reduces ΔG
‡
 to 
ΔG
‡
catalyzed  improving the chances of the reaction taking place. 
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reactions. The endergonic (energy consuming) or exergonic (energy producing) nature of 
chemical reactions is determined by the difference in the Gibbs free energy (ΔG) of its 
products and the substrates. The transition state theory proposed in 1935 suggests the 
formation of a transition state between the reactants and the products [15][16]. The 
transition state is believed to have a Gibbs free energy value higher than that of both the 
reactant and the product. This theory was capable of explaining why exergonic reactions also 
require a little energy to initiate the reaction. Hence in order to initiate a chemical reaction, 
an energy equivalent to difference in the Gibbs free energy of the transition state and the 
reactants (ΔG(transition-state – reactants) or ΔG
‡) would be required. This energy is called activation 
energy. Enzymes control the rate of chemical reactions by reducing the activation energy of 
chemical reactions. This happens with the help of the formation of an enzyme-substrate 
transition complex which requires a much lower activation energy [17]. Figure 1 represents 
the change in free energy of an endergonic reaction in the absence and presence of a 
catalyst. 
As mentioned earlier, most enzymes are proteins or protein complexes. Proteins are 
encoded in the genetic material of organisms as genes. The enzyme-coding DNA or RNA 
gene is transcribed to messenger RNAs (mRNA) through a process called ‘transcription’ with 
the help of the enzyme RNA polymerase. A ribonucleoprotein complex called the ribosome 
then binds to mRNAs and synthesize polypeptide chains through the process called as 
‘translation’. This transfer of information from the genes to proteins is the central dogma of 
molecular biology(Figure 2). The protein then may also go through post-translational 
modifications. Some of these proteins bind with other proteins to form catalytically active 
protein-complexes. Many proteins and protein complexes also require further modification 
Figure 2 – The central dogma of molecular biology 
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called ‘activation’ to form its catalytically active configurations.  
Metabolism of a cell is regulated by direct regulation of enzymes activity or by regulating the 
availability of the enzyme by controlling the steps involved in protein formation. Regulation 
of its metabolism helps the cell to manage resources, deal with environmental stresses and 
allows them to specialize for performing specific functions (as in the case of multicellular 
organisms). Perturbation of enzyme activity has popularly been used by researchers to 
understand their function and relevance. Gene KO studies involve disrupting the genes 
coded in the genetic material making them unavailable for the transcription [18]. RNA 
interference (RNAi) technique is used to control gene expression at the post transcription 
level [19]. However unlike gene KO, RNAi only reduces the expression and does not 
eliminate it completely which makes them quite useful in studying essential genes [20–24]. 
Various approaches such as depleting available substrate levels, modifying protein 
structures, blocking active sites of enzymes, etc are also widely used by researchers to study 
enzyme activity [25, 26]. The metabolic changes between the perturbed and non-perturbed 
(wild type) cells help to understand the role of specific pathways or processes in the 
organism of interest [27, 28].  
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1.2 TRYPANOSOMA BRUCEI 
Trypanosoma brucei is an insect-borne-protozoan parasite responsible for the potentially 
lethal ‘African Trypanosomiasis’, also known as ‘sleeping sickness’ in humans and ‘Nagana’ in 
animals. The Tsetse fly (Glossina) is the vector responsible for the transmission of the T. 
brucei parasite. African Trypanosomiasis has been reported exclusively in 36 countries of 
sub-Saharan Africa which hosts the world’s entire Tsetse fly population [29]. The human T. 
brucei strain has two major subspecies: T. brucei gambiense and T. brucei rhodesiense. They 
are morphologically indistinguishable [30] but the gambiense strain is believed to account 
for 98% of the reported cases [29]. Figure 3 shows an image of T. brucei cells in blood. 
 
1.2.1 History of T. brucei research 
Pre-colonial times 
The Trypanosoma family is supposed to have been around for a very long time and is 
believed to have been associated closely with the hominid evolution. This seems to be why 
humans are resistant to all species of Trypanosoma except the gambiense and rhodesiense 
as these subspecies are believed to have evolved later [31]. Veterinary papyrus of Kahun 
Papyri believed to be from 2nd millennium BC ancient Egypt talks about a cattle disease 
“ushau” during their time. The papyrus describes the symptoms of the disease which were 
similar to the symptoms of present day nagana [31, 32]. These ancient Egyptians are thought 
to have used an ointment from bird fat to prevent insects biting their cattle [31]. Abu 
Abdullah Yaqut, the famous Syrian slave turned geographer, talked about an underground 
village of dying inhabitants in the country of gold, a scene very similar to that of a sleeping 
sickness epidemic. The oldest case report of sleeping sickness is from the 14th century by Ibn 
Khaldoun who reported the death of Sultan Mari Jata of Mali with trypanosomiasis like 
Figure 3 - T. brucei parasites in blood[225] 
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symptoms [31]. Arabian slave traders are also believed to have looked for swollen lymph 
nodes in the back of the neck to identify doomed slaves suffering from sleeping sickness 
before purchasing them according to the English physician, Thomas Winterbottom [33]. 
Colonial times 
During the early days of the modern times, causalities on board slave ships led to an 
increased interest in the sleeping sickness. Doctors were pressed by ship captains and slave-
traders to find the causative agent behind this strange disease [31]. British royal naval 
surgeon John Atkins in 1734 reported the symptoms of late(neurological) stage symptoms of 
sleeping sickness from his observations [33]. Later in 1803, Thomas Winterbottom published 
his report on sleeping sickness in which he reported the characteristic swollen lymph nodes 
in patients suffering from sleeping sickness [33]. One of the associations of nagana with 
tsetse flies was made by the famous Scottish medical missionary and explorer, David 
Livingston who lost his cattle to the disease in the Limpopo and Zambezi river valleys in 1852 
[31][34]. In 1895, the Scottish pathologist and microbiologist David Bruce discovered 
trypanosomes in the blood of nagana affected cattle in Zululand for the first time [35]. In 
1899, Plimmer and Bradford published a paper on the parasites naming it Trypanosoma 
brucei after Bruce. In the same year, Frederick Walter Mott observed foreign mononuclear 
cells in the brain of 2 Congolese patients during post mortem autopsies [36]. Soon later in 
1901 Robert Michael Forde observed “wriggly worms” in the blood of a steam-boat captain 
from the river Gambia [37]. A few months later English physician Joseph Everett Dutton 
identified the parasites as trypanosome and named them T. gambiense in 1902 [31]. The link 
between trypanosomes and sleeping sickness was however not yet established [36]. In 1902, 
the Royal Society of London sent a sleeping sickness commission comprising of Cuthbert 
Christy (a British epidemiologist), George Carmichael Low (a Scottish clinician) and Aldo 
Castellani (an Italian bacteriologist) to the Uganda region [36]. Castellani then found 
trypanosomes in the cerebrospinal fluid of patients and identified them as the causative 
agent of Sleeping sickness for the first time [38]. Castellani thought these trypanosomes 
were different from T. gambiense based on the morphological features and named them T. 
ugandensis [36], although they were found to be the same later. In 1903, Bruce reported 
conclusive proof for the transmission of the parasites via tsetse fly [33, 36]. Bruce is reported 
to have thought the transmission was purely mechanical [31] and it wasn’t until 1909, when 
studies by the German surgeon Friedrich Karl Kleine showed that the transmission involved 
17 
 
life cycle stage transitions. Bruce then was later capable of describing the complete lifecycle 
of T. brucei [39]. The second subspecies of human trypanosomes, T.b.rhodesiense, was 
finally identified in 1910 by John William Watson Stephans & Harold Benjamin Fantham [39]. 
 
1.2.2 Lifecycle of T. brucei 
The T. brucei parasite is capable of growing and multiplying in both the host (mammals) and 
the vector (tsetse fly) (See Figure 4). The insect stage begins as the parasite enters the tsetse 
midgut during blood meal from an infected person. Here the parasites transform into the 
procyclic trypomastigotes. These reproduce by longitudinal binary fission and move to the 
anterior part of the midgut where they transform into long mesocyclic trypomastigotes. The 
mesocyclic trypomastigotes then migrate to the salivary gland of the insect where they 
develop into epimastigotes attached to the salivary gland. These finally develop into the 
metacyclic trypomastigotes awaiting insect bite and transmission into a mammalian host. 
The metacyclic T. brucei parasites are transmitted through insect bite into the mammalian 
host.  
In the blood these parasites develop into the long slender bloodstream forms which then 
reproduces through longitudinal binary fission. Symptoms of the hemolymphatic stage may 
include fever, swollen lymph nodes, severe headache and joint pain. The parasites are then 
Figure 4 – Lifecycle of Trypanosoma brucei[30] 
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distributed through the circulatory system and reach the blood brain barrier. T. brucei is 
capable of crossing the blood brain barrier and infecting the brain and cerebrospinal fluid, 
leading to irreparable damage of the central nervous system (CNS). At this stage (the 
neurological phase), the host suffers from motion and speech disorder and erratic sleep 
pattern (giving the disease the name ‘sleeping sickness’). With the damage to the CNS, the 
host can fall into coma and eventually perish. Some slender trypomastigotes then 
irreversibly change to short stumpy forms in preparation for the insect stage [30]. African 
trypanosomiasis is lethal if left untreated, however cases have been reported where the 
hosts overcome the parasites but acts as a ‘healthy carrier’[40].  
 
1.2.3 Characteristics of T. brucei cell 
 
The T. brucei cell is typically 16-42µm [41] and has all the basic features of a eukaryotic cell. 
It is mononucleated, flagellated, has endoplasmic reticulum (ER), a single Golgi stack and an 
elongated mitochondrion [42]. The nuclear genome of T. brucei consists of 11 pairs of 
megabase chromosomes, intermediate and minichromosomes. Apart from this, being a 
member of the class Kinetoplastida, the parasite has a characteristic organelle in the 
mitochondrion called the kinetoplast that carries the mitochondrial DNA. Together with the 
nuclear genome, the total size of the T. brucei genome is 35 megabases per haploid genome 
[43]. T. brucei also have multiple peroxisome-like organelles that houses enzymes involved in 
important metabolic pathways such as glycolysis and isoprenoid biosynthesis called 
glycosomes [44]. Figure 5 represents a simplified representation of a Trypanosomatid cell. 
Figure 5 - A simplified representation of the Trypanosoma cell[42] 
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Another interesting feature of the T. brucei cell is the presence of a 
Glycophosphatidylinositol (GPI) anchor linked protective coat. In the mammalian host, the 
protective coat is composed of variable surface glycoproteins (VSG) and protects the 
parasites from the host immune system [45]. In the insect stage, the protective coat is 
composed of GPI-anchored proteins called procyclins that protect the parasites from being 
digested by the insect’s enzymes [46]. 
 
1.2.4 Current Drugs and Treatment 
The major task involved in trypanosomiasis treatment is early diagnosis. There have been 
four major drugs registered for trypanosomiasis. Pentamidine and suramin are used to treat 
early stage (hemolymphatic stage) of T.b.gambiense and T.b.rhodesiense infections 
respectively. Melarsopol and eflornithine are the drugs used to treat the second 
(neurological) stage of Human African Trypanosomiasis (HAT) with eflornithine being 
effective only against T.b.gambiense [29]. Although these are life saving drugs provided free 
of cost to the affected countries [47], they cause adverse side effects in patients with some 
of them even being fatal. Particularly in the second stage treatment, the drug action involves 
crossing the blood-brain barrier and killing the parasite which can sometimes lead to 
reactive encephalopathy. This lack of an efficient treatment regime is the key driving factor 
in African trypanosomiasis research. Recently Nifurtimox-Eflornithine combination therapy 
(NECT) has been found to more successful in patients in the neurological phase of the 
infection [48][49] and is now the recommended therapy by World Health Organization 
(WHO). However even this treatment report multiple adverse side-effects. In the 1735 
patients from 9 countries under NECT treatment, monitored in 2010-11, at least one adverse 
event was reported in 60.1% of the patients and a total of 3060 adverse events were 
reported. 9 deaths were also reported in the study with cause of death owing to reactive 
encephalopathy [48]. There is hence still a need for a more efficient treatment regime 
against African Trypanosomiasis. 
Eflornithine is the only anti-Trypanosomiasis drug approved for use for which the mode of 
action has been conclusively determined. It depletes the amount of catalytically active 
ornithine decarboxylase in T. brucei cells which hampers Trypanothione biosynthesis and 
makes the cell susceptible to oxidative stress [50]. It is also the most efficient of anti-
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Trypanosomiasis drugs. There is hence a clear advantage in using drugs targeting specific 
metabolic processes. And so the study the parasite metabolism to identify essential 
metabolic processes and the use of target based drug screening/designing approaches could 
lead to the discovery of other more efficient drugs against Trypanosomiasis. 
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1.3 SYSTEMS BIOLOGY 
1.3.1 Introduction to systems biology 
Traditional research in biology drew its roots from physics and chemistry. And hence it also 
inherited the reductionist mechanistic approach of study which was made popular by René 
Descartes, Isaac Newton and other great minds of their time. Based on this approach, all 
components of a cell could be studied individually and the behaviour of the cell can be 
predicted by combining the results of the individual studies. An example of the successful 
interpretation of this theory for higher plants was made by Jacques Loeb from his 
observations on the responses of seedlings to light and gravity which was published in 1912. 
Aristotle, the Greek physician is believed to have stated that “the whole is something over 
and above its parts and not just the sum of them all” [51]. With the popularity of the 
reductionist mechanistic approach in physics in the 17th century, Aristotlean views were 
shelved [52]. It wasn’t until Paul Weiss’s study on the effects of light and gravity on insect 
behaviour that conclusive experimental proof against the mechanistic theory was found 
[53]. He observed that although the final phenotypic response to the stimuli was identical 
among individuals, the series of responses that led to the final phenotype was different 
among them. This brought back the ‘whole is greater than the sum of the parts’ concept 
proposed by Aristotle. The renewed interest also led to the coining of the term ‘holism’ by 
Jan Smuts [54] and the popularity of Systems Biology, the holistic approach of studying 
complex biological systems. 
Kirschner in 2005 stated that the formulation of a definition for Systems Biology is a difficult 
task. As a start, he suggested that Systems Biology is the study of the behaviour of complex 
biological organization and processes in terms of the molecular constituents [55]. The 
organism level study of biological systems involves the integration of multiple wet-lab (cell 
biology, biochemistry, etc) and dry-lab (mathematical modelling, bioinformatics, etc) 
approaches. With the development of the next-generation sequencing and ‘omics’ 
technologies in the 21st century, a massive amount of genomic, proteomic and metabolic 
information was made available to researchers. The effective combination of this mountain 
of information essentially requires a mathematical model in the form of a network of 
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metabolites, proteins and the genes-catalyzing-them. The type of modelling used depends 
on the type of the data available and the aim of the study. For example, metabolic models 
help study cellular metabolism and regulatory networks help study regulation in cells. Large 
networks such as genome-scale networks are impossible to analyze by hand. However, with 
the advancement in computational approaches in mathematical modelling, it is now possible 
to study and understand these biological networks. 
1.3.2 Types of Modelling in Systems Biology 
Since the rise of Systems Biology, multiple mathematical approaches have been developed 
to study life (Figure 6). Based on the data modelled, available biological information, the 
complexity of the data and the objective of the study; modelling approaches can be 
classified as following: 
a) Network topology studies 
Network topology approach in studying biological systems is the most basic of modelling 
Figure 6 - Basic types of modelling in Systems Biology 
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studies in systems biology. This approach is most useful in the case of extremely large 
network lacking detailed information. The model is studied as a network of nodes 
representing metabolites or reactions or both connected by edges. The edges of a network 
can be directed or undirected depending on the type of biological data. Protein-protein 
interaction networks usually have undirected edges while metabolic networks have directed 
edges. Analyses such as network robustness, centrality studies, modularity studies, network 
motif analysis, identification of network hubs, etc help gain important insights into the 
organization of system elements such as identifying vulnerabilities, important pathways and 
regulators [56]. The network topology approach however does not take into consideration 
the time and physiological context of the biological systems [57]. Network topology 
approach has been applied in the study of transcription factor binding networks [58], 
protein-protein interaction networks [59], protein-phosphorylation networks [60], metabolic 
interaction networks [61][62], genetic and small molecule interaction networks [63] and co-
expression networks [64]. 
b) Boolean modelling 
A Boolean network is a set of nodes capable of only binary values (1 or 0, ON or OFF) related 
by logical functions. These functions involve a combination of AND, OR and NOT operations 
on the values of other nodes [65]. The set of the Boolean values of nodes in the model is 
considered as the state of the model [66]. Boolean networks add a dynamic level to the basic 
network. The set of logical functions determining the transition of the model can be used to 
predict the next state of the model. A Boolean network of n nodes has a solution space of 2n 
network states [66]. Boolean modelling simulations can lead to prediction of steady states in 
the solution space (also known as attractors) and the set of initial states capable of achieving 
the steady states (also known as the basin of attraction) [66]. Boolean modelling approach 
has proven very useful in the study of regulatory [67] and signalling networks [68].  
c) Constraint-based modelling 
The constrained-based modelling approach in systems biology involves defining a model as a 
set of linear equations with constraints to restrict the solution space. In the case of 
metabolic networks, the reactions are converted to linear equations with the metabolites as 
coefficients and reactions becoming variables. Constraints on the reactions are set based on 
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the law of conservation of mass, reactions thermodynamics and available experimental data 
[69]. Unlike kinetic modelling, the constrain-based approach does not require information 
from enzyme kinetics studies or initial metabolite concentrations, making them the go-to 
choice for large metabolic networks such as genome-scale metabolic models [61, 70–73]. 
The flow of metabolites in the model is represented by a “flux” through the reactions. This 
metabolic flux is represented as number of metabolites per gram dry weight per unit time 
(mmol/gDW/hr). Multiple algorithms have been developed to study constraint-based 
models, the most popular being the flux balance analysis [74]. 
d) Kinetic modelling 
Kinetic modelling involves representing the biological system as a set ordinary differential 
equations (ODEs) or partial differential equations (PDEs) and solving them in order to predict 
the state of the system after a given period of time [75, 76]. Kinetic modelling uses 
additional information on the system elements such as metabolite concentrations, reaction 
rates and compartment size to perform dynamic simulations. Determining reaction rates 
require detailed reaction kinetics studies of the reactions involved in the model [77]. 
Reaction rate equations use information from reaction kinetics to calculate the change in 
concentration of the metabolites as a function of time. Kinetic models can be simulated 
using either deterministic or stochastic algorithms. Limitation to kinetic modelling include 
the difficulty in determining the kinetics of reaction involved and computationally expensive 
algorithms especially in the case of stochastic simulations greatly limiting the size of the 
model [75]. 
e) Hybrid modelling approach 
All approaches in modelling of biological systems have their own positive and negative 
aspects. Furthermore, different approaches are used to study the different levels of cellular 
mechanism such as Boolean modelling for regulatory networks and kinetic modelling for 
metabolic networks. Studying these processes separately leads to the loss of certain 
influence on their results [78]. Owing to these reasons, recently there have been efforts to 
combine the various approaches in order to reduce limitations and improve application. 
Hybrid modelling has been used to study the E. coli central metabolism [79], mucus 
production in Pseudomonas aeruginosa [80], integrating signalling with transcription 
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regulation and metabolism [81], etc. With the development of efficient algorithms, 
improving reliability of results and overall ability to model different levels of the cellular 
machinery, the hybrid modelling approach seems to be the future direction of 
computational systems biology. 
 
As mentioned earlier, the choice of modelling approach used in a study depends on the 
objective of the study and the data available. This research project aims is to analyze the 
cellular metabolism of T. brucei. And so given that the annotated genome of T. brucei was 
published in 2008 [82] and biochemical databases such as KEGG [83] has been successful in 
gathering information and making it available to the scientific community, the constraint-
based modelling approach was selected for use in this project. And so detailed description of 
this technique and the algorithms used to study these models are discussed in the next 
chapter. 
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1.4 CONSTRAINT-BASED MODELLING AND GENOME-SCALE 
METABOLIC RECONSTRUCTION 
 
Note to the reader 
This section shares much of its content with the chapter, “Understanding Protozoan 
Parasite Metabolism and Identifying Drug Targets through Constraint-based Modelling” 
authored by Francis Isidore Totanes, Sanu Shameer, David R. Westhead, Fabien Jourdan and 
Glenn A. McConkey (see APPENDIX 1 for the abstract and complete text). The chapter was 
accepted as part of the book titled “Analysis of parasite biology – from metabolism to drug 
discovery”. The book is edited by S. Müller, R. Cerdan and O. Radulescu and will be volume 7 
of the Wiley Book Series, Drug Discovery in Infectious Diseases. 
 
1.4.1 Genome-scale metabolic models 
A genome-scale metabolic reconstruction or model is a representation of a cell as a network 
of all the metabolic reactions that have been identified to occur within the given cell. 
Organism-level systems biology involves the use of large datasets from high-throughput 
measurements, reconstruction of cellular systems, mathematical modelling and in silico 
simulations [84]. The main objective of this approach is to provide an understanding of the 
workings of complex biological systems and to attain this development of mathematical 
models is required. These models attempt to closely replicate wet lab experiments with the 
goal of computationally generating hypotheses at the organism level (also called genome 
scale) that can be experimentally validated [85]. Genome sequencing data, knowledge on 
gene-protein-reaction (GPR) relationships, and biochemical and enzymatic data on the 
metabolism of an organism are combined to create a genome-scale model. Computation 
based on these models allows the calculation of possible phenotypic states of the model 
organism [74]. Genome-scale models can also be used to predict the function of previously 
uncharacterised genes and rectify incorrectly annotated genes. Gene deletions, gene over- 
or under-expression strategies are applied to genome-scale models to predict genes and 
pathways that may be altered for bioengineering the production of therapeutically- or 
industrially-important compounds [86]. These models can also be used to predict genes and 
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enzymes that are essential for the survival of an organism. These predicted essential genes 
and enzymes may be potential drug targets and therefore important in drug discovery and 
development [87]. 
Genome sequence and gene annotation data are used to identify specific roles of individual 
proteins within the system. A metabolic network (i.e. a network of metabolites 
interconnected via reactions involving the said metabolites) is developed utilising published 
data on elucidated protein function and cellular location, enzyme thermodynamics and 
reaction stoichiometry. Data from closely related organisms, e.g. orthologous gene data, are 
sometimes used in the absence of reported information on the organism of interest [88]. 
Reactions and corresponding metabolites are tabulated into a matrix that accounts for the 
number of metabolites consumed and produced within the given reactions. Additional 
constraints on the fluxes through the reactions (often expressed in metabolite amount per 
dry weight of the parasite per hour) with upper and lower boundaries are incorporated to 
control the flux values and represent the reversibility of reactions [89]. 
1.4.2 Constraint-based Modelling  
Constraint-based modelling is an important in silico approach which takes into account the 
different biochemical processes (i.e. reactions) and the flow of metabolites (i.e. species) in 
order to closely represent the metabolic network of an organism without the necessity for 
individual enzyme kinetics. It models the possible steady-states of the metabolic network (a 
state at which the metabolite concentrations do not change over time) because of which 
enzyme kinetic parameters (e.g. Michaelis constant KM) that would need to be derived from 
recombinant expression and biochemical assays for all enzymes are not required. This is an 
important advantage for genome-scale modelling since these parameters are seldom known 
for every enzyme encoded in a genome. Moreover, these enzyme parameters are strongly 
dependent on environmental conditions (pH for instance). Even with the steady state 
assumption, too many fluxes will need to be computationally predicted. In order to focus on 
more relevant flux distributions, specific constraints, often based on experimental data, are 
entered into the system to represent limits of enzymatic fluxes as well as available 
metabolites. The steady state assumption allows the use of linear programming (i.e. a 
mathematical technique that computes the optimal output of a model whose constraints are 
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given by a set of linear equations) to solve for the maximum or minimum flux values [74] . 
Finally, the growth of the organism is predicted based on the production of essential 
components required for biomass production [90]. 
Constraint-based modelling has been used to predict the cellular response of an organism in 
different conditions. This allows a more in-depth comprehension of the complex metabolic 
networks in organisms [91]. As a result, functional annotations for hypothetical proteins and 
correction of erroneous annotations are possible [89]. By restricting the amount of specific 
metabolites, changes in the production of biomass components in constraint-based models 
can be used to predict the growth rate of the organism [92]. Single gene knockout 
simulations in constraint-based modelling have been used to pinpoint possible drug targets 
against pathogenic organisms [89]. Constraint-based modelling of cellular networks have 
been utilised in order to identify drug targets in cancer cells [93]. This technique can also be 
utilised in the development of bacterial strains used for the production of metabolites of 
nutritional or pharmaceutical interests. Gene knockouts that will redirect the consumption 
of precursor metabolites to allow the overproduction of metabolites of interest can be 
identified using flux balance analysis [94].  
1.4.3 Steps in genome-scale metabolic reconstruction 
Genome-scale metabolic reconstruction involves two stages – an automated reconstruction 
and a manual curation stage. Figure 7 describes a simplified protocol for genome-scale 
reconstruction 
a) Automated Genome-scale Metabolic Network Reconstruction 
As mentioned earlier, a genome-scale metabolic reconstruction is a representation of a cell 
as a network of all the metabolic reactions that have been identified to occur within the 
given cell. As it is time consuming to manually add every single reaction one after the other, 
many automated tools [95–97] and algorithms have been developed to help generate a draft 
which can then be manually curated to better describe the cellular network.  
Automated genome-scale draft reconstruction tools use an annotated genome of the 
organism of interest to mine biochemical databases (or reactions pools) in order to identify a 
set of reactions associated with the enzymes encoded in the genome. Some of these tools 
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also predict the cellular localization of the enzymes in order to develop multicompartment 
models. This subset of chemical reactions along with their gene-protein-reaction relationship 
forms the draft of the metabolic reconstruction [98]. Some automated genome-scale 
metabolic reconstruction tools such as the SEED server is even capable of annotating the 
genome of interest and have proved to be quite efficient with prokaryotic reconstructions 
[99]. All automated draft reconstruction tools have their own reaction pools from which 
reactions are selected for the draft. PathoLogic, the automated draft reconstruction tool 
employed in Pathway Tools, for instance uses the MetaCyc database as its pool [96]. The 
AUTOGRAPH pipeline is well known for implementing the use of a user-defined manually 
curated metabolic model as the reaction pool for generating the initial draft [97]. More 
details on these tools will be discussed further later on in this write-up. 
Most draft reconstruction tools and servers use non-organism specific reaction pools to 
enable their application on diverse species. These drafts are hence prone to false positive 
Figure 7 - A simplified representation of the steps involved in genome-scale metabolic 
reconstruction, model validation and model prediction 
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and false negative hits that results in the draft containing reactions known to be absent in 
the organism of interest and not containing reactions which are known to be present in the 
organism of interest respectively. Organism specific reactions which are absent in the 
reaction pool are also missed in these automated reconstructions. Many automated 
genome-scale reconstructions also fail to identify and incorporate transport reactions into 
the model. Manual curation is hence necessary to fix these issues and create a more realistic 
representation of the genome-scale metabolism of interest [100].   
b) Manual Refinement of Genome-scale Model 
The manual curation step in genome-scale reconstruction involves modifying the model 
draft so that it better represents the organism in real life. It involves adding reactions 
missing in the draft and removing reactions known not to exist in the organism of interest. 
The manual curation stage involves re-evaluation and refinement based on literature and 
experimental observations. The manual curation stage is in essence a never ending process. 
It is usually coupled with simulation and validation of the model with experimental data in 
order to identify how well the model is able to represent the actual metabolism. Another 
important part of manual curation is the addition of metadata to the model such as InChI 
and SMILES identifiers to the metabolites, and Enzyme Commission (EC) number, pathway 
and enzyme localization information to the reactions. With the recent increase in genome-
scale metabolic reconstructions, detailed protocols for manual curation have been published 
[100].  
c) Standardization and Model Formats 
In 2005, Le Novère et al. reported that "most of the published quantitative models in biology 
are lost for the community because they are either not made available or they are 
insufficiently characterized to allow them to be reused” [101]. With the increasing 
importance of metabolic models in research, standard formats were established to improve 
exchange and reusability. Currently metabolic models are accepted in the scientific 
community in the form of standardized machine readable formats such as Systems Biology 
Markup Language (SBML) [102], CellML [103], BioPax [104], etc. Additionally specific 
standards were developed to encode graphics notations (SBGN) [105] and simulation 
descriptions (SedML) [106].  
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One of the major issues that affect the understanding and reusability of existing metabolic 
models is the lack of a single identifier system for metabolites and reactions. This leads 
modellers to generate their own identifiers or borrow identifiers from popular biochemical 
databases such as Kyoto Encyclopedia of Genes and Genomes (KEGG) [83], Biochemical 
Genetic and Genomic (BiGG) [107] and BioCyc [108]. Since genome-scale reconstructions 
tend to have thousands of reactions and metabolites, the use of different ID systems makes 
the comparison of models or mapping experimental data difficult and time consuming. As a 
result, the scientific community stresses on the inclusion of metadata along with the model 
elements in the form of annotations. Some modellers also provide additional information on 
model components in the form of InChI, SMILES, EC numbers, etc. The Minimum Information 
Required In the Annotation of Models (MIRIAM) guidelines published in 2005 [101] describe 
an efficient solution to this problem. According to the MIRIAM guidelines the model should 
clearly provide a description of all model elements, relate to a publication, list its authors 
and contact information along with the simulation conditions. In the case of model elements 
annotations, the MIRIAM guidelines advice authors to link those to external databases using 
an annotation triplet: "data-type", "identifier" and "qualifier". Here the "data-type" refers to 
the general part of the link to a database resource and the "identifier" refers to the specific 
ID in the particular database. The "qualifier" is a term (selected from a predefined 
namespace) used to represent the relationship to the resource. According to the BioModels 
database [109] there are two types of qualifiers, a) model qualifier that represents the 
relationship between a modelling object and its annotation and b) biological qualifier that 
represents the relationship between a biological object represented by a model element and 
its annotation [110]. The implementation of the MIRIAM guidelines can thus improve the 
reusability of metabolic models. However, since different modellers can use references to 
different database resources, comparison of different models implementing different 
identifier systems is still not straightforward. The InChI system [111] developed by 
International Union of Pure and Applied Chemistry (IUPAC) provides a unique identifier for a 
chemical entity (i.e. metabolite) and hence this can be used to determine identical 
metabolites and reactions between two different models. With the implementation of these 
standardizations, metabolic models developed can be easily read, understood, integrated 
with experimental data and even combined to generate larger metabolic models. 
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1.4.4 Examples of genome-scale reconstruction in other 
Trypanosomatids 
a) Leishmania major  
Chavali et al. [89] developed a reconstruction of the Leishmania major metabolic network 
utilising published literature and gene/enzyme databases. The network takes into account a 
total of 560 genes, 1,112 reactions and 1,101 metabolites. Stoichiometric equations of 
metabolic reactions were atom- and charge-balanced, and thermodynamic properties of 
these equations were also considered. Biomass production was assigned as the overall 
objective of the metabolic network. Biomass components include amino acids, fatty acids 
and DNA. The estimated amount of amino acid per gram of dry weight was computed based 
on the open reading frames in the genome of the organism, while the DNA component was 
computed by taking into account the G-C content of L. major DNA. Fatty acid components 
were based on previously published literature. For the computation of fluxes, subcellular 
locations of the different reactions were also considered. Linear programming optimization 
was used to compute the flux distribution for the entire network at maximum biomass 
production.  
To identify essential genes, single and double gene deletions were simulated by forcing zero 
flux through reaction/s associated with particular gene/s. The effect of the deletion on the 
growth of the organism was then categorised as lethal (0% growth), growth-reducing 
(between 0 and 90% growth) and no effect (greater than 90% growth). Lethal double gene 
deletions were further classified as either trivial or non-trivial. A total of 69 lethal single gene 
deletions were identified, while 19,285 and 56 trivial and non-trivial double gene deletions 
were identified, respectively [89]. Furthermore, using the sequences of the enzymes 
involved in the predicted set of essential reactions, inhibitors (e.g. antipsychotics and 
antibiotics) were identified from existing drug databases and were tested experimentally for 
target validation [112].  
b) Trypanosoma cruzi 
The iSR215 is a metabolic network reconstruction of Trypanosoma cruzi strain CL 
Brenner core metabolism developed by Roberts et al. [113]. In this study, two models were 
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created for T. cruzi. The full model was based on direct genetic and biochemical data 
involving T. cruzi as well as data on other related species obtained from published literature. 
It takes into account 215 genes and 162 reactions in four subcellular compartments. Another 
model simulated the metabolic network of the epimastigote form of the parasite. Proteomic 
data from epimastigote cultures was obtained to identify specific proteins that are present in 
this stage of the parasite. Proteins absent in the epimastigote are removed from the full 
model by forcing a null flux into the involved reactions. Redirections of metabolic fluxes 
through certain pathways in the epimastigote model was observed as a result of the absence 
of trypomastigote and amastigote stage-specific reactions. The model was validated by 
comparing the predicted metabolic by-products in aerobic and anaerobic conditions with 
data presented in published literature. By-products observed in the model were found to be 
mostly consistent with data reported in literature. 
Single reaction knockouts were predicted for each reaction in the full and the 
epimastigote models. A greater number of lethal reaction knockouts (40 reactions) were 
observed in the epimastigote model compared with that of the full model (26 reactions). 
This has been associated with the limitations imposed by the redirection of pathways in the 
absence of a number of reactions in the epimastigote model. Double reaction knockouts 
were also simulated in both models. Similarly, the epimastigote model yielded greater 
number of trivial and non-trivial deletions, 2,880 and 183, respectively, as compared with 
the full model (1,872 and 96, respectively). The predicted essential reactions were then 
compared with published experimental data species related to T. cruzi to further validate the 
results of the metabolic model. Forty-six out of the 58 published gene targets available were 
consistent with the results of the metabolic network. All non-lethal reactions in published 
literature were consistent with the results of the network [113].  
 
1.4.5 Methods to analyze constraint based models 
With the recent rise in popularity of constraint-based models, a huge number of approaches 
and algorithms have been developed to answer various biological question using constraint 
based models. Lewis et al managed to cluster the different approaches into approaches for 
integrating ‘omics’ data, integrating regulatory mechanisms, thermodynamic parameter 
based optimization, loop removal, objective function development, gap-filling, reaction 
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perturbation design, reaction addition design, gene-deletion design, flux balance analysis 
(FBA) based approaches and objective function independent analyses [114]. Figure 8 displays 
a more detailed view of this classification. FBA-based approaches are the most popularly 
used approaches to study metabolism. Here we will discuss the FBA algorithm and some of it 
widely used extensions. 
a)  Flux balance analysis of genome-scale metabolic models 
Flux balance analysis is a mathematical approach to study the flow of metabolites in a 
constraint-based model when assuming the model to be at steady state (i.e. the 
concentration of metabolites in the model is constant). The first step to flux balance analysis 
is the creation of a mathematical representation of the metabolic reactions in a given 
metabolic network. Reactions and corresponding metabolites involved in specific reactions 
are tabulated into a matrix (i.e. Stoichiometric matrix, or S-matrix) that accounts for the 
number of metabolites consumed and produced within the given reactions. Columns of the 
Figure 8 – the phylogeny of constraint-based modelling approaches [114] 
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matrix represent the reactions while rows represent the metabolites. The number of 
metabolites produced or consumed in a given reaction is represented in the matrix as a 
positive or negative number, respectively. The stoichiometry of metabolites in each reaction 
provides a constraint onto the resulting network.  
Consider a network of m metabolites and n reactions for which the S-matrix, a sparse matrix 
of size ‘m × n’ is S. If v is a vector of fluxes f1,f2,…,fn for the n reaction i.e.    
  
  
 
  
  then when 
assuming steady state S.v = 0 
In addition to the stoichiometry based constraints, each reaction is assigned a flux boundary 
(i.e., upper and lower bounds) which represent the permissible fluxes for the said reaction. 
These constraints therefore define the allowable rates at which metabolites are produced or 
consumed within the system [74]. 
If fi is the flux through reaction i in the network, then fiMIN ≤ fi ≤ fiMAX where fiMIN and fiMAX 
is the lower and upper bounds of flux through the reaction i respectively. 
Following the creation of the S-matrix and the assignment of flux boundaries for the 
reactions, an objective function is selected based on the study. A reaction representing the 
said function (e.g., production of biomass components from precursors [90]) is included into 
the matrix. Biomass reactions, for example, are either based on experimentally obtained 
data [71][74] or from data obtained from closely related organisms [89, 115].  
Consider the metabolic model described in Figure 9 comprising of metabolites A-F and 
Figure 9 - An illustration of sample 
metabolic model 
A, B, C, D and E are metabolites of the sample 
metabolic network. R1, R3 and R4 are 
reactions in the sample metabolic network. B 
is the metabolite contributing to the biomass 
of the sample model through the reaction R2. 
f1, f2, f3 and f4 are the fluxes through R1, R2, 
R3 and R4 respectively 
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reactions R1-R4 carrying a flux of f1-f4. Such that  
R1: A  B + C 
R2: 2B   
R3: C  D 
R4: B  E 
 And R2, the consumption of 2 molecules of B, is considered as the objective function of the 
model. 
If A,D and E are boundary metabolites (i.e their concentration in the environment is so large 
compared to the other metabolites in the system that very negligible change in 
concentration is observed), they are excluded from the S- matrix 
Then the S-matrix for the model,   
      
     
  ;         f           
  
  
  
  
  and  
the objective coefficient vector, C =  
 
 
 
 
  
Since the model is assumed to be at steady state, S.v = 0 
i.e.            
      
     
  
  
  
  
  
      
Using these stoichiometric constraints, we have the following system of linear equations 
representing the model 
f1 –f2-f4 = 0, 
f1-f3=0 
=>                     f2 = f1 - f4, 
f1 = f3 
Next based on the flux constraints we have 
Figure 10 – The solution space of the sample 
metabolic model 
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f1MIN ≤ f  ≤ f MAX 
f2MIN ≤ f  ≤ f MAX 
f3MIN ≤ f3 ≤ f3MAX 
f4MIN ≤ f4 ≤ f4MAX 
Using these equations the solution space of the model can be defined as shown in figure 10. 
Linear optimization 
Any point inside the solution space defined by the constraints is a solution for the model i.e. 
even with the defined solution space, one can have a very large number of solutions. The 
most common analysis of the FBA solution space is the linear optimization analysis based on 
the objective function of the model. The set of linear equations representing the model, 
generated from the S-matrix, and the objective function are used to build a linear 
programming problem which is then solved for maximum or minimum value of the objective 
function. The Simplex method developed by the American mathematician George Bernard 
Danztig is perfect for the analysis. This method explores the vertices of solution space until it 
finds the maximum/minimum value of the objective function. 
To illustrate this method, consider a simple maximization problem for the objective function, 
Z = 2X1 + 3X2 
0 ≤ X1 ≤ 5 
0 ≤ X2 ≤ 6 
Find max(Z). 
The solution space and the basic idea of how the Simplex algorithm works is shown in Figure 
11. The algorithm begins by selecting an initial starting point and then exploring the edge of 
the solution space until the objective function is maximized.  
The initial starting point at the beginning of the algorithm plays a role in how many steps are 
required to reach the optimum objective value. Moreover the algorithm can use multiple 
paths to explore the solution space and different paths may very well end up at different 
optimal solutions. This simplex algorithm can also get stuck at a local maxima and miss the 
global maxima of the objective function in the solution space. Various approaches such as 
multi-start analysis (which consists of the search of the optimal solution while starting at 
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different initial points) have been used to reduce the probability of missing the global 
maxima. Given the limitations of LP optimization being an NP-hard problem [116], the 
results from the simplex algorithm are more than satisfactory.  
Focusing back to the example metabolic model discussed earlier in Figure 9, LP optimization 
can be used to find the solution with the maximum value of the objective function in the 
solution space. The objective function ,  
                                                                     Z = CT.v      
where CT is transpose matrix of the objective coefficients and v is the vector of fluxes 
 
(a) (b) 
(c) (d) 
Figure 11 – Steps involved  in using the simplex method in LP optimization  
For LP problem  Z = 2X1 + 3X2 where  0 ≤ X1 ≤ 5 and 0 ≤ X2 ≤ 6 ; To find max(Z)  
(a) Calculate the solution space 
(b) Select an initial point in the solution space (Z = 0) 
(c) Move along the edge of the solution space to the next vertex so that the value of Z is maximum. 
Moving along the Y-axis, the value of Z at the next vertex will be 10 while moving along the X-axis, the 
value of Z at the next vertex will be 18 and so since both Z is greater than 0 and Z along X-axis is 
greater than Y-axis. We move along X-axis (Z =18) 
(d) Similarly move along the edge of the solution space to the next vertex where Z =28 (as 28 > 18). The 
algorithm stops here as at the next vertex is Z = 10 and 10 ≯ 28 
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Z =        
 
 
 
 
 
  
  
  
  
   
 
 
 
 
 = f2 
Hence max(Z) = max(f2) and so the points in the solution space with the highest value of f2 
would be optimal solution for the model. Figure 12 shows the LP optimized solution of the 
example metabolic model discussed in the previous section. 
LP optimization in FBA hence can be used to predict the state of the metabolism favoured by 
the organism and can help simulate living organisms. Metabolism supporting maximal 
biomass accumulation [89], maximal or minimal secretion of relevant by-products [117], 
maximization of ATP production [118] has been widely studied using FBA LP optimization.  
Flux Variability Analysis 
Flux variability analysis calculates for every reaction, the maximal and minimal flux values 
possible when biomass is optimized. FVA algorithms function by first optimizing the 
metabolic model to calculate the maximum flux through the objective reaction. This flux or a 
percentage of it is then set as the lower bound value of the flux through the objective 
function reaction and maximization-minimization optimizations are performed to calculate 
the maximum and minimum flux possible through each and every reaction in the model. Flux 
variability analysis helps determine the flexibility of all the reactions at this optimized 
configuration of the model. Some reactions may be 100 percent flexible with the maximum 
and minimum flux values corresponding to the upper and lower bound constraints while 
Figure 12 – The optimal solution of FBA analysis for the sample metabolic model 
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other might be completely rigid with only a single value of the flux being possible when the 
objective is optimized(or nearly optimized). FVA analysis also help identify reactions through 
which no flux is possible, revealing blocked regions of the metabolic network. Identification 
of blocked reactions is very useful during the gap-filling and curation stages of genome-scale 
metabolic reconstruction. The FVA analysis is a simple yet extremely useful technique [116]. 
The cost of FVA computation rises with the size of the metabolic network. With the rise in 
popularity of very large networks; new, faster and more efficient algorithms have been 
developed [119]. 
Single and multiple deletion studies 
Gene and reaction deletion studies are popular techniques used to assess the susceptibility 
of metabolic networks to perturbations in itself and the environment. Single gene deletion 
involves forcing a zero flux through all reactions in which the gene of interest is critical. The 
effects of this perturbation are then studied. Gene deletion studies can be used to identify 
genes essential for the model. In gene pair deletion studies, each gene pair is simultaneously 
“knocked-out” and its effects on the model is observed. This study helps in the prediction of 
double KO mutant behaviours. 
Single reaction deletion study involves forcing a zero flux through a reaction and analyzing its 
effect on the rest of the network. This study helps in the identification of critical reaction and 
essential nutrients. Similar to double gene deletion studies, double reaction studies are 
performed to identify pair of reactions which when knocked out has significant 
repercussions.  
Phenotypic phase plane analysis 
Phenotypic phase plane (PhPP) analysis is a technique used to study the behaviour of the 
model when two metabolic fluxes are varied. It is very frequently used to study nutrient 
uptake rates and their effects on the objective function. The analysis involves the use of 
metabolite “shadow prices” which are calculated when solving linear equations during LP 
optimization. Shadow price (γ) for metabolite refers to the sensitivity of the objective 
function to the availability of the metabolite[120]. Regions with the identical shadow prices 
for the metabolites associated with the two reactions are identified in a 2D plot of their 
fluxes. These regions are called demarcate regions (see Figure 13). The demarcate region in 
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the PhPP associated with the value of flux producing metabolites of interest that does not 
support steady state is called “infeasible region” of the PhPP (see Figure 13). 
The ratio of the two shadow prices is used to calculate the relative sensitivity of the 
objective function to the two metabolites. If γA and γB are the shadow prices of A and B 
when their production rates (or uptake rates in the case of nutrient uptake) are represented 
along the x and y axis in the PhPP plot respectively, this ratio can be represented as γA/ γB. A 
γA/ γB > 0 suggests that the objective function is dependent on the availability of both 
metabolite A and B. These demarcate region are called regions with dual substrate limitation 
(see Figure 10). However, a γA/ γB < 0 suggests that although the objective function is still 
dependent on the availability of both metabolite A and B, one of them is deterrent to the 
objective function (see Figure 10). These demarcate regions are called “futile regions”. |γA/ 
γB|> 1 suggests that the objective function is more sensitive to available metabolite A than 
metabolite B, |γA/ γB|< 1 suggests that the objective function is more sensitive to available 
metabolite B than metabolite A, |γA/ γB|= 0 suggests that the objective function is 
independent to availability of metabolite A and |γA/ γB|= ∞ suggests that the objective 
function is independent to availability of metabolite B. Isoclines or lines represented by Y’ = 
(γA/ γB )X’ + c (where c can be any real number) are used to represent this information on the 
PhPP plot (see Figure 13). 
Figure 13– an example of for a phenotypic phase plane result 
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Another important result of the PhPP analysis is the line of optimality. The line of optimality 
is defined as “the line representing the optimal relation between the two metabolic fluxes 
corresponding to the axis of the PhPP” [121]. This line can be calculated by setting a fixed 
value for the flux producing one of the two metabolites and then using LP optimization of 
the objective as a function of the flux producing the other metabolite in the PhPP which can 
be then used to find the line of optimality (see Figure 13).  
b) Other Analytical approaches for genome-scale metabolic models 
As mentioned earlier many more approaches have been used to analyze constraint-based 
models. 146 analyses have been deployed in the COBRA toolbox alone by 2012 [114]. 
Regulatory FBA (rFBA) uses Boolean constraints on reaction fluxes to integrate constraint 
based models (CBMs) with metabolic regulation [122]. Dynamic FBA (DFBA) uses non-linear 
programming or a series of linear programming to perform dynamic simulation of CBMs 
[123]. Flux coupling analysis can be used to predict the dependency of fluxes with each other 
in CBMs [124]. Minimal reaction set algorithm uses Mixed Integer Linear Programming 
(MILP) to identify minimal sets of reactions capable of supporting a defined value of biomass 
flux in CBMs [125]. Gene nutrient interaction analyzes the dependence of the essentiality of 
genes with the availability of various nutrients in the medium [126]. Techniques such as 
integrative Metabolic Analysis Tool (iMAT) [127] and Gene Inactivity Moderated by 
Metabolism and Expression (GIMME) [128] helps generate context specific metabolic models 
from genome-scale metabolic models using data from gene expression studies. GIM3E or 
Gene Inactivation Moderated by Metabolism, Metabolomics and Expression is an extension 
of the GIMME method that is capable of also using metabolomics data along with expression 
data to generate context based models. The modelling community is very much actively 
involved in developing new methods and optimizing existing techniques to analyze different 
aspects of CBMs. The application of these tools to various CBMs has improved greatly owing 
to increased popularity of genome-scale metabolic reconstruction and the systems biology 
approach to studying metabolism.  
1.4.6 Applications of genome-scale metabolic models in 
identifying potential drug targets 
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Potential drug targets in pathogens should meet several important criteria. Primarily, the 
target protein or enzyme must be necessary for the survival of the pathogenic organism. In 
relation to the metabolic network, the protein is often involved in pathways ultimately 
leading to the production of biomass components. Enzymes involved in carbon, lipid, 
nucleotide or protein metabolism are potential targets [89]. Moreover, the druggability of a 
protein target, which is defined as the likelihood of altering the function of the target upon 
exposure to a given compound, is assessed through a number of ways. An important 
characteristic of a druggable target is the presence of potential binding sites in the three-
dimensional structure of the protein. These binding sites can further be assessed based on 
their shape, surface lipophilicity and predicted affinity for drug compounds [129]. Similarities 
in protein structures with known drug targets, also referred to as ‘guilt by association’, have 
also been utilised in determining the druggability of a target [130]. Comparison with 
homologous targets in other pathogens has also been used to identify potential targets with 
similar binding sites and possible ligand interactions, particularly with antibiotics [131]. 
Lastly, high homology to the binding pockets of important human enzymes makes the 
protein in the pathogen an unlikely drug target, owing to an increased likelihood of side-
effects [94]. 
Enzymes that are essential for the survival of a pathogen can be identified using flux balance 
analysis by simulating individual gene or reaction knockouts and observing their effect on 
the objective function. In this case, it is important to accurately define the specific gene-
protein-reaction association [132]. It is crucial that targets identified are involved in primary 
metabolic pathways, rather than in secondary metabolism that are often non-essential to 
the growth of organism. Additionally, the objective function can be adjusted to represent 
the production of the minimum component requirements of an organism. This may result in 
an accurate prediction of the essentiality of certain reactions or genes [90]. Genes that 
encode isozymes may be considered non-essential since the organism is capable of 
producing another enzyme with a similar function. On the other hand, a gene that 
contributes to a protein complex that is essential to an organism is considered essential [94]. 
Potentially, double gene knockouts can be targeted by a drug combination that can slow 
down, if not prevent the development of drug resistance. In addition, the use of drug 
combinations may have synergistic effects. In vitro testing has demonstrated that some drug 
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combinations exhibited greater inhibitory effect when compared to the sum of the effect of 
individual drugs when given separately. Yet little is known of the flux restrictions that 
produce the synergy [112].  
 Apart from focusing on enzymes in a metabolic network, a metabolite-centred approach can 
be applied towards identifying potential drug targets. Metabolic choke points, or reactions 
that solely produce or consume one or a few metabolites, are presumed to be essential if an 
inhibition at this point will result in the deprivation of an essential by-product or the 
accumulation of a possibly toxic metabolite [115]. Molecules similar to the metabolites 
involved in choke point reactions (i.e. single reaction connected to a number of important 
reactions or pathways) may be used as a competitive inhibitor for the given reaction and 
may be able to target more than one enzyme [133].  
Drug repositioning or repurposing involves the use of a currently available drug in addressing 
a different disease pathology. Repurposing of drugs that have been approved for another 
purpose benefits from the fact that these drugs have already been tested on humans and 
thus toxicity and adverse effect information are already available [88, 93]. This shortens the 
time frame for drug development and reduces the developmental costs [134]. Available 
resources, such as the DrugBank, provide an extensive database of drugs and their 
corresponding drug targets [135]. A number of studies have utilised the DrugBank to identify 
potential drugs that can target essential proteins to inhibit the growth of pathogenic 
organisms and cancer cells [88, 93, 136]. 
In a study by Chavali et al. [112], data on identified essential genes obtained from a 
previously developed L. major model were used to screen FDA-approved drugs that can 
potentially be used as anti-leishmanials. The protein sequences of L. major genes included in 
the metabolic network reconstruction were aligned against the sequences of drug targets in 
the DrugBank and STITCH databases. Inclusion and exclusion criteria such as FDA approval 
status, druggability and drug toxicity were also incorporated in the drug screening. As a 
result, 15 genes representing potential drug targets for a total of 240 FDA-approved drugs 
were identified. Protein sequences of eight genes involved in non-trivial deletions were also 
identified as potential drug targets for a total of 37 FDA-approved drugs. Among the 
combined list of potential drugs targeting essential genes (single genes or gene pairs), nine 
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have been reported in literature to have anti-leishmanial activity, while 71 have been shown 
to have activity against L. major in previous high-throughput in vitro drug screenings. It is 
important to note that through this screening, halofantrine, an anti-malarial drug, has been 
identified and tested in vitro to have anti-leishmanial activity at concentrations of 3 microM 
and higher. Furthermore, drug combinations with disulfiram, a drug used to treat chronic 
alcoholism, and antibiotics/antipsychotics have also been demonstrated to show anti-
leishmanial activity in vitro. These drug combinations have also produced significantly 
greater inhibition when compared with the sum of the inhibitory effects of the individual 
drugs. 
1.4.7 Popular Tools used in Genome-scale metabolic 
network reconstruction and Constraint-based 
modelling 
With the recent rise in popularity of genome-scale metabolic modelling studies, many tools 
have been developed to generate the metabolic models and to analyze them. Some of the 
most popular of these tools are discussed in this section of the chapter. 
a)  Tools for genome-scale metabolic reconstruction 
i. Pathway Tools 
Pathway tools [137] is a complete Systems Biology software suite. It can be used for 
constructing the model draft, curating the model, integrating experimental data and 
performing model simulations. The model is maintained as a Pathway/Genome Database 
(PGDB) composed of frames for every pathway, reaction, enzyme, protein complex, 
metabolite and curator. A PGDB frame is comparable to a webpage in a website. The suite is 
composed of four core components: PathoLogic, Pathway/Genome navigator, 
Pathway/Genome editor and MetaFlux. 
The PathoLogic [96][137] tool uses an annotated genome to query the MetaCyc [108], a 
database of metabolic pathways collected from more than 2400 species curated with 
experimental data, and builds an initial draft of the metabolic model from the search hits. 
This step is the initial stage in genome based reconstruction when using pathway tools.  
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The Pathway tools Pathway/Genome navigator [137] helps in querying and visualizing the 
PGDB model. This includes the cellular overview of all pathways, pathway frame, reaction 
frame, enzyme/protein frame, metabolite frame and transcription factor frames, etc. 
Annotator information is also made available through the pathway/genome navigator 
through the curator frames, affiliation frames and citation frames. The genome browser 
which can be used to visualize a particular gene in the genome is also a part of the 
Pathway/Genome navigator. The frames are also linked to one another which helps the user 
smoothly move to a frame mentioned in a particular frame, very much similar to hyperlinked 
text in a webpage (analogous to a frame) of a website (analogous to the PGDB). The 
Pathway/Genome navigator also allows hyperlinking to external servers which can prove 
very useful during annotation when providing link to public databases such as the PDB and 
the KEGG Databases. The Pathway/Genome navigators also support HTML text formatting 
which can help in customizing the annotation text displayed such as representing 
information in tables. 
The Pathway/Genome editor [137] is the editor where information such as common name, 
synonyms, summary, citation and other information regarding a particular frame can be 
entered or altered. In the case of pathways, there exist a pathway editor and a pathway 
information editor. The former determines the reactions in a pathway and the hierarchy of 
the constituent reactions while the latter is used to add / edit / delete the information 
displayed on the pathway frames. 
The Pathway tools MetaFlux [92] is the built in flux balance analysis (FBA) tool. Missing 
reactions in PGDBs can be predicted using the Gap filler. Using flux balance analysis, 
simulations such as gene silencing or knockouts can be studied in order to determine lethal 
genes and potential drug targets.  
ii. The SEED server 
The SEED server [99] is another important resource in genome-scale reconstruction. The 
ModelSEED component of this server implements an efficient pipeline which can be used to 
generate good quality metabolic model drafts of prokaryotes. The genome of interest is first 
annotated using the RAST server [95] to generate a preliminary model draft. The pipeline 
then generates a biomass equation for the draft and performs an autocompletion step so 
that the model is capable of producing the biomass components. This model can then be 
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"fitted" to experimental data through flux balance analysis. The ModelSEED pipeline also 
contains a modified version of the GrowMatch algorithm which helps in model optimization 
by identifying missing transport reactions, conflicts between GPRs and gene essentiality 
data, gaps in the metabolic network and extra reactions in the model [138]. ModelSEED also 
provides users with 60,183 RAST annotated microbial genome and 521 medium 
compositions to facilitate reconstruction and simulation.  
iii. The Autograph Pipeline 
Most automated draft reconstruction tools are based on organism non-specific databases to 
generate the primary metabolic draft. This could lead to adding reactions known not to exist 
in the organism into the reconstruction draft and missing organism-specific reactions from 
the draft. In 2006, Notebaart et al. published the AUTOGRAPH pipeline in which existing 
manually curated genome scale models were used to generate metabolic drafts for closely 
related organisms [97]. In this pipeline, orthologous genes between the template (for which 
there exists a manually curated model) and the target (the organism for which the model is 
being built) genomes were identified using bioinformatics tools such as INPARANOID [139]. 
The list of orthologs were then used to select components of the manually curated model to 
build the target organism’s metabolic draft. Selecting the right template organism and model 
is an important step in this pipeline and determines the quality of the resulting metabolic 
draft. This method has been proved to generate more accurate metabolic drafts. 
b) Tools for Ortholog search 
i. Inparnoid tool 
InParanoid is an orthologous and paralogous gene detection algorithm [139]. Orthologous 
genes or orthologs are homologous genes separated by speciation event. A simple example 
of an orthologous pair is the mouse and human ⍺ Haemoglobin. On the other hand 
paralogous genes are homologous genes separated by gene duplication. The genes coding 
for human ⍺ and ß haemoglobin is an example for paralogous gene pair. The occurrence of 
gene duplication events after speciation event results in the formation of paralogous genes 
called inparalogs. These are co-orthologous to the homologous gene(s) in other species. The 
InParanoid 4.1 standalone tool analyses two proteomes with an optional outgroup proteome 
and identifies all orthologous genes among them. It also identifies in-paralogous sequences 
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to form paralogous clusters. InParanoid identifies orthologous gene pairs and the inparalogs 
using a confidence score which is based on the distance of each inparalog to the ‘ seed’ 
ortholog. 
 The InParanoid standalone tool is coded in perl programming language and requires 
perl to be installed on the system. It uses the ‘blastall’ and ‘formatdb’ functions from the 
NCBI legacy blast package to build a private sequence database of the two proteomes and 
then perform sequence similarity searches. It also requires the perl module XML::Twig to 
successfully run.  
c) Tools for performing simulations using constraint-based models 
i.  The COBRA Toolbox and COBRApy 
 The COnstraint-Based Reconstruction and Analysis (COBRA) Toolbox is a collection of 
methods for the development, analysis and simulation of metabolic networks. These 
methods are based on an approach that utilises physicochemical, biological and data-driven 
constraints to identify phenotypic states of a given metabolic network under a given 
condition [140][141]. Version 1.0 of the toolbox was initially released in 2007, and was then 
updated to version 2.0 in 2011. Apart from the COBRA archive, installation of this toolbox 
requires MATLAB, libSBML [142] and the SBML Toolbox [143] and linear programming 
solvers (e.g., GLPK, Gurobi, CPLEX). Currently, it offers a wide range of functionalities as 
shown in table 1 [141]. COBRApy is a version of the COBRA Toolbox that runs using Python 
instead of MATLAB, which is a proprietary software [144]. The MATLAB COBRA Toolbox 
accepts models in MATLAB, SBML and Microsoft excel formats while its Python 
implementation accepts SBML, JSON and COBRA model object. Although the toolbox has 
functions to evaluate model correctness during import, error detection may not be as good 
compared with other applications. One example of such an issue is that if a reaction in the 
input file contains an undeclared metabolite, the function instead of returning an error 
message, proceeds to add the reaction to the cobra model object without the undeclared 
metabolite leading to an incorrect and unbalanced reaction. However, the COBRA Toolbox 
provides a number of advanced features that are not present in most FBA 
applications/software as shown in Table 1 . Finally, it is important to note that the COBRA 
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Toolbox is well maintained and it is constantly being improved using methods and programs 
contributed by active community members [145] 
 
ii. OptFlux 
OptFlux is a free software application that uses GLPK software for linear programming and 
LibSBML to read and handle metabolic models in SBML format, though other formats can 
also be loaded (e.g. Metatool or flat files). FBA simulations can be performed alongside 
adjustments in environmental conditions. The software also uses the BioVisualizer plug-in to 
visualise pathways and networks in the form of nodes and edges. OptFlux has a user-friendly 
Graphical User Interface with a menu bar that is easy to navigate. Similar to the COBRA 
Toolbox, OptFlux can also perform Flux Variability Analysis and Minimization of Metabolic 
Adjustment (MOMA) [146]. 
iii. Acorn 
Acorn is a web-based application with a desktop-based graphical editor that has been 
designed to handle large genome-scale metabolic model. Users are required to install Acorn 
Table 1 - Features of COBRA Toolbox (version 2.0) 
Feature Details 
Flux balance analysis 
Flux variability, Gene deletion studies, Geometric FBA, Growth-
rate optimization, Loop law, MOMA, Robustness analysis 
Fluxomics C13 data fitting and flux estimation, Experimental design 
Gap filling detectDeadEnds, gapFind, growthExpMatch 
Input/output Read/write SBML (level 2, version 4), SBML (level 3 fbc) 
Metabolic 
engineering 
GDLS, OptGene, OptKnock 
Reconstruction Create submodels using omics data, Model curation tools 
Sampling 
Artificial centering hit and run (ACHR) sampling, Updated ACHR 
sampling (parallel/multipoint) 
Test suite Examples are provided for testing, Verify installations 
Visualization Display maps, Overlay data (flux distributions, flux variability) 
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and set-up an account in order to utilise the application. Models in SBML format can be 
imported into the application for analysis. Flux balance analysis as well as flux variability 
analysis can be conducted with objective parameters and nutritional conditions set by the 
user. Essential genes and reactions can also be identified by the software. Pathways can be 
visualised using the desktop editor showing the corresponding flux values calculated for 
each reaction. Selected models and results of perturbations can also be shared using the 
application [147].  
A summary of the various popular FBA Tools is presented in Table 3 
d) Tools for visualization and analysis of genome-scale metabolic networks 
i. Cytoscape 
Cytoscape [148] is an open source software project developed to analyze biological networks 
and integrate it with biological data. Although it was initially developed for biological 
networks, Cytoscape has found it application with non biological network. Among other 
features Cytoscape offers a completely customizable visualization feature and many 
powerful automated layout algorithms for biological network. Node and edge visualization 
attributes such as colour, opacity, size, label text, etc can be set to a particular value or as a 
function of an attribute of the node or edge respectively. However, the main strength of 
Cytoscape is that it allows users to develop their own plugins (in Cytoscape 2x) and apps (in 
Cytoscape 3x) to add their own features and analyses. The Cytoscape app store available at 
http://apps.cytoscape.org/ also allows users to share their apps with other Cytoscape users. 
ii. MetExplore 
MetExplore [149] is a web server developed to study experimental data in the context of 
metabolic networks. It contains more than 250 publicly available metabolic models. 
MetExplore supports mapping of metabolites using standard identifiers such as InChI and 
molecular mass. Users registered on MetExplore can import their own metabolic networks 
into the server, visualise, curate and share them. Analysis of metabolic pathways using 
methods such as subnetwork extraction based on experimental data through MetExplore, 
which does not rely on pre-drawn pathways, contributes to a better understanding of the 
changes in the metabolism of an organism. 
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1.4.8 Popular databases useful in genome-scale metabolic 
reconstruction 
Table 4 presents the comparison of the information presented in the databases commonly 
used in Genome-scale metabolic reconstruction. 
a) Trypanosomatid Gene/Protein databases 
i. GeneDB 
GeneDB [150] is the primary genome repository for pathogens sequenced by the Wellcome 
Trust Sanger Institute. The database contains genomic data from more than 40 pathogens 
(including T. brucei) and includes genomic sequences actively undergoing annotation. It also 
contains additional data on gene products collected from a variety of sources. The T. brucei 
data available in GeneDB is currently being subjected to manual curation. Data available on 
the database include gene, Coding sequence (CDS), protein sequences and gene annotation 
along with additional information such as inference on the gene/gene-product from 
published studies, gene ontology, protein sequence domain and secondary structure 
features. 
ii. TriTrypDB 
The EuPathDB [151] collection of databases provides sequence information along with 
related protein information and experimental data on Eukaryotic pathogens. Users are also 
allowed to submit comments on genes/proteins improving the value of these data. 
EuPathDB maintains well curated databases for Trypanosomatidae through TriTrypDB [152]. 
TriTrypDB contains genomic data (sequence and/or annotation) of 14 Trypanosomatidae 
species (C. fasciculata, L. braziliensis, L. donovani, L. infantum, L. major, L. mexicana, L. 
tarentolae, T. brucei, T. congolense, T. cruzi, T. evansi, T. grayi, T. rangeli and T. vivax). Apart 
from genomic data, these databases also include functional data on RNA and protein 
expression, putative functions, protein interactions, localisation and features, as well as gene 
polymorphisms, orthology and homology. User queries can be done by performing a 
keyword search using gene names or gene IDs. Initial search results can be combined with 
succeeding search parameters using Boolean operations (i.e. “and”, “or”, “not”) and are 
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presented in a workflow showing the total number of hits at each step. Users are required to 
register in order to store search strategies, save and download data and add comments on 
gene sequences [151]. 
 
b) Chemical databases 
Chemical Databases such as ChEBI [153] and ChemSpider [154] provide a good resource on 
the metabolites during model reconstructions and comparison. These databases report 
chemical formula, InChI identifier, alternative names and chemical properties for chemical 
entities. 
c) Biochemical databases 
i. Kyoto Encyclopedia of Genes and Genomes (KEGG) 
Biochemical information in databases provides an excellent resource on the metabolic 
capabilities of an organism. One of the most popular biochemical database is the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) [83]. The KEGG database collects information 
on genes, enzymes, metabolites, biochemical reactions and biological pathways among 
many other types of information. KEGG also has a popular web service, allowing other tools 
and databases to quickly mine them for information. As of April 2014, the KEGG web service 
was reported to have 400-500 thousand unique users per month. KEGG pathway maps are 
also frequently used by many to map omics data sets. These maps are generated by merging 
all known biological pathways and are well maintained.  
ii. MetaCyc 
MetaCyc [108], one of the most important Pathway/Genome Database (PGDB) in the BioCyc 
collection, is another important biochemical database. It is a collection of all pathways, 
reactions and metabolites generated from all the BioCyc PGDBs that provides a good 
biochemical reaction pool during gap filling. PathoLogic, the draft reconstruction tool in 
Pathway Tools completely relies on MetaCyc to generate the draft PGDBs.  
iii. Enzyme databases 
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Enzyme databases such as BRaunschweig ENzyme DAtabase (BRENDA) [155] and Expert 
Protein Analysis System (ExPASy) [156] enzyme databases are quite useful resources for 
thermodynamic information of reactions in systems biology. In addition, BRENDA allows 
users to submit biochemical reactions identified in various species providing other users with 
substrates specific to the reaction in a particular species. 
d) Model repository 
i. BioCyc 
The BioCyc database collection (www.biocyc.org) is a huge set of PGDBs generated by 
Pathway Tools. As of 7 November 2014, BioCyc contains 5,500 databases in 3 categories: Tier 
1, Tier 2 and Tier 3. Tier 1 databases are literature based manually curated databases while 
Tier 2 and Tier 3 databases were computationally predicted using the Pathway Tools 
software and lack intense manual curation (34). BioCyc is hence a very rich biochemical 
resource providing easy to browse metabolic models.  
ii. Biochemical Genetic and Genomic Database 
The Biochemical Genetic and Genomic (BiGG) database [107] is another database of 78 
manually curated published genome-scale metabolic models. These models provide a good 
source of biochemical information for specific organisms and also provides cross links to 
other databases. 
iii. BioModels 
BioModels is one of the most popular model databases for both metabolic and non-
metabolic models [109]. As of January 2016, it has 583 curated models and 796 non-curated 
models published in peer-reviewed literature. BioModels also hosts automatically generated 
112,898 metabolic, 27,531 non-metabolic and 2,641 genome-scale metabolic models [109]. 
An important feature of BioModels is that it allows users to query not just the model 
components but even the annotation and metadata provided in the model, making it a very 
important resource. 
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Table 2 - Summary of databases useful in model reconstruction 
Database Biochemical data Pathways Proteins Gene 
Experimental 
data 
Metabolic 
models 
Metabolite Organism specific Reference 
BiGG 
     
✓ 
 
✓ [107] 
BioModels 
     
✓ 
 
✓ [109] 
BRENDA ✓ 
   
✓ 
 
✓ ✓ [155] 
ExPASy ✓ 
       
[156] 
ExploreEnz ✓ 
       
[157] 
ChEBI ✓ 
     
✓ 
 
[153] 
ChemSpider 
      
✓ 
 
[154] 
EuPathDB / TriTrypDB ✓ ✓ ✓ ✓ ✓ 
  
✓ [151, 152] 
GeneDB 
  
✓ ✓ 
   
✓ [150] 
KEGG ✓ ✓ ✓ ✓ 
  
✓ ✓ [83] 
MetaCyc ✓ ✓ ✓ ✓ 
  
✓ 
 
[108] 
UniProtKB 
  
✓ ✓ 
   
✓ [158] 
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Table 3 – Popular tools used to analyze contain-based models 
Project name Operating system 
Programming 
language 
License Project home page Reference 
Acorn 
Platform 
independent 
Java, C++ GNU GPL v2 http://code.google.com/p/a-c-o-rn/ [147] 
COBRA Toolbox v2.0 
Platform 
independent 
MATLAB GNU GPL version 3 https://opencobra.github.io/cobratoolbox/ [159] 
COBRApy v0.2.1 
Platform 
independent, 
including Java 
Python (≥2.6) / 
Jython (≥2.5) 
GNU GPL version 3 or 
later 
https://opencobra.github.io/cobrapy/ [144] 
OptFlux 
Platform 
independent 
Java GNU GPL version 3 http://www.optflux.org [146] 
SurreyFBA 
Platform 
independent 
C++ GNU-GPL http://sysbio3.fhms.surrey.ac.uk/ [160] 
Sybil 
Platform 
independent 
R statistical 
environment 
GPL-3 
http://www.cs.hhu.de/en/research-
groups/bioinformatics/software/sybil.html 
[161] 
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1.5 OBJECTIVE OF THE STUDY 
As explained earlier Trypanosoma brucei is the causative agent of Human African 
Trypanosomiasis (HAT) and is responsible for the huge losses of life and livestock in sub-
Saharan Africa. The WHO neglected tropical disease roadmap targets the elimination of HAT 
by 2020 [162]. The key to drug development is understanding the metabolism of the 
pathogen and its weak-points. The primary objective of this thesis is to develop a manually 
curated genome-scale metabolic model of T. brucei in order to facilitate the study of the 
parasite metabolism from a systems biology perspective.  
The TrypanoCyc Pathway/Genome Database was developed in 2008 thanks to a combined 
effort of the International Trypanotolerence Centre (The Gambia) and the Wellcome Trust 
Sanger Institute(UK). In 2012, a team of experts on Trypanosomatid metabolism and 
bioinformaticians started the TrypanoCyc annotation project. The aim of the project was to 
curate the TrypanoCyc database in order to provide accurate information on T. brucei 
metabolism to the public. The secondary objective of my project is to host, maintain and 
curate the TrypanoCyc database and automate its annotation system; at the same time 
helping to drive the curation effort. 
T. brucei parasites display very different metabolism in the insect and mammalian hosts in 
order to survive in these very different nutritional environments. The tertiary objective of 
this project hence involves the study of how well the genome-scale metabolic model is 
capable of predicting developmental stage specific behaviour and to build developmental 
stage-specific models from the genome-scale model to better describe T. brucei behaviour.  
The overall objective of this project is to establish a system for the transmission of up-to-
date findings on T. brucei metabolism to the scientific community through the TrypanoCyc 
database and to arm computational systems biologists with a manually curate genome-scale 
metabolic model to study the parasite metabolism, with the hope that these resources will 
help in better understanding of T. brucei metabolism and the subsequent development of 
better anti-trypanosomiasis treatment therapies. Both projects were carried out in parallel 
in order to capitalize on the curation efforts made on the TrypanoCyc database by the 
annotation team in the curation of the metabolic model. Incorrect or missing metabolic 
information identified during manual curation of the genome-scale metabolic model was 
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also used to update the TrypanoCyc database after validation from the experts in the 
annotation team. Figure 14 describes the overall design of the project. 
Figure 14– Scheme used to construct, update and synchronize the TrypanoCyc database and 
genome-scale metabolic network 
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2. RESULTS AND DISCUSSION 
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Note to the reader 
In order to provide a simple and clear description of the results from this project, they have 
been divided into two categories based on the objectives of the project discussed earlier. In 
the first section, results related to the TrypanoCyc database and the annotation project will 
be discussed. The second section will be dedicated to results associated with the 
development of the manually curated genome-scale metabolic model of T.brucei and the 
study of the parasite metabolism using constraint-based modelling. Each section involves a 
journal article (one published, one currently in preparation) and additional results and 
discussions to describe the results obtained after the publication and those that were 
deemed to be out of the scope of the articles. 
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2A. RESULTS AND DISCUSSION 1: 
     THE TRYPANOCYC DATABASE 
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2A.1 ARTICLE 1 
The TrypanoCyc database is a Pathway/Genome Database (PGDB) with a curation team 
involving experts studying the various aspects of T. brucei metabolism 
(www.metexplore.fr/trypanocyc). An article on the database has been published in the 
Nucleic Acid Research (NAR) Database Issue in 2015 (accepted in September 2014)  
Shameer, S., Logan-Klumpler, F. J., Vinson, F., Cottret, L., Merlet, B., Achcar, F., … Jourdan, F. 
(2015). TrypanoCyc: a community-led biochemical pathways database for Trypanosoma 
brucei. Nucleic Acids Research, 43(Database issue), D637–44. doi:10.1093/nar/gku944 
As mentioned earlier, this section involves a copy of the published article, which discusses 
the information, functionalities and services available on TrypanoCyc.  
Article impact 
As of January 1st 2016, the article has been cited 3 times and 670 PDF versions of it has been 
downloaded from the NAR website. Of the 4,681,163 publications tracked by Altmetrics, the 
TrypanoCyc paper has been ranked #452,846; including it among the top 10% of all research 
outputs ever tracked by Altmetrics. 
Additional statistics on the paper can be found at http://tinyurl.com/jrm5gbh or through 
NAR website.
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ABSTRACT 
 
The metabolic network of a cell represents the 
catabolic and anabolic reactions that interconvert 
small molecules (metabolites) through the activity of 
enzymes, transporters and non-catalyzed chemical 
reactions. Our understanding of individual metabolic 
networks  is  increasing  as  we  learn  more  about 
the enzymes that are active in particular cells un- 
der particular conditions and as technologies ad- 
vance to allow detailed measurements of the cellu- 
lar metabolome. Metabolic network databases are 
of increasing importance in allowing us to con- 
textualise data sets emerging from transcriptomic, 
proteomic and metabolomic experiments. Here we 
present  a  dynamic  database,  TrypanoCyc  (http: 
//www.metexplore.fr/trypanocyc/), which  describes 
the generic and condition-specific metabolic network 
of Trypanosoma brucei, a parasitic protozoan re- 
sponsible for human and animal African trypanoso- 
miasis. In addition to enabling navigation through the
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BioCyc-based TrypanoCyc interface, we have also 
implemented a network-based representation of the 
information through MetExplore, yielding a novel en- 
vironment in which to visualise the metabolism of 
this important parasite. 
 
INTRODUCTION 
 
Trypanosoma brucei is the causative  agent of African  try- 
panosomiasis (commonly known as sleeping sickness in hu- 
mans and  Nagana  in animals).  The disease is fatal  if un- 
treated  in humans  (1) and  the  economic  impact  of  try- 
panosomes  on agriculture  in Africa is immense. The drugs 
available for the trypanosomiases are inadequate for a num- 
ber of reasons and better therapeutic options  are required 
(2). Many drugs work through  interfering with enzymes in- 
volved in cellular metabolism.  The only anti-trypanosomal 
drug whose target is known is eflornithine,  an inhibitor  of 
ornithine decarboxylase (3), a key enzyme in the polyamine 
biosynthetic  pathway.  A comprehensive  understanding of 
parasite metabolism therefore contributes to current efforts 
in drug discovery and understanding drug resistance (4). 
Global untargeted molecular profiling data sets (e.g. tran- 
criptomics, proteomics and metabolomics data) are now be- 
ing generated for trypanosomes and the effects of life cycle, 
environmental perturbation, specific genetic manipulation 
and  drug  action  are being dissected in a systematic  man- 
ner (5). Interpreting and integrating these data to allow bio- 
logical inference and hypothesis generation  is a major chal- 
lenge. Metabolic  network-based methods  offer a means to 
contextualise and integrate data to help inference of biolog- 
ical function  (6). Reliable, comprehensive databases  collat- 
ing information on metabolic  networks  and pathways  are 
therefore  crucial to optimize  understanding derived from 
postgenomic  data sets. Metabolic  databases  such as Leish- 
Cyc (7) (for Leishmania), and the Library of Apicomplexan 
Metabolic  Pathways  (8) (for apicomplexan parasites)  are 
among the few examples where this information is available 
in parasitology. 
Creation  of a metabolic network database  is achieved by 
gathering  information on all of the metabolic  transforma- 
tions an organism  can perform  (9). A first outline  of this 
information is generally retrieved from genomic orthology. 
Genes coding for enzymes are identified through  sequence 
similarity  searches and  then,  using enzyme activity infor- 
mation, metabolic reactions catalyzed by these enzymes are 
added to the network database. Several automatic and semi- 
automatic tools  are  available  to  perform  these  genome- 
based metabolic network reconstructions (10–13). 
In spite of their undoubted utility, genome-based  recon- 
struction  has limitations  since it is based primarily  on se- 
quence  homology  comparisons between  the  organism  of 
interest  and  databases  encompassing  information from  a 
multitude  of organisms (14). Incorrect  annotations readily 
propagate across databases (15). Moreover, evolution works 
through  modification  of function  following  alteration  of 
genes encoding  proteins.  For  instance,  trypanosomes use 
N1 ,N8  bis-glutathionyl spermidine (trypanothione) (16) as 
a key cellular redox-associated metabolite.  Trypanothione 
is retained  in its reduced  form  by the enzyme trypanoth- 
ione reductase  (EC 1.8.1.12). This enzyme is evolutionar- 
ily derived  from  glutathione reductase  (EC 1.8.1.7), with 
which it shows great homology.  In the absence of accom- 
panying biochemical evidence, genome annotations would 
simply predict trypanosomes as possessing a glutathione re- 
ductase,  and metabolic  reconstructions would assume try- 
panosomes  employ canonical glutathione-based redox bal- 
ancing.  Cases like this highlight  the  necessity of refining 
genome-based  metabolic  reconstructions by incorporating 
advanced biochemical knowledge (15). 
Moreover,  simple genome  reconstructions do  not  take 
into  account  the sub-cellular  localization  of the enzymes 
(although  various  methods  are  now  being  developed  to 
tackle this issue as canonical signals determining cellular lo- 
calization come to light (17)). Finally, the genome provides 
a view of the total metabolic capability of an organism, re- 
gardless  of environmental and  genetic conditions.  In try- 
panosomes, however, different metabolic strategies are used 
at different points in the life cycle. In the tsetse fly, the try- 
panosome’s main carbon  source is proline (18) while in the 
human-host it is glucose (19). Some reactions are active in 
one condition  but not in another. This information is par- 
ticularly important when looking for potential drug targets. 
Web servers such as KEGG (20) and  BioCyc (14) rep- 
resent metabolism  as a set of pathways,  reflecting classical 
textbook  views of biochemistry.  However, the pathway  ap- 
proach  fragments metabolism  in ways which constrain  our 
ability to decipher the broader impact on the metabolic net- 
work; hence, methods  that  also enable connected  network 
views of metabolism  are desirable. We have therefore  com- 
bined building a pathway-based TrypanoCyc database with 
its integration into the MetExplore  web server (21), to offer 
both  pathway  and network-based inference and visualiza- 
tion. 
 
 
A  HIGHLY  CURATED  DATABASE  OF  T.  BRUCEI 
METABOLISM 
 
The T. brucei TREU  927 genome is 26 Mb in size, with a 
karyotype  of 11 megabase chromosomes (22) and contain- 
ing a predicted 9068 protein-coding genes. In a collaborative 
project between the International Trypanotolerance Centre 
in The Gambia  and  the Sanger  Institute, the genome se- 
quence was processed using the Pathologic  metabolic  net- 
work  reconstruction tool  of Pathway  Tools  (23), creating 
a Pathway/Genome Database (PGDB)  where gaps (called 
‘pathway holes’) in the predicted  metabolic pathways  were 
filled by hypothetical reactions,  even without  an obvious 
gene association.  The result of this first automatic recon- 
struction  was the starting point of the current TrypanoCyc 
database. 
An international consortium of investigators,  expert  in 
various aspects of trypanosome metabolism, was assembled 
to produce  a highly annotated TrypanoCyc database. As 
recommended  by Thiele & Palsson (24) we started the Try- 
panoCyc initiative in 2012 with a two-day ‘jamboree’. Each 
expert  was offered a specific set of pathway(s)  in his/her 
area of expertise to curate. A dedicated web interface, called 
TrypAnnot (a password protected  part of the website avail- 
able  to  annotators, not  described  here)  stores  submitted 
annotations in a curation  database, making  it possible to 
track  all annotations, which are automatically taken  from
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Figure 1. TrypanoCyc page for the 6-phosphogluconate dehydrogenase (1.1.1.44) reaction. (a) Reaction name and GeneDB link (specific to TrypanoCyc), 
(b) Detailed  description  of the reaction,  (c) Localizations  of the reactions  as suggested by annotators, (d) Confidence score for the reaction  (specific to 
TrypanoCyc), (e) Annotation tables displaying content of the TrypAnnot database (specific to TrypanoCyc). 
the database  and added to the web page of the correspond- 
ing reaction.  The TrypanoCyc project has so far had 1368 
editing events, among which are 653 annotations made on 
464 reactions. Furthermore, since the first automated recon- 
struction  in 2008, 17 pathways,  35 enzymatic-reactions, 10 
transport reactions,  41 enzymes, 2 protein  complexes and 
104 metabolites have been added to TrypanoCyc. Extended 
summaries  for some pathways  have also been made avail- 
able in the database. 
T. brucei cells contain  multiple membrane-bounded or- 
ganelles, including the mitochondrion and an unusual 
peroxisome-related organelle, the glycosome (25,26), in 
which the first seven steps of glycolysis occur, as well as a 
series of other pathways  (19). Annotators, therefore,  spec- 
ify the sub-cellular  localization  of reactions,  if known,  in 
the annotation interface. Life cycle stage specificity for each 
reaction  is also important, since trypanosomes use differ- 
ent  metabolic  pathways  in different  environments;  hence 
annotators can specify one or more developmental  stages 
in which reactions occur. Note that this information is not 
available in the reconstruction provided by KEGG (see Ta- 
ble 1 for comparison). The level of knowledge on each reac- 
tion varies from experimentally verified to indirect evidence 
of activity regardless of manual curation. To reflect the level 
of confidence of the annotation we have used the scoring 
system proposed  by Thiele & Palsson (9) (see Table 2). For 
instance, of the 464 annotated reactions, 84 were annotated 
based  on  direct  evidence from  protein  purification,  bio- 
chemical assays or comparative gene expression studies and 
hence can be considered with the highest confidence. Dur- 
ing curation  we found numerous falsely predicted reactions 
and pathways; 60 pathways,  14 enzymatic reactions, 20 en- 
zymes and 56 metabolites have been removed from the origi- 
nal reconstruction. Nevertheless we retained some reactions 
if they are known to occur in related trypanosomatids, or 
else when they have been proposed  to exist, erroneously,  in 
the literature.  Although  such reactions  are kept,  they are 
not  linked to any pathway  and  they are assigned a nega- 
tive confidence score to highlight the fact that according to 
our present knowledge they are not actually present. For ex- 
ample, a methionine cycle that regenerates methionine from 
methylthioadenosine resulting from polyamine  biosynthe-
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Figure 2. Proteomics data loaded in TrypanoCyc using the cellular overview tool. (a) The diagram shows all the metabolic pathways in gray boxes. Colored 
squares correspond  to reactions with associated proteomics values. The color scale is displayed in the ‘Omics Viewer Control  Panel’; it can be tuned using 
dedicated parameters. The ‘REACTION’ dialog appears when clicking on a reaction. (b) It is then possible to get back to the corresponding reaction page 
and read the annotators’ comments. 
sis has been proposed  (27). However,  metabolic  labelling 
experiments have subsequently  indicated  that  the pathway 
is not  active  in trypanosomes, at  least  in the  conditions 
used (28). The reactions  EC 4.2.1.109 (methylthioribulose 
1-phosphate dehydratase) and EC 3.1.3.77 (5-(methylthio)- 
2,3-dioxopentyl-phosphate phosphohydrolase), required to 
complete  the  pathway,  are  included  in the  database, but 
assigned  negative  scores to  highlight  that  they are unde- 
tectable in spite of previous predictions in the literature (27). 
We consider it useful to keep such entries such that users of 
the database  can find explicit reference to these reactions 
they might seek upon reading literature  pertaining  to these 
reactions. 
Since metabolic databases  focus mainly on pathways and 
seldom  consider  sub-cellular  compartments, they  usually 
lack information on intracellular transport reactions.  Cur- 
rently, TrypanoCyc contains only 35 such reactions. This is 
because we did not incorporate transport reactions into our 
annotation platform  and because experimental  knowledge 
on intracellular transport processes is still sparse. However, 
the dynamic nature of TrypanoCyc means additional anno- 
tation  and incorporation of measured  and probable  trans- 
port  reactions  (e.g. taken  from  existing manually  curated 
metabolic models of the closely related organism Leishma- 
nia major (29)) will form  part  of the  iterative  process  of 
database refinement.  We also perform  gap filling in each 
compartment using graph approaches and testing metabolic 
scenarios as suggested (9,10) and successfully implemented 
for other organisms (30). 
Many additional databases  provide information that can 
complement metabolic network databases.  Linking to these 
other  data  sources  enhances  our  ability  to  learn  about 
an organism’s metabolism.  TrypanoCyc, therefore,  links to 
multiple databases  including BRENDA (31,32), expasy.org 
(33), ExplorEnz  (34), Pubmed  and UniProt (35). The Trit- 
rypDB database (36) is the central resource for trypanoso- 
matid  genomes and  associated  functional  genomics data, 
while GeneDB  houses the sequence information gathered 
and annotated through the Wellcome Trust Sanger Institute 
(37). For each gene, TrypanoCyc offers a direct link to the 
corresponding TritrypDB and GeneDB pages.
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Figure 3. Navigation between pathway and network representation using MetExplore and TrypanoCyc. (a) Each pathway page has an hyperlink allowing 
to load and visualize the pathway  in MetExplore (circled in red on the pathway page screenshot). (b) When clicking on this link in the Glycolysis page, it 
is loaded in MetExplore; the red box corresponds  to the cytosolic part and the green one to the glycosomal part. (c) Using MetExplore, it is then possible 
to generate a combination of various pathways. TCA cycle, succinate shunt, glycolysis and the pentose phosphate pathway were selected. (d) All reactions 
of these pathways are added to the cart (red box on the right). A third compartment, mitochondrion, appears (purple box). A reaction allowing transport 
between cytosol and glycosome appears in the network (red arrow). (e) In the tabular view of MetExplore, a TrypanoCyc button (visible in the third column 
of [c] table) allows to link back to TrypanoCyc. 
 
Table 1.  Description  of the confidence score system used in TrypanoCyc to evaluate the level of curation  of each reaction 
 
Reconstruction Compartments Life cycle stages Pathways Enzymatic reactions Unique metabolites 
Draft  reconstruction 1 0 238 1120 796 
2008      
KEGG August 2014 1 0 61 656 646 
TrypanoCyc August 9 4 209 1025 842 
2014      
The BioCyc library is a collection of 3563 PGDBs. Based 
on the quality  of the PGDBs  and the level of manual  cu- 
ration,  this  central  repository  classifies them  into  Tier  1 
(highly curated),  Tier  2 (moderately  curated)  and  Tier  3 
(non-curated) categories.  Prior  to  the  release  of  BioCyc 
v18.1, only 6 PGDBs (EcoCyc (38), MetaCyc (14), Human- 
Cyc (39), AraCyc  (40), YeastCyc  and  LeishCyc (7)) were 
published  in the Tier 1 category.  Due to the quality of in- 
formation being made available on TrypanoCyc, it was in- 
cluded in BioCyc’s Tier 1 category with the release of Bio- 
Cyc v18.1 in June 2014. 
REACTIONS, PATHWAYS AND NETWORK MINING 
Browsing TrypanoCyc content and expert annotations 
 
As a Pathway  Tools-based  website, TrypanoCyc provides 
a dedicated  web page  for  each  metabolic  network  entity 
(pathways, reactions, metabolites, enzymes, proteins and 
genes). The reaction  page architecture was, however, mod- 
ified in order  to allow additional annotation information. 
These include the annotation confidence score (Figure 1d), 
stage specificity and compartmentation with links to key lit- 
erature  (Figure 1e). A comment  box is also included, con- 
taining detailed free-text information on the reaction.  Fig-
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Table 2.  Overview of TrypanoCyc content before and after curation  and comparison with the KEGG database 
 
Evidence type Confidence score Description 
Biochemical data 4 Direct evidence for gene product  function and 
  biochemical reaction: protein purification, 
  biochemical assays, experimentally solved protein 
  structures  and comparative gene-expression 
  studies. 
Genetic data 3 Direct and indirect evidence for gene function: 
  knock-out characterization, knock-in 
  characterization and over expression. 
Physiological data 2 Indirect evidence for biochemical reaction based 
  on physiological data: secretion products  or 
  defined medium components  serve as evidence for 
  transport and metabolic reactions. 
Sequence data 2 Evidence for gene function: genome annotation, 
  SEED annotation. 
Modelling data 1 No evidence is available but reaction is required for 
  modelling. The included function is a hypothesis 
  and needs experimental verification. The reaction 
  mechanism may be different from the included 
  reaction(s). 
Not evaluated 0  
Negative hypothesis –1 Although  there is no evidence against this 
  reaction, it is expected to not exist 
Evidence against the reaction –2 Direct/indirect evidence against the hypothesis is 
  available 
ure 1 shows the webpage for the pentose phosphate pathway 
enzyme, 6-phosphogluconate dehydrogenase (EC. 1.1.1.44). 
Search   requests   on   database   content   can   be  made 
through a quick search box found at the top right-hand cor- 
ner of the interface page, as well as through  the advanced 
search options  available from the menu bar. Each pathway 
representation is available with different levels of detail, the 
simplest view displaying only the reactions and metabolites 
while the detailed view displays all available information in- 
cluding the molecular structure  of all metabolites involved. 
Additionally,  for every pathway in TrypanoCyc, we provide 
a link to visualize the pathway in MetExplore. 
 
Mining stage specific metabolism using cellular overview 
 
To exemplify the integration of molecular profiling data in 
the TrypanoCyc database we used published  results from 
a Stable Isotope  Labelling  of Amino  acids in Cell culture 
experiment, comparing  protein  levels in bloodstream form 
(BSF) and  procyclic form  (PCF)  trypanosomes (41). The 
data  set contains  3552 gene IDs  along  with their  relative 
protein levels in the two tested stages of T. brucei (expressed 
as log PCF/BSF values). A TrypanoCyc cellular overview 
shows enzymes that  differ in abundance between the two 
life cycle forms (Figure 2; for step by step instructions see 
Supplementary Data  S1). 
Mapping  other molecular  profiling data  in TrypanoCyc 
can be achieved using the Pathway Tools Omics Viewer (42), 
which displays all pathways in a single representation. Data 
sets can be loaded using the options listed on the right-hand 
side of the page (Supplementary Material  S2 is a version of 
this data set in an Omics Viewer-compliant  format). Figure 
2a shows an image of the overview after loading  the pro- 
teomics data of (41). Individual  reactions can be viewed by 
moving the mouse over them and clicking the link in the 
pop-up  dialog  box.  This opens  the  related  reaction  page 
containing  the  annotation table,  giving access to  specific 
TrypanoCyc annotators’ comments about  the enzyme and 
its activity as well as the generic information pertaining  to 
that  reaction  in the MetaCyc  database. For  example,  the 
overlaid data clearly show that the respiratory chain is up- 
regulated in procyclic stages. Browsing the reaction page of 
any of those up-regulated proteins  shows additional infor- 
mation  from the annotators. For example, for ubiquinone- 
cytochrome C reductase (EC 1.10.2.2), two TrypanoCyc an- 
notators report  that  this reaction  is active in the PCF  but 
not in the long slender BSF of T. brucei (see Figure 2b), thus 
agreeing with the observations from the proteomics experi- 
ment. 
 
Using MetExplore to create user-defined sub-networks from 
TrypanoCyc 
 
To complement the classical pathway-oriented BioCyc rep- 
resentation of data, we also offer a novel way to visualize the 
content of TrypanoCyc via our MetExplore  web server (21) 
(for step by step instructions see Supplementary Data  S3). 
Each pathway  page contains  a hyperlink  (Figure 3a), that 
opens MetExplore  with the selected pathway  (Figure  3b). 
Importantly, the MetExplore  viewer takes into account the 
localization of reactions. For example, Figure 3b shows how 
the glycolytic pathway  is divided into  two compartments 
(glycosome and cytosol represented by green and red boxes, 
respectively). 
Another  advantage  of MetExplore  is that  it provides  a 
tabular  representation of compartments, pathways,  reac- 
tions, enzymes, genes and metabolites  in the database. It is 
also possible to filter these tables by compartments, path- 
ways or reactions. For instance, by filtering simultaneously 
on the pentose  phosphate pathway,  TCA  cycle, succinate 
shunt and glycolysis, only reactions and metabolites related 
to these pathways  are displayed  in their  respective tables 
(Figure 3c). The user can also add reactions of interest to a 
‘cart’ (red box on Figure 3d). It is then possible to visualize
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the content of this cart in the network representation. From 
Figure 3d, it is evident that the network perspective is much 
more effective in representing compartments and transport 
reactions. Furthermore, the glycosome (green box) and cy- 
tosol (red box) are demonstrably connected  by a reaction 
involved in the succinate shunt (marked by a red arrow on 
Figure 3d). For a more flexible representation MetExplore 
also offers a downloadable version of the Cytoscape visual- 
ization software (43), pre-loaded  with the cart content. 
Finally,  each MetExplore  reaction/pathway with a de- 
scription in TrypanoCyc has been hyperlinked to the corre- 
sponding  reaction/pathway pages, allowing the user to go 
back to the expert annotations anytime (Figure 3e). 
 
 
 
CONCLUSION 
 
Since 2012, TrypanoCyc has  been  under  extensive cura- 
tion with the help of the scientific community  and is now 
counted  among the seven Tier 1 databases  within the Bio- 
Cyc repository.  Collaborative annotations help in improv- 
ing the quality  of the database by reducing errors,  reduc- 
ing the workload for individual annotators and also provid- 
ing inferences from multiple perspectives given the various 
types of experts in the community. 
T. brucei metabolic plasticity allows the parasite to adapt 
to divergent  nutritional environments  offered by different 
hosts.  For  drug  target  identification,  for  example,  focus- 
ing on enzymes and  metabolic  pathways  expressed in the 
parasite-stages  that  are replicative in the mammalian host 
is critical. TrypanoCyc is the first comprehensive metabolic 
network database  for parasites including stage specificity as 
a key component of the collected data.  LeishCyc (7), for 
the related parasite L. major, has also been established, and 
in the future these two databases  should, ideally, be linked, 
given the significant degree of similarity  in the metabolic 
networks of these evolutionarily  related parasites. 
TrypanoCyc and the related  annotation database allow 
anyone  with an interest  to join the annotation team.  The 
size of  the  consortium helps  guarantee   the  sustainabil- 
ity of TrypanoCyc as does the involvement  of permanent 
staff both at INRA, Toulouse, and the University of Glas- 
gow. The Toulouse bioinformatics facility provides the Try- 
panoCyc  server. TrypanoCyc is freely available  and is not 
password protected. 
TrypanoCyc  database   content   can   be   mined   in   a 
pathway-oriented manner  using the BioCyc-like web inter- 
face but also in a network perspective using the MetExplore 
web server, which allows tailored building and visualization 
of sub-networks. Two options are available to programmati- 
cally access TrypanoCyc: through pathway tools using Java- 
Cyc or PerlCyc and through  MetExplore  using its web ser- 
vice. 
TrypanoCyc is a unique knowledge source for people in- 
vestigating T. brucei metabolism. The availability of SBML 
(44) files (provided  as Supplementary Material  S4) based 
on the curated  network  reconstruction in TrypanoCyc will 
underpin  efforts to explore trypanosome metabolism using 
flux balance analysis (45) or other constraints-based tech- 
niques. It will also serve as a potential  model organism for 
early eukaryotes. 
SUPPLEMENTARY DATA 
Supplementary Data  are available at NAR Online. 
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2A.2   ADDITIONAL RESULTS 
 
Note to the reader 
In this section we shall discuss additional results related to the TrypanoCyc database. These 
results/functionalities were not presented in the publication either because they were 
obtained after the publication or because they were decided to be out of the scope of the 
publication. 
 
2A.2.1  The TrypanoCyc update report 
In order to keep track of changes made to the database, an update report is maintained on 
the TrypanoCyc server with information regarding the BioCyc ID of the object subjected to 
modifications, type of change(s), the date the change was made, the annotator responsible 
for validating the change and information on whether the changes were made manually or 
as a part of automated script. The report is a normal tab separated file with columns titled 
Date, Tocken_name, changes and comment. The column date holds the information 
regarding the date the change was committed to the database in DD/MM/YY format. The 
“Tocken_name” column holds the ID of the database element (metabolite, reaction, 
pathway , compartment or annotator) in TrypanoCyc. The “changes” column is used to 
describe the change to the database element briefly. The “comment” column states the 
reason for the change, mentions the annotator(s) involved and provides publication 
associated with the new information if one is available. Entries in this section were tagged 
with the string ‘(manual)’ if the changes were made manually. Figure 15 displays the first few 
lines of the TrypanoCyc update report. 
 
 
Figure 15 – First three line of the TrypanoCyc update report 
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In some cases, bulk changes to the database were made using scripts written with the help 
of the JavaCyc library (e.g. to add updated T. brucei gene identifiers or to move multiple 
reactions from one compartment to another). In order to register these modifications on the 
TrypanoCyc update report, java classes ‘ReportElement’ and ‘GenerateUpdateReports’ were 
created. These classes can be used to create a new report with the new entries or append an 
existing report with the new entries. 
Access to the TrypanoCyc update report was provided to the users of the TrypanoCyc 
website. An HTML table of the TrypanoCyc update report (ordered such that recent entries 
appear earlier) is first generated and an SHTML page with the TrypanoCyc template 
incorporating this HTML table is generated. Script involved in generating the TrypanoCyc 
update history SHTML page is scheduled to run during the daily TrypanoCyc update and 
ensures the information available is up-to-date. The TrypanoCyc update history page is 
available online and can be accessed from the top menu bar (Analysis > Reports > History of 
updates) or via the web link http://vm-TrypanoCyc.toulouse.inra.fr/TrypanoCyc_log.shtml 
(see Figure 16).  
 
Figure 16 – The online version of the TrypanoCyc update report 
2A.2.2  Tutorials for Pathway and Reaction pages 
Tutorial pages for reaction and pathways were developed to highlight the information 
presented in TrypanoCyc webpages. To keep the TrypanoCyc tutorial simple and user-
friendly, an in-page tutorial system was selected for implementation. The Intro.js library 
[163] with the help of the d3.js library (http://d3js.org/) was used to develop the in-page 
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tutorial for the pathway and reaction pages. The tutorial highlights important sections of the 
pages such as pathway evidence, pathway diagram, pathway confidence, pathway summary 
and credits in the pathway page and EC number, genes involved, reaction diagram, cellular 
localization, confidence score, TrypanoCyc annotations and credits in the reaction page. A 
dialog box was used to describe each section and holds four buttons: ‘Skip’ – to skip the 
tutorial, ‘Do not show this again’ – to never display the tutorial again, ‘Back’ – to go back to 
the previous section and ‘Next’ – to go to the next section. In order to avoid using cookies, 
HTML local storage variables ‘DoNotShowPathwayTutorial’ and 
‘DoNotShowReactionTutorial’ were used to keep track of whether the user selected ‘Do not 
show this again’ option in the tutorial dialog box. Figure 21 displays how TrypanoCyc tutorial 
highlights information on present in the database. 
2A.2.3  Adding LeishCyc to TrypanoCyc 
The LeishCyc PGDB for Leishmania major was published in 2012 and was initially available at 
www.leishcyc.org. However the LeishCyc website is currently offline. Given the close 
evolutionary relationship between L. major and T. brucei and the similarity in their 
metabolism, LeishCyc was added to the TrypanoCyc server. The Pathway/Genome Database 
(PGDB) of Leishmania major, LeishCyc [164] was downloaded from the BioCyc repository 
[108] and added to Pathway Tools on the TrypanoCyc server. Links to LeishCyc and 
TrypanoCyc were placed on the right-hand-side of the top menu bar, allowing users to 
switch between the two databases (see Figure 17). 
Figure 17 –LeishCyc on the TrypanoCyc website 
LeishCyc is available on the TrypanoCyc website. Links to switch between LeishCyc and TrypanoCyc are provided on the top 
menu bar (highlighted with red boxes) 
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2A.2.4  TrypanoCyc User Statistics 
In order to keep track of TrypanoCyc usage and webpage statistics, Google Analytics have 
been used. A Google analytics account was created and the generated Google analytics 
JavaScript was added to the “UserCustomFooter.shtml” file in the Pathway Tools HTML 
folder, which would add it to all TrypanoCyc webpages. This would allow Google to track the 
connections made to TrypanoCyc and help generate website usage statistics such as number 
of new and returning visitors, number of session, duration of each session, country and 
language used by user, etc. 
Between November 2013 and November 2015, TrypanoCyc has had over 5700 sessions, 
4200 users and 14,500 page-views with an average pages-per-session of 2.52 and an average 
session duration of 3 minutes. Figure 18 illustrates the trend in TrypanoCyc usage during the 
same time period. Statistics suggest that TrypanoCyc has been used from at-least 107 
countries. Disregarding the 999 session with unknown location, the top 10 countries with 
highest number of TrypanoCyc sessions include United States (25.59%), France (19.59%), 
China (4.51%), United Kingdom (4.19%), Japan (2.57%), Russia (2.44%), Germany (2.19%), 
Brazil (1.79%), South Korea (1.57%) and Italy (1.32%). Figure 19 shows a world map with 
countries coloured based on TrypanoCyc usage. 
The bounce-rate is the measure of how many times users “bounced-off” the website by 
browsing only one page. Over the duration of the 2 years, TrypanoCyc has had an average 
bounce-rate of 76.27%. Another interesting information gathered by Google analytics is that 
although most of the TrypanoCyc sessions have been accessed from desktops (>98%), it has 
also been accessed through mobile and tablet browsers in 80 and 14 sessions respectively. 
Figure 20 provides a summary of the TrypanoCyc usage statistics collected. 
Figure 18 – TrypanoCyc session statistics Nov 2013-15 
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Figure 19 – TrypanoCyc usage statistics based on country 
Figure 20 – TrypanoCyc usage statistics Nov ‘13 – Nov ‘15 
 a) A set of plots to summarize the TrypanoCyc usage trend b) Percentage of new and returning visitors  
(a) (b) 
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2A.3  ADDITIONAL DISCUSSION 
The release of the T. brucei genome [82] in 2005 made it possible to connect together all the 
results from previous studies on the parasite like piecing together a puzzle. The TrypanoCyc 
database collects information regarding T. brucei metabolism and makes it available to 
scientific community. Information provided on TrypanoCyc includes gene-protein-reaction 
(GPR) relationships, metabolic and transport reaction, reaction EC numbers, information on 
the metabolites involved in the metabolism, information on metabolic pathways found in T. 
brucei and annotations on enzyme activity and localization. Databases such as TriTrypDB 
[152] and GeneDB [150] provide excellent information on the T. brucei at the genomic and 
proteomic levels. TriTrypDB goes the extra mile by collecting genomic and proteomics level 
experimental data on T. brucei. Collecting similar experimental data and developing 
proteome level analyses would hence be similar to reinventing the wheel. Hence efforts of 
the TrypanoCyc database were focussed on collecting information on the reactions and 
pathways in T. brucei metabolism. The cellular overview tool available on TrypanoCyc 
provided the perfect tool to study T. brucei genomics, proteomics or metabolomics data 
within the context of all the known metabolic capabilities of the parasite, a feature not 
available of TriTrypDB. The two databases hence complemented each other perfectly. Cross-
links between the TrypanoCyc and the TriTrypDB were added in order to help users carry-on 
their search for information on T. brucei from one database to the other. With TrypanoCyc 
focussing on information on reactions and pathways and TriTrypDB focussing on information 
on genes, proteins and analyzing collected experimental data, duplicating of effort is avoided 
and information on T. brucei is shared with the public much efficiently. 
TrypanoCyc webpages display a variety of information on T. brucei reactions and pathways. 
Users unfamiliar with TrypanoCyc and other BioCyc based PGDBs are likely to miss some of 
this information. The best example for this is the icon system used by Pathway Tools to 
display the curation status of a pathway. The icon is present at the top right corner of the 
TrypanoCyc pathway page and mousing over the icon provides a description of the icon. 
Although pathway tools employ many icons to represent different types of evidence, in 
TrypanoCyc, in order to keep it simple and easy to interpret we have used only two icons to 
represent whether the pathway has been curated or not (Figure 21a). However feedback 
from TrypanoCyc users including members of the annotation team, led to the conclusion 
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that the information was not understood. With the help of the TrypanoCyc tutorial, which is 
invoked at least once for every user, this icon is highlighted and its purpose is explained 
(Figure 21b). Hence we can assume that that the information conveyed by the icon system is 
no longer missed by the user. In this manner, the TrypanoCyc tutorial helps to make sure the 
users are aware of the information on the TrypanoCyc pathway and reaction pages. 
          Inferred computationally (not curated)                     Inferred by curator (curated) 
Maintaining update logs is good practice in Database management [165]. The TrypanoCyc 
update report keeps tracks of all modification to the database including bulk edits. In the 
case of incidences such as data corruption where the database becomes unrecoverable, this 
log can be used to update an older backup of TrypanoCyc database. Additionally, since 
TrypanoCyc is a database on T. brucei metabolism, changes to the database almost always 
involve one or more biological reasons. For example, the lack of glutathione peroxidase 
activity has been reported in T. brucei and so the associated reaction was removed from 
TrypanoCyc. This information would hence be interesting to the users of TrypanoCyc. This 
surmise led to the addition of the TrypanoCyc update report on the website.  
 
Figure 21 – Icon system used in TrypanoCyc to convey Pathway curation status  
(a) TrypanoCyc uses two icons to represent whether the pathway is manually curated or not 
(b) curation status icon highlighted by the TrypanoCyc tutorial 
(a) 
(b) 
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From the TrypanoCyc usage data collected via Google analytics, it is evident that the 
database has been accessed from at least 107 countries by more than 4000 users. From the 
TrypanoCyc usage statistics (Figure 18), it interesting to see that TrypanoCyc usage increased 
gradually since January 2015 when the database was published (see Result 1 Article). In July 
2015 the database usage almost reached almost a 1000 sessions. Interestingly there was a 
decrease in TrypanoCyc usage from August to October which coincides with Summer and 
Autumn holidays. Although the database usage needs to be monitored for a longer period to 
make strong conclusions, the usage trends recorded so far and the fact that 76.6% of the 
users of TrypanoCyc are returning visitors (Figure 20b) seems to suggest that database has 
been useful to the community. In most websites the bounce-rate is considered a negative 
statistic. However, in TrypanoCyc since all data related to the reaction/pathway are provided 
in the same page, users looking for annotations such as stage-specific behaviour, etc do not 
need to browse further unless they would like to explore other metabolic elements. Hence 
the high bounce rate is not a bad statistic in the case of TrypanoCyc. 
One of the complicated challenges to a community based annotation project is the 
coordination of annotation. The TrypanoCyc annotation team consists of 36 experts from all 
areas of trypanosome research. Most of these experts are principal investigators and head of 
labs and are quite occupied with their research and administrative responsibilities. Hence 
care was taken to distribute the annotation responsibilities among multiple curators (ex: 
revising the protein-N-glycosylation pathway [166] – Bütikofer and Urbaniak). Another 
strategy followed was to collect information from the annotators in parts. Information was 
also gathered from researchers outside in the annotation team (ex: Threonine metabolism 
summary [167] - Yoann Millerioux). Sometimes the same enzyme or pathway may also be 
studied by researchers studying different aspects of the trypanosome metabolism. Input 
from multiple annotators in this case grants alternative perspectives of the same cellular 
mechanism (ex: alkyl DHAP reductase – Opperdoes and Bütikofer). One key feature of the 
annotation system is that changes to the TrypanoCyc database were not made unless they 
were verified by at least one expert. 
TrypanoCyc annotation like manual curation of a genome-scale metabolic model is a 
continuous process. The aim of this community-based annotation project is to slowly but 
continuously gather information. Currently only 464 of the 1042 reactions on TrypanoCyc 
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have annotations from experts. In the case of pathways, only 24 of the 163 pathways are 
annotated and even fewer has T. brucei specific summaries. However given the continuous 
nature of this project, the database will continuously gather more and more information. 
The community also aims to grow and involve more and more researchers in the annotation 
as time goes on. And because of this we expect the current drawbacks of TrypanoCyc will 
diminish in time.  
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2B. RESULTS AND DISCUSSIONS 2:    
GENOME-SCALE METABOLIC MODEL 
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2B.1 ARTICLE 2 
A manually curated genome-scale metabolic model for T. brucei was built during this project. 
At the time of writing this thesis, I am in the process of finalizing the manuscript with the co-
authors for the article on the reconstruction and analysis of the manually curated T. brucei 
metabolic model. The journal selected for this article is the BioMed Central (BMC) System 
Biology. 
The current version of the article is included in this section.  
Supplementary data for the paper is provided in the appendix or will be provided online 
(until paper is accepted) as follows 
1. Essential genes identified from Single gene deletion studies............................(APPENDIX 2) 
2. Essential gene pairs identified from Double gene deletion studies result.........(APPENDIX 3) 
3. Essential reactions identified from single reaction deletion studies result........(APPENDIX 4) 
4. List of publications consulted during manual curation......................................(APPENDIX 5) 
5. Genome-scale metabolic model..................................................... http://1drv.ms/1RboAK2 
6. Blood stream form iMAT solution based on Urbaniak  et al[168].. http://1drv.ms/1PYyh9m 
7. Blood stream form iMAT solution based on Gunasekara et 
al[169]................................................................................................ http://1drv.ms/20MFh1d 
8. Blood stream form iMAT solution based on Vasquez et al[170]..... http://1drv.ms/1Rboylu 
9. Blood stream form iMAT solution based on TrypanoCyc comments 
.............................................................................................................. http://1drv.ms/1PYy2Ls 
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Genome-scale metabolic reconstruction of the 
protozoan parasite Trypanosoma brucei 
 
Sanu Shameer, Nathalie Poupin, Florence Maurier, Frédéric Bringaud, Fiona Achcar, Peter Bütikofer, 
Ludovic Cottret, Michael P. Barrett and Fabien Jourdan 
 
 
 
 
 
Background: Trypanosoma brucei is a protozoan parasite responsible for the potentially lethal disease African 
Trypanosomaisis, also known as Sleeping sickness (in humans) and Nagana (in animals). The lack of efficient 
treatment regimes for this disease has motivated researchers to explore the metabolism of this pathogen. 
 
Results: In this paper we would like to present the first curated genome-scale metabolic model of T. brucei 927 
strain. The metabolic model comprises of 1077 genes, 1689 reactions, 1677 metabolites and 8 compartments and 
was used to study the parasite metabolism and predict genes and nutrients essential for survival. Annotations 
from the TrypanoCyc database were used to develop a metabolic model, from the genome-scale metabolic 
model, specific to the parasite metabolism in the mammalian host. Compared to the genome-scale model, the 
Blood Stream Form (BSF) model shows much better results when predicting the metabolic behaviour of BSF 
parasites reported in 27 published gene knockout/silencing studies. These results highlight the importance of 
context specific modelling especially in organisms in which life cycle involves more than one environment. 
 
Conclusion: Genome-scale models are capable of predicting metabolic characteristics of the organism shared by 
all life cycle stages. Stage specific models are required to better predict metabolic modulations and consequently 
potential drug targets. 
 
 
Introduction 
 
Trypanosoma brucei is the causative agent of 
the potentially lethal disease African 
Trypanosomiasis,  also  known  'sleeping 
sickness' in humans and 'nagana' in animals. 
This protozoan parasite is transmitted through 
the Glossina fly, also known as Tsetse fly, 
during  blood  meals  and  have  been  reported 
only  in  the  sub-Saharan  regions  of  Africa. 
More than 7000 cases of Human African 
Trypanosomiasis (HAT) were reported in 2010 
alone[1]. The current treatment regimes 
available  for  HAT  are  expensive,  inefficient 
and had been reported to have severe side 
effects[2], [3]. There is hence a great deal of 
interest in the scientific community to study 
the metabolism of T. brucei in order to identify 
a more efficient treatment. 
The life cycle of the T. brucei parasite has 
mainly two stages – the insect stage and the 
mammalian host stage. The parasite displays 
very different metabolism in the two very 
different   host   environments   [4],   [5].   The 
blood-stream-form (BSF) parasites in 
mammalian hosts rely on the blood and 
cerebrospinal fluid for nutrients while the 
procyclic  form (PRO)  of  the  parasite  in  the 
insect  host  survives  on  nutrients  from  the 
insect gut and by-products of tsetse-fly 
endosymbiotes to survive [6]. 
 
Understanding the metabolism is the key to 
developing  new  and  effective  treatment 
regimes. Many databases such as TrypanoCyc 
[7], TriTrypDB [8] and GeneDB [9] collect 
knowledge on T. brucei metabolism in order to 
make this information freely available to the
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public. The TrypanoCyc Pathway/Genome 
Database (www.metexplore.fr/trypanocyc) is a 
publicly available knowledge base on T. brucei 
metabolism [10] built using the pathway tools 
software [11]. The TrypanoCyc database is 
curated and annotated by a team of 36 experts 
from different areas of trypanosomatid 
metabolism and has been under constant 
curation since 2012. 
 
The development of computational and 
mathematical  approaches  in  systems  biology 
has  made  the  study  of  metabolism  from  a 
whole  cell  perspective  possible  [12],  [13]. 
Such study involves the development of a 
genome-scale metabolic network with aims to 
represent all the metabolic capabilities of the 
cell in question, followed by the analysis of the 
model using constraint based modelling [14] 
and comparison of the results of this analysis 
with experimental data in order better 
understand  the  parasite  metabolism  [15].  In 
this   paper,   we   would   like   to   introduce 
iSS1077, the first manually curated genome- 
scale metabolic reconstruction of Trypanosoma 
brucei 927 strain.  We will also discuss the use 
of the genome-scale model versus life cycle 
stage specific models (e.g. blood-stream-form 
model) by comparing their ability to predict 
the essentiality of genes during specific life 
cycles stages of the parasite . Construction of 
the  stage  specific  models  was  achieved  by 
using either experimental data or the expert 
manual annotations available from the 
TrypanoCyc database with the integrative 
Metabolic Analysis Tool (iMAT)[16]. 
 
Materials and Methods 
 
Building the genome-scale metabolic model 
 
Developing a genome-scale metabolic model 
involves three major steps (i) producing an 
initial draft reconstruction (ii) manual curation 
and (iii) validation with experimentally 
observed results [15]. The last two steps are 
iteratively repeated in order to train the model 
to describe the observed metabolic processes 
better [15]. 
 
a)   Automated metabolic draft reconstruction 
 
The TrypanoCyc database is a community 
annotated metabolic database specific to T. 
brucei [7]. In addition to gene-protein-reaction 
(GPR) associations, the database contains 
annotations  and  comments  on  the  cellular 
localization of the enzymes and the cell cycle 
stage(s) they have been reported to be active 
in. The TrypanoCyc-based model in the 
Systems Biology Markup Language (SBML) 
format  was  generated  using  Pathway 
Tools[11]. This model was further processed 
by replacing generic metabolites in the model 
such as NADH-P-OR-NOP with specific 
metabolites such as NADH and NADPH. 
Additional data available on TrypanoCyc such 
as confidence scores and annotations from 
experts were also added to the model. 
 
Although,  the  TrypanoCyc-based  model 
inherits the curated metabolic information 
available in TrypanoCyc such as metabolic 
reactions, thermodynamic constraints, GPR- 
relationships, cellular localization,  confidence 
scores, stage specific activity  of enzymes, etc; 
it lacks many model elements such as transport 
reactions, exchange reactions and biomass 
equation required to perform flux balance 
analysis (FBA), a mathematical approach used 
to compute the flow of metabolites in a 
metabolic network at steady state [17]. 
 
In order to generate this missing information, 
we took advantage of the previous efforts in 
modelling trypanosomatid metabolism, more 
specifically, the manually curated iAC560 
genome-scale metabolic model [18] of the 
closely related species Leishmania major. 
Applying the AUTOGRAPH pipeline [19] to 
Leishmania major and T. brucei genomes, we 
were able to create a T. brucei model based on 
information contained in  iAC560  model. The 
AUTOGRAPH pipeline involves the 
identification of all pairs of orthologous genes 
in the two closely related species and then uses 
the Gene-protein-reaction (GPR) relationship 
information in  the existing manually curated 
models of one of these organisms to develop 
an initial metabolic draft of the other. A 
modified in-house Inparanoid [20] stand alone 
package  was  used  to  identify  orthologous 
genes between the translated coding sequences 
(CDS) of T. brucei and L.major, which were 
available  from the  TritrypDB  database.  This 
orthologous genes information was then used 
to extract the associated reactions from the 
iAC560 model to generate an iAC560-based-T. 
brucei-model. 
 
The iAC560-based-T.brucei-model and the 
TrypanoCyc-based model were then merged to 
develop a partially curated draft (see Figure 1).
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Since the TrypanoCyc database uses MetaCyc 
[21] identifiers for metabolites and the 
iAC560-based model uses BiGG [22] 
identifiers, the models derived from them 
inherited their respective metabolite and 
reaction identifiers (IDs). The MetaCyc IDs in 
the TrypanoCyc-based model were converted 
to BiGG IDs in order to facilitate merging of 
the two models. An attribute called the sbml-
merge-index was used to track the origin of 
every reaction in the merged model. An sbml-
merge-index of 3 meant the reaction was 
imported from the TrypanoCyc-based model 
while an sbml-merge-index of 2 meant the 
reaction was originally present in the iAC560-
based-T.brucei-model (the sbml-merge-index 
of 1 was reserved for hypothetical reactions 
added during manual curation). When a 
reaction was identified to be present in both the 
draft models, it was assigned an sbml merge 
score of 5 (3 + 2).  
a) Manual curation, simulation and validation 
loop 
Manual curation is the most time consuming 
step in developing genome-scale metabolic 
networks and is only limited by time or 
available biological information[15]. All 
properties of the elements in the model such as 
GPR relationships, intracellular localization of 
reactions, reaction reversibility, etc were 
closely inspected and validated. Manual 
curation was followed by model simulations 
and the validation of these simulation results 
by comparing them to experimental data. In 
case of discrepancies between simulation 
results and experimental data, the model was 
further curated and the process was repeated.  
One of the most important manual curation 
steps involves the curation of the biomass 
equation. A biomass equation is a pseudo 
chemical reaction used in genome-scale 
metabolic reconstructions to represent the 
consumption of metabolites towards 
biomass[23]. It is usually comprised of amino 
acids (for protein building), lipids (for cellular 
composition, signalling, etc), carbohydrates 
(for energy storage), polyamines (for dealing 
with osmotic stress, etc), deoxyribonucleotides 
(for DNA), ribonucleotides (for RNA)  and 
ATP (to represent energy required for growth) 
[15]. Biomass equations are organism-specific 
and hence the iAC560 biomass equation had to 
be modified to better represent T. brucei 
biomass. Mannan is the main carbohydrate 
found in L.major [24] but it is not found in T. 
brucei and hence had to be replaced with 
glucose since no storage sugar has been 
identified in T. brucei so far. Lipid 
composition of T. brucei was obtained from 
published literature [5] and trypanothione was 
also added to the biomass since it was deemed 
to be essential in the parasite cell [25]. 
The model was also curated based on 
information regarding enzyme activity,  
 
The model was also curated based on 
information regarding enzyme activity, 
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enzyme localization, validated pathways, 
reported transport mechanisms and T. brucei 
responses in various RNAi and medium 
perturbations studies,  inferred from published 
articles (supplemental data 4), Database 
annotations and personal communication with 
biologists actively studying the T. brucei 
metabolism. 
 
During the course of the manual curation and 
model validation cycle, in addition to the 
biomass, the initial metabolic model underwent 
139 additions, 637 deletions and 129 
modifications. Hypothetical reactions such as 
transport and exchange reactions lacking 
definite proof were tracked by assigning an 
sbml-merge-index with a value of 1. The final 
curated T. brucei  metabolic model has 1077 
genes and was hence named iSS1077 based on 
the naming convention introduced by Reed et 
al in 2003 [26]. Figure 1 provides an overview 
of the genome-scale metabolic reconstruction 
pipeline. 
 
Flux Balance Analysis 
 
Flux balance analysis (FBA) is a mathematical 
approach used to study the flow of metabolites 
in a metabolic network at steady state. FBA is 
performed by converting the metabolic model 
into a set of linear equations and then solving 
them for the optimal value of the objective 
function under a set of specified linear 
constraints [17]. 
 
Changes in concentration of metabolites in a 
model over time can be represented by the 
product of its stoichiometry matrix (S) and a 
vector of the flux through all the reactions (v). 
When a model is at steady state, the change in 
concentration of metabolites is equal to 0. 
 
=>                     S.v = 0 
 
This assumption generates a set of m linear 
equations with r variables where m and r are 
the number of metabolites and reactions in the 
model.  A  set  of  upper  bounds  and  lower 
bounds for the reaction fluxes is used to 
constrain the solution space obtained when 
solving the linear equations. 
 
=>                 LBi ≤ fi ≤ UBi 
 
,where fi is the flux through ith 
reaction      in      the      model 
and LBi and UBi are the upper 
and lower limits for fi 
These bounds can be derived from reaction 
capacity or thermodynamic (directionality) 
information. Biologically meaningful solutions 
in this solution space are then identified by 
optimizing an objective function. 
 
=> 
 
optimal solution, Z = max(v
T
.c) or min(v
T
.c) 
 
,where v
T  
is the transpose of 
vector of fluxes v  and c is the 
vector of the coefficients of 
reactions in objective function 
 
The objective function represents the cellular 
objectives of the cell. In the case of T. brucei, 
as  typically  assumed,  biomass  accumulation 
was proposed as the objective of cellular 
metabolism  and  hence  the  biomass  equation 
was set as the objective function. 
=>        optimal solution, Z = max(fbiomass) 
Linear  programming  optimization  was  then 
performed to identify a state of the model at 
which biomass production is maximized. The 
result of this optimization is a flux distribution, 
providing flux values for all the network 
reactions    when    biomass    production    is 
maximized. FBA problems are very likely to 
have more than one optimal solution and hence 
more than one optimal flux distribution. 
Analyses such as Flux variability analysis 
(FVA) are used to explore these alternate 
solutions. FBA analyses on the iSS1077 were 
performed using the COBRApy package[27]. 
 
Flux Variability Analysis 
 
Flux variability analysis (FVA) is a technique 
that uses FBA analyses to calculate the 
maximum   and   minimum   possible   fluxes 
through a reaction when the objective function 
is constrained to an optimal or suboptimal 
value[28]. In this study, FVA analyses were 
used to identify reactions in the metabolic 
network that are incapable of carrying any flux 
(i.e the maximum and minimum flux through 
these reactions are 0) when biomass production 
was   optimized.   One   of   the   objectives   of 
manual curation is to minimize these blocked 
reactions  and  hence  FVA  helps  to  identify 
parts of the model that require curation. 
 
Another application of FVA is to help 
identifying parts of the metabolic network that 
require   curation   to   'unblock'   a   blocked
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reaction. This was achieved by temporarily 
adding, for each metabolite in the model, a 
reversible exchange reaction that transports the 
metabolite from/to the model, one metabolite 
per iteration and performing FVA analysis on 
the blocked reaction of interest in each case. 
The list of metabolites for which the exchange 
reactions allowed a flux through the previously 
blocked reaction of interest then helps 
identifyparts   of   the   metabolism   that   may 
require curation to “unblock” the blocked 
reaction. 
 
Gene and reaction deletion studies 
 
Gene and reaction deletion studies are used to 
simulate the metabolic behaviour of the 
parasites when a particular gene is silenced or 
a reaction is controlled.  The knock out (KO) 
of a single gene is simulated by enforcing a 
zero flux through all reactions for which the 
associated protein is essential for catalysis. 
Genes for which the simulated KO results in a 
zero flux through the biomass equation are 
predicted to be essential for T. brucei growth 
according  to  the  metabolic  model  and  are 
called essential  genes  (or lethal  genes) [29]. 
Similarly, a reaction deletion is simulated by 
forcing a zero flux through the particular 
reaction and observing its effect on the model. 
 
Single gene deletion studies for all 1077 genes 
in the iSS1077 model were performed in order 
to predict their essentiality in T. brucei 
metabolism. Double gene deletion studies were 
similarly performed by knocking out in silico 
pairs of genes that have been identified as not 
essential from single gene deletion studies and 
observing their effects on biomass production. 
Gene pairs for which the deletion results in a 
zero biomass flux are identified as lethal-gene- 
pairs or essential-gene-pairs. 
 
In the case of single reaction deletion studies, 
the effects of temporarily forcing a zero flux 
through all 1689 reactions, one reaction at a 
time, on the flux through the biomass equation 
is observed. As in gene deletion studies, a zero 
biomass flux in reaction deletion simulations 
suggests that the reaction “deleted” is essential 
in T. brucei according to the metabolic model. 
Similar to double gene deletions, double 
reaction deletion studies involved by forcing a 
zero  flux  through  all  pairs  of  reactions  that 
have  been  identified  as  not  essential  from 
single reaction deletions. Reaction pairs where 
the “deletion” results in a zero biomass flux are 
identified as essential reaction-pairs. 
 
These analyses for the iSS1077 were also 
performed using the COBRApy package. 
 
Internal validation of the metabolic model 
 
Internal validation of the model was performed 
in order to confirm that the model respects the 
law of conservation of mass, one of the basic 
constraints in constraint-based modelling [14]. 
This test involves blocking all exchange 
reactions in the model and adding a temporary 
drain (an exchange reaction to transport the 
metabolite from the model to the extracellulart 
space) for a metabolite in the model. This drain 
is then set as the objective for the simulation 
and FBA analysis is performed. If the model is 
able  to  sustain  a  flux  through  this  drain,  it 
infers   that   the   model   is   producing   the 
particular metabolite from nothing.. For 
example in the case of ATP in the cytoplasm, 
once the flux through all exchange reactions in 
the model are blocked, a reaction draining 
cytoplasmic ATP was created and set as the 
objective for linear optimization. A non zero 
solution of the optimization suggests that 
cytoplasmic ATP is being generated in the 
model without any nutrients being required by 
the model. This situation is a clear violation of 
the law of conservation of mass, one of the 
basic principles of chemistry. This test was 
performed for every metabolite in the model. 
 
External validation of the metabolic model 
 
External validation of the metabolic model was 
performed by simulating single gene and 
reaction deletion studies for all the genes and 
reactions in the model and validating the 
predicted gene and reaction essentiality with 
published RNAi/KO and essential nutrients 
results. The number of positives and negatives 
prediction results gives an insight into the 
prediction accuracy of the model. 
 
Evaluating the need for stage-specific model 
 
RNAi and KO results reported in 27 published 
studies (see Table 1) were used to generate a 
list of 68 gene deletions scenarios for which 
lethality (if the deletion of the gene is lethal to 
the model or not) is known in Blood stream 
forms (BSF), Procyclic forms (PRO) or in both 
the life-cycle stages. In silico gene deletion 
studies  were  used to  evaluate  the iSS1077’s
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prediction accuracy in these deletion scenarios. 
Attention was also focussed on how well the 
model performs when simulating only the 
deletion   scenarios   for   which   a   common 
response (lethal or not lethal) was observed in 
both BSF and PRO. 
 
Preprocessing     experimental     data     and 
TrypanoCyc comments 
 
Two comparative SILAC proteomics datasets 
from Urbaniak et al [30], Gunasekaran et al 
[31] and one ribosomal profiling dataset from 
Vasquez et al [32] were collected to develop 
BSF models. The datasets were separately 
processed to generate four gene activity files 
where genes were given a score of 1, 0 and -1 
based on whether the gene was associated with 
a highly expressed protein, a protein for which 
expression data is unclear or a protein with 
lower expression based on the data. In the case 
of the two comparative proteomics datasets, a 
protein expressed higher in the blood-stream 
Analysis Tool (iMAT) algorithm proposed by 
Shlomi et al [16] uses gene expression data 
and  Mixed Integer  Linear  Programming 
(MILP) optimization to generate a context- 
specific model from a global genome-scale 
model. Reaction activity input files based on 
BSF data are used by the algorithm to tag 
reactions as highly expressed and lowly 
expressed reactions. It then creates an MILP 
problem to maximize the instances of a flux 
greater than a minimum threshold through the 
highly expressed reaction and the instances of 
a flux lower than the threshold through the 
lowly expressed reactions. The MILP problem 
can be described as 
 
+          -                   + 
=>        max(∑(yi   + yi ) + ∑(yj  )) 
 
where i ϵ the set of highly expressed reactions 
RH, j ϵ the set of lowly expressed reactions RL , 
y 
+  
is a Boolean variable that takes a value 1 
i 
only  when  the  flux  through  the  reaction  is 
greater  than  the  threshold  in  the  forward 
-
form  compared  to  the  procyclic  form  was direction, yi is the Boolean variable that takes
given a score of 1 while others were given a 
score  of  0.  In  the  case  of  the  ribosomal 
profiling    data,    proteins    associated    with 
translational    efficiencies    greater  than  1  , 
between 1 and -1 and lower than -1 were given 
scores  1,  0  and  -1  respectively.  Each  gene 
activity  file  was  then  used  to  generate  a 
reaction activity file where reactions were 
assigned a score of 1, 0 and -1 based on their 
GPR relationships. 
 
The TrypanoCyc database houses expert 
annotations on the stage specific T. brucei 
reaction activity. Like the other datasets 
discussed  earlier,  reactions  reported  to  be 
active and not active in BSF stages were given 
a   score   of   1   and   -1   respectively.   Other 
reactions were given a score of 0. 
 
These five reaction activity files for BSF 
generated from three experimental datasets and 
the TrypanoCyc annotations were then used for 
developing BSF models using the iMAT 
algorithm [16]. 
 
Developing Blood stream form models using 
iMAT 
 
T. brucei parasites display different metabolic 
capabilities during the different stages of their 
life-cylce. Hence all reactions in the iSS1077 
may not be active in all developmental stages 
of  the  parasite.  The  integrative  Metabolic 
a  value  1  only  when  the  flux  through  the 
reaction is greater than the threshold in the 
reverse   direction   and   yj
+     
is   the   Boolean 
variable that takes a value 1 only when the flux 
of through the reaction is lower than the 
threshold (irrespective of the direction). 
 
A BSF model was built by removing reactions 
of the genome-scale metabolic model that 
carries a zero flux in the iMAT solution. This 
BSF model will hence be a sub-model of the 
initial iSS1077 model encompassing only the 
specific metabolic capacities of the BSF form 
T. brucei. 
 
Results 
 
Genome scale metabolic reconstruction 
 
The  genome-scale  metabolic  model  for 
T.brucei was built using the pipeline described 
in Figure 1. The TrypanoCyc-based model 
consisted of 1246 reactions, 1408 metabolites 
and 861 genes. This primary model lacks a 
biomass equation and many intracellular 
transport and exchange reactions. This 
additional information was gathered in a 
secondary  T.  brucei  model  based  on 
information contained in the Leishmania 
iAC560   model.   More   precisely,   ortholog 
groups  between  L.major and  T.  brucei  were 
used to generate the iAC560-based T. brucei 
model  as  described  by  the  AUTOGRAPH
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pipeline[19]. 5324 ortholog groups between 
L.major and T. brucei were identified using the 
Inparanoid tool[33]. The resulting model 
consisted of 968 reactions, 1099  metabolites 
and 393 genes. The TrypanoCyc-based model 
and   the   iAC560   based   model   were   then 
merged to generate a semi-curated metabolic 
model of T. brucei with 2195 reactions, 2006 
metabolites and 1095 genes. This model was 
then subjected to manual curation and the final 
manually curated version of the model named 
iSS1077 has 8 compartments, 1689 reactions, 
1677 metabolites and 1077 genes. 
 
General properties of the genome-scale 
metabolic model 
 
The iSS1077 model contains Gene-protein- 
reaction (GPR) relationships for 1077 genes. 
This accounts for 10.5 % of genes in the T. 
brucei 927 genome obtained from the 
TriTrypDB  database.  Of  the  1689  reactions, 
the model comprises 1193 metabolic reactions, 
495  transport  reactions  and  a  biomass 
equation. The 495 transport reactions consist 
of  184  reactions  involved  in  exchange  of 
metabolites with the extracellular medium and 
321 reactions representing intracellular 
reactions.   The   model   also   contains   1677 
metabolites and 8 compartments. 
 
The  number  of  reactions  with  and  without 
gene-association in the model are found to be 
911(54%) and 778(46%) respectively. Of the 
reactions without gene association 129 are 
related to exchange of nutrients with the 
extracellular space, 307 are intracellular 
transport reactions, 12 reactions are related to 
source and sink reactions required for 
simulations and the remaining 330   reactions 
(27.7 % of total reactions) are involved in 
chemical transformations. The breakdown of 
iSS1077   reactions   based   on   the   type   of 
reaction,    EC number and    intracellular 
localization are summarized in Figure 2. 
 
In silico gene KO and reaction deletion 
studies 
 
43 genes were identified as lethal/essential 
genes through single gene deletion analysis. In 
silico double gene deletion studies involving 
only the non-lethal genes identified by the 
previous single gene deletion study predicted 
22 lethal gene pairs. The genes in these gene- 
pairs   were   predicted   to   be   not   essential 
individually but a knock-out of both the genes 
results  in  a  zero  flux  through  the  biomass
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equation. 
 
Single reaction deletion analysis was also 
performed in order to identify the essential 
reactions in the metabolic network. 99 essential 
reactions were identified from this analysis of 
which only 9 reactions and the biomass 
equation were not catalyzed by a T. brucei 
gene. Double reaction deletion studies of the 
remaining reactions revealed 319 essential  
reactions  pairs  including  two exchange 
reaction-pairs. 
 
Internal and external validation of the 
genome-scale metabolic model 
 
Internal validation of the metabolic model was 
performed to confirm that the metabolic model 
does  not  violate  the  law  of  conservation  of 
mass  (see  method  section).  The  accuracy of 
single gene and reaction deletion results 
provides an insight into the quality of the 
metabolic model. Results of RNAi or KO 
experiments from published studies were 
compared to the predicted essential genes to 
determine the accuracy of the in silico gene 
deletion studies.  26 of the 43 lethal genes have 
already been validated as essential in various 
studies (see supplementary data 1). Of the 
remaining 
17 predicted essential genes, 11 have been 
associated    with    experimentally    validated 
essential pathways such as the Kennedy 
pathway[5],           [34]–[36],           isoprenoid 
biosynthesis[37]. 
 
Of the 99 essential reactions, 14 are exchange 
reactions used to maintain fluxes and 17 are 
intracellular transport reactions. 36 of the 69 
remaining reactions have already been 
experimentally validated to be essential while 
19 reactions are associated with essential 
pathways ubiquinol biosynthesis[38] and 
Kennedy pathway. Three of predicted essential 
reactions have been identified as not essential 
based the literature (see supplementary data 3). 
 
Essential reaction studies also revealed 
exchange reactions which were essential for 
biomass built up. Of the 14 essential exchange 
reactions, 10 are reactions associated with the 
the uptake of amino acids L-lysine, L-valine, 
L-tryptophan, L-isoleucine, L-histidine, L- 
leucine, L-tyrosine, L-phenylalanine and L- 
cysteine and have already been proposed as 
essential nutrients for T. brucei survival [39]. 
Uptake of L-ornithine was also predicted as 
essential   from   the   analysis,   which   is   in 
agreement with the fact that T.brucei does not 
have a functional arginase and other pathway 
for  ornithine  biosynthesis  is  not  known  in 
brucei [40]. Double reactions deletion studies 
reveales   two   pairs   of   essential   exchange 
reaction  pairs.  The  throenine-homoserine 
uptake  reaction  pair  suggests  either 
homoserine or threonine is required by the 
model. This is in  accordance  with what has 
been reported in published literature [6] where 
it was found that T. brucei procyclics are 
capable of converting homoserine to threonine 
while blood-stream forms need threonine 
directly from the host. 
 
Evaluating   the   need   for   stage   specific 
models 
 
In  order  to  determine  if  there is a  need for 
refining the genome-scale model to stage 
specific criteria,  we collected validated  gene 
essentiality data from 27 published studies (see 
references in Table 1) to evaluate the quality of 
the iSS1077 model. Information was gathered 
on 68 gene deletion scenarios associated with 
the metabolism across the two major life cycle 
stages of the T. brucei parasite, namely, the 
procyclic  (insect  stage)  form (PRO)  and  the 
blood stream form (BSF). Of the 68 gene 
deletion  scenarios,  35  were  reported  to  be 
lethal in BSF, 7 were lethal in PRO, 4 were 
non-lethal   in BSF, 8 were non-lethal in both 
BSF and PRO, 13 were lethal in both the BSF 
and PRO forms and in 1 case lethal effects 
where observed in BSF but not in PRO (Table 
1). The essentiality of these genes in the  T. 
brucei  genome-scale  model  was  tested  by 
using   FBA.   Genes   involved   in   8   of   the 
reported gene deletion scenarios were found to 
be absent from the model. For the remaining 
62   genes,   the   essentiality   of   the   genes 
predicted from the model was in only 55% 
agreement with the reported essentiality. It was 
observed that most of the false negative 
predictions (25 out of 32) were observed for 
genes essential in either BSF or PRO stages. 
When the model was used to predict the 
essentiality of only the genes reported to be 
essential or not in both BSF and PRO stages, 
the model performed much better with a 
prediction   accuracy   of   75%.   Hence   the 
genome-scale  model  was able to  predict the 
properties of the  metabolism common  to  all 
forms of the parasite with reasonable accuracy. 
However the results emphasize that there is a 
need for building stage-specific models when
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Figure 3 : Consistency of  predictions of the  iSS1077 model with published data 
(a) Consistency with T.brucei behaviour 
from all studies 
(b) Consistency with T.brucei behaviour 
common to both BSF and PRO
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studying  the  stage-specific  parasite 
metabolism. Table 1 compares the predictions 
of essentiality of genes with information 
published from previous studies. 
 
Building Blood stream form models 
 
BSF models were generated from three 
published experimental datasets [30]–[32] (see 
methods) and based on the annotations stored 
in the TrypanoCyc database using the iMAT 
algorithm [16]. Results from the external 
validation of the four BSF models are shown in 
Table 2. We can see that the predictions from 
the BSF models built using Urbaniak et al, 
Gunasekaran et al, and Vasquez et al, were 
74%, 70% and 74% in accordance with 
published information respectively. The BSF 
model   built   from   TrypanoCyc   annotator 
comments was found to be more in accordance 
with the data (75%) than the other models. 
 
Discussion 
 
In this paper, we present the first manually 
curated genome-scale metabolic network 
reconstruction of the protozoan parasite 
Trypanosoma brucei, responsible for Human 
African Trypanosomiasis. Apart from normal 
eukaryotic features, T. brucei possesses 
additional features such as glycosomes, a 
kinetoplast, flagellum and a GPI-linked 
protective coat composed of variable surface 
glycoprotein (VSG) in blood stream forms[41] 
and procyclins in the procyclic form[42]. 
Glycosomes  are  peroxisome-like  membrane 
bounded organelles and are known to house 
enzymes responsible for essential metabolic 
pathways such as  glycolysis, gluconeogenesis 
[43], mevalonate pathway [44] and isoprenoid 
biosynthesis [44], [37], [45]. Glycosomal 
enzymes are most commonly identified by the 
presence   of   peroxisomal   targeting   signals 
(PTS1 at the C-terminal or PTS-2 at the N- 
terminal)   [46].   The   presence   of   proteins 
without  PTSs  in  the  glycosomes  identified 
from   glycosomal   proteome   extracts   also 
support other theories such as the   “piggy- 
back” transport of proteins on proteins with 
PTSs [47]. 85 reactions have been annotated to 
be   glycosomal   in   TrypanoCyc   and   125 
reactions were annotated to be glycosomal 
based on the iAC560 L.major model. The 
TriTrypDB [8] and GeneDB [9] databases 
contain enzyme-localization information and 
have proven to quite useful during the curation 
stages and the final iSS1077 model has 84 
glycosomal reactions. The T. brucei flagellar 
activity is important in parasite survival and 
clearance of immunoglobulim (Ig) bound 
VSG[48]. Given this importance, the flagellum 
has been represented in iSS1077 with the 
flagellar ATPase that generates energy for the 
flagella based motion[48]. VSG coats are 
essential for T. brucei survival in mammalian 
host[41]. Since the VSG is by definition 
variable, its exact composition cannot be 
determined. In order to try and overcome this 
issue, we have used   a drain of   Glycosyl- 
phosphatidyl Inositol (GPI) anchor precursors
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from the metabolic network to approximate for 
VSG formation. 
 
The design of the biomass equation is very 
important in genome-scale-metabolic 
reconstructions, especially in studies where the 
biomass build up is considered as the objective 
of the organism. In this reconstruction we had 
primarily used the growth function from the 
iAC560 L.major model which in turn derives a 
part of its biomass equation from studies on 
E.coli and other organisms [18]. The 
composition of this biomass equation was 
updated using T. brucei data available in 
published  literature.  Since  biomass 
composition  varies  with  change  in 
environments  and  the  changes  in  the 
coefficient of biomass components is known 
not to significantly affect the overall biomass 
yield [49], [50], the iAC560 coefficients for 
the metabolites were considered sufficient for 
the reconstruction. From accuracy of the gene 
and reaction deletion results of the genome- 
scale metabolic model and from the prediction 
quality of the BSF models, we can see that the 
biomass equation in iSS1077 is sufficiently 
designed for qualitative studies such as 
predicting gene/reaction lethality. 
 
Results of gene essentiality studies on genome- 
scale  metabolic  networks  provide  an  insight 
into the vulnerabilities of the cell. These results 
can also be compared to currently known 
information to evaluate the quality of the 
metabolic model. 26 of the 43 predicted 
essential  genes  from our  study have  already 
been validated. One of the major applications 
of in silico KO studies is the generation of 
hypotheses which provide additional direction 
to search for novel drug targets against T. 
brucei. The remaining 17 genes are 
hypothesized as essential genes and should be 
investigated for their importance in T. brucei 
metabolism,   especially   the   11   in   silico 
essential genes associated with essential 
pathways. 
 
The iSS1077 also has 328 metabolic reactions 
for which the T. brucei catalyzing enzyme is 
unknown. However, apart from the biomass 
equation, only 9 of them were identified to be 
essential in reaction essentiality studies. 7 of 
these 9 essential non-catalyzed reactions are 
involved in Ubiquinone-10 biosynthesis. The 
remaining 2 are methionine-synthase,  a false 
positive prediction owing to a missing reaction 
in the model, and alkyl 
dihydroxyacetonephosphate   (DHAP) 
reductase. Alkyl-DHAP reductase is involved 
in the synthesis of alkylacylglycerol (AAG) 
from DHAP. The gene responsible for this 
reaction  has  not  yet  been  identified  in  T. 
brucei. AAG is required for ether phosphatidyl 
ethanolamine biosynthesis via the Kennedy 
Pathway, a known essential pathway in T. 
brucei [51][5][34]. Previous studies have 
pointed out that alkyl-DHAP reductase could 
be   glycosomal   [52].   Identification   of   the 
enzyme  responsible  for  this  reaction  could 
prove helpful in controlling T. brucei growth. 
 
Combining experimental data with genome- 
scale metabolic models is extremely useful in 
understanding  metabolism.  The  most 
commonly studied forms of T. brucei are the 
procyclic   forms   (PRO)   and   blood-stream- 
forms (BSF). These forms of the same parasite 
exhibit many differences in their metabolism. 
A simple example of this is can be observed in 
the initial stages of the threonine metabolism. 
Threonine in T. brucei is used in peptide 
biosynthesis and as a source for acetyl-CoA, an 
important   precursor   in   lipid   biosynthesis. 
Figure 4 describes the initial steps in threonine 
metabolism in T. brucei. Both forms of T. 
brucei can take up threonine from the medium 
but only the PRO is capable of using 
homoserine from the medium. This makes 
threonine   an   essential   nutrient   in   BSF. 
However, when using the iSS1077 model, one 
cannot predict that threonine uptake is essential 
unless homoserine uptake is removed from the 
network. Many such differences in metabolism 
are present in T. brucei and hence, in order to 
accurately predict BSF behaviour, the genome- 
scale metabolic model has to be converted to a 
BSF  model  when  studying  BSF  behaviour. 
This also means that when using genome-scale 
models to understand experimental results one 
has to convert the generic model to a 
stage/context specific model before integrating 
it with the data. We have highlighted this issue 
in our results by comparing published gene- 
essentiality data  with  model  predictions  (see 
Table 1 and Table 2).   The need for context 
specific models has already been identified in 
other organisms[16], [53], [54] and many 
techniques have been implemented in order to 
develop tissue specific models from genome- 
scale models [22] further cementing our 
conclusion. As in multicellular organisms, this
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issue should be more prominent in organisms 
like trypanosomatids that display very different  
metabolisms at different developmental 
stages[4], [5], [55]. 
Having showed that BSF models developed 
using iMAT from the TrypanoCyc comments 
provided better predictions than the ones 
developed from high-throughput experimental 
data sets, it seems to be evident that data from 
experiments targeting specific enzymes and 
pathways can lead to a much more accurate 
understanding of metabolism. Although 
collection of individual annotations/notes on T. 
brucei metabolism for free access such as the 
ones available on TrypanoCyc, TriTrypDB, 
GeneDB, etc can be time-consuming and 
cumbersome, the end result being a cache of 
extremely valuable information makes the 
effort worthwhile. 
We have shown that BSF models generated 
using the iMAT algorithm performed 
significantly better than the generic genome-
scale model in predicting BSF behaviour. 
Nevertheless, these models still show some 
inaccuracy in gene essentiality predictions. The 
search for reducing errors in generating BSF 
models led us to an observation on the 
underlying assumptions of the iMAT 
algorithm.  Although, the algorithm tries to 
maximize the number of reactions catalyzed by 
proteins identified to be expressed from 
experimental data, it does not however take 
into consideration that an enzyme being 
expressed could mean that only one reaction 
catalyzed by that enzyme is “active” and not 
all the reactions catalyzed by the enzyme have 
to be active. Including this criterion into iMAT 
could help generate better tissue/life-cycle-
stage specific models.  
Genome-scale metabolic models are never 
perfect and are always limited by the amount 
of information available on the metabolism. 
They have to be continuously curated based on 
information gathered from ongoing research. 
Two prominent examples of this are the 
Recon1[56] and Recon2[13] reconstructions 
for H.sapiens and iJE660[57], iJR904[26], 
iAF1260[58] and iJO1366[59] reconstructions 
for E.coli. The iSS1077 model will not be 
exempted from this paradigm and will have to 
undergo continuous curation. One potential 
direction of improvement is working on 
glycosomal metabolism. One of the interesting 
facts about glycosomes in T. brucei is that it 
does not allow the exchange of the popular 
currency metabolites ATP, ADP, NADP and 
NADPH among others, with the cytosol [60]. 
This suggests that a balance in the 
consumption and production of these 
metabolites has to be maintained in the 
glycosome and any disruption to this balance 
can lead to the failure of 
glycolysis/gluconeogenesis. Since we did not 
have enough information to set adequate 
constraints on fluxes to reproduce the large 
difference between the fluxes through 
glycolysis/gluconeogenesis and other reactions 
of the metabolic network, the model is unable 
to reproduce the perturbations of the ATP/ADP 
and NADP/NADPH balance in the glycosome. 
Another avenue to improve the iSS1077 model 
would be to curate the coefficient of biomass 
 
Figure 4 : Initial stages of 
threonine metabolism in 
T.brucei 
Both procyclic and blood-
stream forms of T.brucei are 
capable of threonine uptake 
from the medium. Procyclic 
forms are also capable of 
using homoserine from the 
medium to synthesise 
threonine with the help of 
enzyme homoserine kinase 
(HSK) and threonine 
synthase (ThrS). 
Genome-scale metabolic models are never 
perfect and are always limited by the amount 
of information available on the metabolism. 
They have to be continuously curated based on 
information gathered from ongoing research. 
Two prominent examples of this are the 
Recon1[226] and Recon2[72] reconstructions 
for H. sapiens and iJE660[227], iJR904[61], 
iAF1260[228] and iJO1366[71] 
reconstructions for E. coli. The iSS1077 m del 
will not be exempted from this paradigm and 
will have to undergo continuous curation. One 
potential direction of improvement is working 
on glycosomal metabolism. One of the 
interesting facts about glycosomes in T. brucei 
is that it does not allow the exchange of the 
popular currency metabolites ATP, ADP, 
NADP and NADPH among others, with the 
cytosol [229]. This suggests that a balance in 
the consumption and production of these 
metabolites has to be maintained in the 
glycosome and any disruption to this balance 
can lead to the failure of 
lysis/gluconeogenesis. Since we did not 
h ve enough info mation to set adequate 
constraints on fluxes to reproduce the large 
difference between the fluxes through 
glycolysis/gluconeogenesis and other reactions 
of the metabolic network, the model is unable 
to reproduce the perturbations of the ATP/ADP 
and NADP/NADPH balance in the glycosome. 
Another avenue to improve the iSS1077 model 
would be to curate the coefficient of biomass 
constituents, which could generate more 
accurate predictions of quantitative properties 
of the model ( e.g. the sensitivity of the odel 
92 
 
 
  
growth rate to the availability of model 
metabolites ).  Being the result of the merging 
of two sbml models using different ID systems, 
the iSS1077 has metabolite and reaction IDs in 
both Biocyc and Bigg IDs. To overcome this 
inconvenience, we have gathered additional 
information on the metabolites 
(Inchi/Smiles/Kegg IDs/Chebi IDs).  Lastly, 
because of the lack of information available on 
intracellular transporters, many intracellular 
transport reactions in iSS1077 are not 
associated with transporters and remain 
hypothetical.  
Conclusion 
 
Genome-scale metabolic models have proven 
to be very useful in interpreting omics datasets 
and studying metabolism at a cellular level. In 
this article we have presented the first 
manually curated genome-scale reconstruction 
of T. brucei and have discussed the need for 
context and developmental-stage specific 
models prior to analysis in order to improve 
the analysis results. 
The lack of an efficient treatment regime and 
the lethal nature of the disease fuels the study 
of Human African Trypanosomiasis. Having 
focussed on the reconstruction in this article 
we have explored only some of the iSS1077’s 
potential. With recent developments in high-
throughput omics technologies, the 
development of novel techniques such as 
genome-scale RNAi screening[61] and 
improvements in their efficiency, huge datasets 
are available for integration with the metabolic 
model. The results from this integration should 
help in a better interpretation of the T. brucei 
metabolism. 
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Table 1: Comparison of results from published studies with predictions from the iSS1077 model 
  
Gene/Name T. brucei genes Deletion lethal as 
observed in studies? 
Deletion 
predicted 
as lethal? 
ELO1 Elongase 1 Tb927.7.4160 No (both) [5] false 
ELO2 Elongase 2 Tb927.7.4170 No (both) [5] false 
ELO3 Elongase 3 Tb927.7.4180 No (both) [5] false 
ELO4 Elongase 4 Tb927.5.4530 No (BSF) [5] - 
ASC5 Acyl-CoA synthetase 5 Tb927.10.3260 No (both) [5] false 
ACBP Acyl-CoA binding protein Tb927.4.2010  & Tb927.11.12830 BSF[5] - 
CK Choline kinase 2 Tb927.11.2090 Both[5] true 
CCT Choline-phosphate 
cytidylyltransferase 
Tb927.10.12810 PRO[5] true 
CPT Choline phosphotransferase Tb927.10.8900 PRO[5] true 
EK Ethanolamine kinase 1 Tb927.5.1140 PRO[5] true 
ECT Ethanolamine-phosphate 
cytidylyltransferase 
Tb927.11.14140 Both[5] true 
EPT Ethanolamine 
phosphotransferase 
Tb927.10.13290 Both[5] true 
CTPS CTP synthase Tb927.1.1240 BSF[5] false 
CLS Cardolipin synthase Tb927.4.2560 PRO[5] false 
PGPS 
Phosphatidylglycerophosphate 
synthase 
Tb927.8.1720 PRO[5] true 
PSS/PSS2 PS synthase/PS 
synthase-2 
Tb927.7.3760 Both[5] true 
PSD Phosphatidylserine 
decarboxylase 
Tb927.9.10080 BSF[5] true 
INO1 Inositol-3-phosphate 
synthase 
Tb927.10.7110 BSF[5] false 
PIS Phosphatidylinositol 
synthase 
Tb927.9.1610 Both[5] true 
GPI-PLC GPI phospholipase C Tb927.2.6000  No (BSF) [5] false 
SMase Neutral sphingomyelinase Tb927.5.3710 Both[5] false 
PLA1 Phospholipase A1 Tb927.1.4830 No (both) [5] false 
LPLA1 Lyso-phospholipase A1 Tb927.9.12700  No (both) [5] false 
ALG3 Dol-P-Man -1,3-
mannosyltransferase 
Tb927.10.6530  No (BSF) [5] false 
GDMPP GDP-Man 
pyrophosphorylase 
Tb927.8.2050 BSF[5] false 
DOLK Dolichol kinase Tb927.9.12790 Both[5] false 
DPMI Dol-P-Man synthase Tb927.10.4700 Both[5] false 
CHW8 Dol-PP phosphatase Tb927.6.1820 BSF[5] false 
(PIG-L) GlcNAc-PI de-N-
acetylase 
Tb927.11.12080 BSF[5] false 
TbGPI10 Tb927.10.5560 BSF[5] - 
TbGPIdeAc2 Tb927.3.2610 BSF[5] - 
TbGUP1 GPI remodellase Tb927.10.15910 No (BSF) [5] false 
GPI transamidase subunit 8 Tb927.10.13860 BSF[5] - 
GPI transamidase subunit Gaa1 Tb927.10.210 BSF[5] - 
MDD Mevalonate-diphosphate 
decarboxylase 
Tb927.10.13560 BSF[5] true 
IDI Isopentenyl-diphosphate 
isomerase 
Tb927.9.9000 BSF[5] true 
 
- Prediction correct   - Prediction incorrect   
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IDI Isopentenyl-diphosphate 
isomerase 
Tb927.9.9000 BSF[5] true 
FPS Farnesyl-pyrophosphate 
synthase 
Tb927.7.3360 BSF[5] true 
PFT Protein farnesyltransferase 
-subunit 
Tb927.3.4490 BSF[5] false 
Trypanothione reducatase Tb927.10.10390 BSF[62] true 
Triose phosphate isomerase Tb927.11.5520 & Tb927.9.9820 BSF[62] false 
Phosphatidyl inositol 
phospholipase C 
Tb927.11.5970 No (both) [62] false 
Ornithine Decarboxylase Tb927.11.13730 BSF[63] true 
Spermidine Synthase Tb927.9.7770 BSF[64] true 
GS Glutathione sythetase Tb927.7.4000 BSF[65] true 
Arginine transport Tb927.11.6680 Both true 
dihydroorotate dehydrogenase, 
putative 
Tb927.5.3830 Both[66] false 
dihydrofolate reductase-
thymidylate synthase 
Tb927.7.5480 BSF[67] true 
aldolase Tb927.10.5620 BSF[68] false 
Glyceraldehyde-3-phosphate 
dehydrogenase 
Tb927.10.6880 & Tb927.6.4280 & 
Tb927.6.4300 & Tb927.9.9820 
BSF [68] false 
PFK Phosphofructokinase Tb927.3.3270 BSF[69] false 
PyK Pyruvate Kinase Tb927.10.14140 BOTH[70], [71] false 
HK Hexokinase Tb927.10.2010 & Tb927.10.2020 BSF[72] false 
PMM Phosphomannomutase Tb927.10.6440 BSF[73] false 
GNA1 Glucosamine 6-phosphate 
N-acetyltransferase 
Tb927.11.11100   BSF[74] false 
UAP UDP-N-acetylglucosamine 
pyrophosphorylase 
Tb927.11.2520 BSF[75] false 
PEPCK Phosphoenol pyruvate 
carboxykinase 
Tb927.2.4210 BSF, No(PRO) [76] false 
AAT Alanine Amino transferase Tb927.1.3950 PRO (when proline is 
the carbon source)[77] 
false 
6PGDH 6-phosphogluconate 
dehydrogenase 
Tb927.9.12110 BSF[76] false 
PDH pyruvate dehydrogenase 
and TDH throenine 
dehydrogenase 
Tb927.10.12700 & Tb927.3.1790 
& Tb927.6.2790 
BSF[55] false 
HSK Homoserinekinase Tb927.6.4430 no(BSF), no( in PRO 
in the presence of thr) 
[6] 
false 
SLS1+SLS2+SLS3+SLS4 Tb927.9.9410 & Tb927.9.9400 & 
Tb927.9.9390 & Tb927.9.9380 
Both[78] true 
Casiene Kinase Tb927.5.800 BSF[79] false 
galE UDP-galactose 4-epimerase Tb927.11.2730 BSF[80] false 
CDS CDP-DAG synthase Tb927.7.220 BSF[81] true 
ARD1 N-acetyltransferase 
subunit 
Tb927.11.4530 Both[82] - 
GMPS GMP synthase Tb927.7.2100 BSF[83] - 
iPGM cofactor independent 
phosphoglycerate mutase 
Tb927.11.11490 & Tb927.10.7930 PRO[84] false 
PTR1 Pteridine reductase 1 Tb927.8.2210 BSF[85] false 
 
95 
 
Table 2: Using published gene essentiality data to compare predictions of BSF models built from different data sources 
     Prediction correct    Prediction incorrect 
   
 Essentiality predicted by BSF models built from 
Enzyme Name Gene ID 
Deletion lethal 
according to 
published  data ? 
Predicted as 
essential in 
iSS1077 
Urbaniak Gunasekara Vasquez TrypanoCyc 
ELO1 Elongase 1 Tb927.7.4160 No (both)[5]  false false false false false 
ELO2 Elongase 2 Tb927.7.4170 No (both) [5] false false false false false 
ELO3 Elongase 3 Tb927.7.4180 No (both) [5] false false false false false 
ASC5 Acyl-CoA synthetase 5 Tb927.10.3260 No (both) [5] false false false false false 
CK Choline kinase 2 Tb927.11.2090 Both[5] true true true true true 
ECT Ethanolamine-phosphate 
cytidylyltransferase 
Tb927.11.14140 Both[5] true true true true true 
EPT Ethanolamine 
phosphotransferase 
Tb927.10.13290 Both[5] true true true true true 
CTPS CTP synthase Tb927.1.1240 BSF[5] false false - false false 
PSS/PSS2 PS synthase/PS 
synthase-2 
Tb927.7.3760 Both[5] true true true true true 
PSD Phosphatidylserine 
decarboxylase 
Tb927.9.10080 BSF[5] true true true true true 
INO1 Inositol-3-phosphate 
Tb927.10.7110 BSF[5] false true true true true 
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synthase 
PIS Phosphatidylinositol 
synthase 
Tb927.9.1610 Both[5] true true true true true 
GPI-PLC GPI phospholipase C Tb927.2.6000  No (BSF) [5] false false false false - 
SMase Neutral sphingomyelinase Tb927.5.3710 Both[5] false false - false - 
PLA1 Phospholipase A1 Tb927.1.4830 No (both) [5] false - - - - 
LPLA1 Lyso-phospholipase A1 Tb927.9.12700  No (both) [5] false - - false - 
ALG3 Dol-P-Man -1,3-
mannosyltransferase 
Tb927.10.6530  No (BSF) [5] false false false false false 
GDMPP GDP-Man 
pyrophosphorylase 
Tb927.8.2050 BSF[5] false true true true true 
DOLK Dolichol kinase Tb927.9.12790 Both[5] false true true true true 
DPMI Dol-P-Man synthase Tb927.10.4700 Both[5] false false false false false 
CHW8 Dol-PP phosphatase Tb927.6.1820 BSF[5] false true true true true 
(PIG-L) GlcNAc-PI de-N-
acetylase 
Tb927.11.12080 BSF[5] false true true true true 
TbGUP1 GPI remodellase Tb927.10.15910 No (BSF) [5] false - false false false 
MDD Mevalonate-diphosphate 
decarboxylase 
Tb927.10.13560 BSF[5] true true true true true 
IDI Isopentenyl-diphosphate 
isomerase 
Tb927.9.9000 BSF[5] true true true true true 
FPS Farnesyl-pyrophosphate 
Tb927.7.3360 BSF[5] true true true true true 
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synthase 
PFT Protein farnesyltransferase 
-subunit 
Tb927.3.4490 BSF[5] false - - - - 
Trypanothione reducatase Tb927.10.10390 BSF[62] true true true true true 
Triose phosphate isomerase 
Tb927.11.5520 
& Tb927.9.9820 
BSF[62] false false false false false 
Phosphatidyl inositol 
phospholipase C 
Tb927.11.5970 No (both) [62] false false false false false 
Ornithine Decarboxylase Tb927.11.13730 BSF[63] true true true true true 
Spermidine Synthase Tb927.9.7770 BSF[64] true true true true true 
GS Glutathione sythetase Tb927.7.4000 BSF[171] true true true true true 
Arginine transport (a.a 
transport) 
Tb927.11.6680 Both true true true true true 
dihydroorotate dehydrogenase, 
putative 
Tb927.5.3830 Both[66] false true true false true 
dihydrofolate reductase-
thymidylate synthase 
Tb927.7.5480 BSF[67] true true true true true 
aldolase Tb927.10.5620 BSF[68] false false false false false 
Glyceraldehyde-3-phosphate 
dehydrogenase 
Tb927.10.6880 
& Tb927.6.4280 
& Tb927.6.4300 
& Tb927.9.9820 
BSF[68] false false false false false 
PFK Phosphofructokinase Tb927.3.3270 BSF[69] false false false false - 
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PyK Pyruvate Kinase Tb927.10.14140 Both[70],[71] false false false false false 
HK Hexokinase 
Tb927.10.2010 
& 
Tb927.10.2020 
BSF[72] false false false true true 
PMM Phosphomannomutase Tb927.10.6440 BSF[73] false true true true true 
GNA1 Glucosamine 6-phosphate 
N-acetyltransferase 
Tb927.11.11100   BSF[74] false false - true false 
UAP UDP-N-acetylglucosamine 
pyrophosphorylase 
Tb927.11.2520 BSF[75] false true true true true 
PEPCK Phosphoenol pyruvate 
carboxykinase 
Tb927.2.4210 BSF[76] false - - true true 
6PGDH 6-phosphogluconate 
dehydrogenase 
Tb927.9.12110 BSF[76] false true false false true 
PDH pyruvate dehydrogenase 
and TDH throenine 
dehydrogenase 
Tb927.10.12700 
& Tb927.3.1790 
& Tb927.6.2790 
BSF[55] false true false false false 
HSK Homoserinekinase Tb927.6.4430 
no(BSF), no( in 
PRO in the 
presence of Thr) 
[6] 
false - - false - 
SLS1+SLS2+SLS3+SLS4 
Tb927.9.9410 & 
Tb927.9.9400 & 
Tb927.9.9390 & 
Tb927.9.9380 
Both[78] true true true true true 
Casiene Kinase Tb927.5.800 BSF[79] false false false false - 
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galE UDP-galactose 4-epimerase Tb927.11.2730 BSF[80] false true true true true 
CDS CDP-DAG synthase Tb927.7.220 BSF[81] true true true true true 
PTR1 Pteridine reductase 1 Tb927.8.2210 BSF[85] false - - - - 
Prediction accuracy 53% 74% 70% 74% 75% 
Number of reactions 
  
1689 781 679 941 715 
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2B.2  ADDITIONAL RESULTS 
 
Note to the reader 
In this section, I will discuss additional methods, algorithms and results which will not be 
presented in the paper. Some of these results were decided to be out of the scope of the 
paper. The algorithms presented here need to be further validated on other models and 
their limitations need to be evaluated carefully. 
 
2B.2.1  Processing the T. brucei metabolic model from 
TrypanoCyc 
The first step of the genome-scale metabolic reconstruction pipeline employed in this 
project involves the generation of a metabolic model based on the TrypanoCyc [172] 
database (see Article 2 Methods). The TrypanoCyc-based model was generated in SBML 
format using the ‘export reactions to SBML function’ of Pathway Tools. Until the release of 
Pathway Tools [137] version 18.0 in March 2014, the SBML files generated by this function 
did not inherit the GPR associations from TrypanoCyc. A JavaCyc 
(https://github.com/solgenomics/javacyc) based script was used to gather this missing 
information from the database and import GENE ASSOCIATION and PROTEIN ASSOCIATION 
fields of the SBML reaction notes. Additional data such as KEGG ids, ChEBI ids, SMILES, InChI, 
confidence scores and reaction annotations from TrypanoCyc were also added to the 
metabolite and reaction notes at this stage. Another issue of this model was that many 
generic metabolites were present in the model, such as “Ribonucleotide-Diphosphates”, 
“Ribonucleotide-Triphosphates” and “NAD-P-OR-NOP” (NADP or NAD). The “compound.dat” 
file found in the PGDB data dump folder contains all information on metabolites in the PGDB 
including parent and child metabolite classes. Based on this file, generic metabolites were 
identified and reactions containing these generic metabolites were replaced with their 
copies containing the respective “child” metabolites (i.e. reactions with “Ribonucleotide-
Diphosphates” were replaced with copies of the same reaction with ADP, GDP, CDP and 
UDP). Unbalanced reactions among these new reactions were then identified by comparing 
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the chemical formulas of the reactants and products and were removed from the model. 
This was done in order to remove incorrect reactions such as CDP + ATP  ADP + UTP which 
could be generated from Ribonucleotide-Diphosphates + ATP  ADP + Ribonucleotide-
Triphosphates in the previous step. Figure 22 describes the steps involved in pre-processing 
the SBML files generated by the Pathway Tools. 
 
Figure 22 – Pipeline for the pre-processing of TrypanoCyc-based model 
2B.2.2  Standardizing metabolite and reaction IDs of the 
TrypanoCyc-based model 
One of the most concerning issues with merging the TrypanoCyc-based model and the 
iAC560-based model is the fact that the former uses BioCyc identifiers for the metabolites, 
reactions and compartments while the latter uses identifiers similar to the BiGG [107] 
identifiers. Metabolites in the iAC560 model also did not have any additional information 
such as INCHI or KEGG IDs to help compare it with the TrypanoCyc-based model. Hence the 
TrypanoCyc-based model IDs need to be converted to BiGG ids to facilitate model 
comparison and merging. 
ID, common name and formula of the TrypanoCyc-based model metabolites were first used 
to identify metabolites with the same IDs in a model generated by merging all the major 
models in the BiGG database. Next similar reactions between the TrypanoCyc-based model 
and the “BiGG model” were identified by comparing substrates, EC number and cellular 
localization of the reactions. 
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The MetaNetX [173] website provides a flat file, chem_xref.tsv, associating metabolite IDs 
from all major databases (including BioCyc, BiGG, SEED [95], KEGG [83], etc) to the 
corresponding IDs in MNXref namespace (http://metanetx.org/cgi-
bin/mnxget/mnxref/chem_xref.tsv). The MNX_IDs were used to create a dictionary of 
BioCyc and BiGG metabolite IDs. 
From the above approaches 788 metabolite identifiers and 411 reaction identifiers from the 
TrypanoCyc-based model were standardized to BiGG identifiers. 
2B.2.3  Using CTS, KEGG and ChEBI web services to find 
additional InChI 
The InChI system [111] is a unique identifier system for chemical compounds developed by 
the International Union of Pure and Applied Chemistry (IUPAC). InChI values can be used to 
efficiently map metabolomics data with the genome-scale metabolic network. The first 
version of the T. brucei metabolic model (after merging TrypanoCyc-based model and 
iAC560-based model) had only 309 metabolites with InChI values. JavaCyc based scripts were 
used to retrieve additional InChI values from MetaCyc. ChEBI and KEGG web services via the 
bioservices python package [174] and the Chemical Translation Service (CTS) [175] web 
service from python via the requests library [176] were used to retrieve additional InChI 
values for metabolites in the model using common-names, chemical formulae and KEGG IDs. 
Through this process additional 1001 InChI values were added to the model. The final model 
after manual curation (iSS1077 model) has 1067 metabolites with InChI values. 
2B.2.4  Manual Curation of the genome-scale metabolic 
model 
Details of the manual curation stage are discussed in Article 2. About 179 published articles 
(see APPENDIX 5) were consulted to curate the model. Two examples of how experimental 
data was used in manual curation is explained here  
a) Example 1 : Comparison to experimentally observed behaviour – Kim et al 2015 
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Kim et al [177] in 2015 published their observations on the difference in the composition of 
fresh and spent medium from their T. brucei blood-stream form study. Hypoxanthine, 
xanthine, L-alanine, L-glutamic acid, L-glyceric acid, pyruvate, succinate and 2-oxoglutarate 
levels were observed to be higher in the spent medium (suggesting that these metabolites 
were secreted by the parasite cells) while L-tyrosine, L-ornithine, L-valine, L-methionine, L-
glutamine, L-threonine, inosine, L-tryptophan and L-isoleucine levels were observed to be 
lower in the spent medium (suggesting that these metabolites were consumed by the 
parasite cells). Constraints on exchange reactions for these nutrients were manipulated to 
simulate observed behaviour. Lower bounds of reactions were set to greater than zero and 
upper bounds were set to lower than zero in order to constrain exchange reactions to 
forward and reverse directions respectively. The model was capable of supporting all 
additional constraints i.e. flux a flux through the biomass was possible, except those on L-
glyceric acid exchange. Metabolic reasons for the release of L-glyceric acid from T. brucei 
into the medium could not be identified from published studies and hence the model could 
not be curated to factor in this observed behaviour.  
b) Example 2 : Forcing flux to simulate validated pathways – Trypanothione pathway 
Trypanothione is the Trypanosomatidae specific thiol used by the T. brucei parasites to 
control oxidative stress. The Trypanothione biosynthetic pathway has been proven to be 
essential in T. brucei [171, 178–181]. Flux was forced to flow through this pathway, based on 
the observations from published studies. However an FBA solution was not possible. Figure 
Figure 23– Trypanothione recycling in the metabolic model 
The final stage of the trypanothione pathway as described in the initial model (a) and the manually curated 
model (b). F1 represents the flux through trypanothione biosynthesis, F2 the flux through peroxide metabolism 
(involving Trypanothione) and F3 the flux through Trypanothione recycling. A drain of Trypanothione disulphide 
to the biomass was included in (b) and the flux through this reaction was represented by F4 = y 
(a) (b) 
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23 displays the trypanothione recycling stage of the trypanothione pathway. Since FBA 
assumes the model is at steady state (i.e. change in concentration of metabolites = 0), the 
sum of fluxes going in and out of each node has to be balanced. Hence in Fig 23 (a), if y ≠ 0 
(flux forced through Trypanothione biosynthesis), then a balance of flux cannot be 
maintained. Hence y can only be 0. This would mean than Trypanothione biosynthesis is not 
required for FBA solution and the model would be incapable of studying the behaviour of 
this pathway. A drain of trypanothione disulphide was created by adding it to the biomass as 
in Fig 23 (b). Now Trypanothione biosynthesis can have a non zero flux value . And since 
Trypanothione is being drained to the biomass, Trypanothione biosynthesis now becomes 
essential as reported in literature. 
2B.2.5  Use of manual curation in identifying errors in 
TrypanoCyc 
During the manual curation of the genome-scale metabolic model, inconsistencies of model 
simulation results with information published in the literature was used to identify 
erroneous and missing information in the model. Since the TrypanoCyc database was used 
to develop the genome-scale metabolic model, identification of errors in the metabolic 
model could be used to identify incorrect or missing information on TrypanoCyc database. 
Updates to TrypanoCyc database based on the manual curation of the metabolic model were 
made only after verification with the TrypanoCyc annotation team. An example of using the 
metabolic model to update the TrypanoCyc database is described here.  
During the manual curation stage, TbALG3 (Tb927.10.6530) was identified as an essential 
gene from single gene deletion studies. However TbALG3 was reported as not essential in 
blood stream forms in previously published studies [27]. The TbALG3 gene is known to be 
involved in protein-N-glycosylation necessary for GPI anchor biosynthesis. Figure 24 is an 
overview of protein-N-glycosylation. In the endoplasmic reticulum membrane, dolichol with 
its hydroxyl group facing the cytosol is phosphorylated twice (Figure 24 (3)-(4)) followed by 
the transfer of two N-acetyl-glucosaminyl groups (Figure 24 (5)-(6)). Mannosyl groups are 
then added to the GlcNAc2-PP-Dol (Figure 24 (7)-(16)). T. brucei is known to be capable of 
using both Man5GlcNAc2-PP-Dol and Man9GlcNAc2-PP-Dol in protein-N-glycosylation (Figure 
24 (17-18)) [27][182]. Man5GlcNAc2-PP-Dol was found to be more commonly used by blood-
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stream forms while Man9GlcNAc2-PP-Dol was found to be more commonly used by procyclic 
form parasites. TbALG3 gene was annotated (by Pathway Tools) to be responsible for both 
Man4GlcNAc2-PP-Dol Man5GlcNAc2-PP-Dol (Figure 24 (11)) and Man5GlcNAc2-PP-Dol  
Man6GlcNAc2-PP-Dol (Figure 24 (13)). Since either Man5GlcNAc2-PP-Dol or Man9GlcNAc2-PP-
Dol was required by T. brucei for protein N-glycosylation[27, 182], TbALG3 gene was 
predicted to be essential. However TbALG3 was known not to be essential in T. brucei[27]. 
Hence TbALG3 gene could not be responsible for the Man5GlcNAc2-PP-Dol biosynthesis. In 
published studies on protein-N-glycosylation in yeast [183], ALG11 was reported to be 
responsible for Man4GlcNAc2-PP-Dol  Man5GlcNAc2-PP-Dol (Figure 24 (11)). An ALG11 
gene have been reported in T. brucei (Tb927.9.9200) in published studies[184]. Hence 
TbALG3 was replaced by TbALG11 as the enzyme responsible for catalyzing Man4GlcNAc2-PP-
Dol  Man5GlcNAc2-PP-Dol (Figure 24 (11)) in TrypanoCyc. More updates were made to the 
Figure 24 – Protein N glycosylation in T. brucei 
 
 
 
(17) (18) 
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pathway based on the Aebi paper [183]. TbALG11 was added as the enzyme for 
Man3GlcNAc2-PP-Dol  Man4GlcNAc2-PP-Dol (EC 2.4.1.131 Figure 24 (10)), TbALG2 was 
added as the enzyme for Man2GlcNAc2-PP-Dol  Man3GlcNAc2-PP-Dol (EC 2.4.1.142 Figure 
24 (9)) and TbALG1 was added as the enzyme for GlcNAc2-PP-Dol  ManGlcNAc2-PP-Dol (EC 
2.4.1.142 Figure 24 (7)). GlcNAc-PP-Dol  GlcNAc2-PP-Dol (EC 2.4.1.141 Figure 24 (6)) in 
yeast is catalyzed by ALG13 and ALG14. Sequences of these proteins retrieved from the 
UniProtKB database were blasted with T. brucei proteome in TriTrypDB and Tb927.6.1960 
was identified as the enzyme responsible in T. brucei for EC 2.4.1.141 (Figure 24 (6)). These 
updates were then reviewed by TrypanoCyc annotation team and appropriate changes were 
made on the TrypanoCyc Database. 
2B.2.6  Visualization of the metabolic network and flux 
distribution 
Visualization of metabolic network and flux distribution provides better understanding of the 
cellular metabolism inferred from the FBA solution. Genome-scale metabolic models 
consists of a large number of metabolites and reactions, and hence a simplified and intuitive 
layout of the network is required to make any meaningful interpretation from the flux 
distribution. The following three steps were used to produce a visualization style for the 
metabolic model and the FBA solution: 
a) Manual layout 
The genome-scale metabolic network was manually laid-out one pathway at a time as it was 
curated in Cytoscape during the manual curation stage of the reconstruction. Pathways 
belonging to the same compartment were placed closer to each other and a virtual 
compartment boundary was created using the nodes of the transport reactions involved 
between the compartments. Common side compounds such as ATP, ADP, H+, etc were 
removed from the main layout to simplify the metabolic network for making better 
inferences from the flux distribution. The biomass equation was also removed to reduce 
edge crossovers and simplify the visualization. The Cytoscape JSON (.cyjs) format was used 
to store the manually set layout. Layouts of new networks were updated by using a python 
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script to set the coordinates of nodes in a .cyjs file based on the manually set layout. The 
final version of the manual layout of iSS1077 model is can be observed in Figure 27. 
b) Visualization of the flux distribution 
Visualizing flux distributions on the metabolic network helps to understand the solutions of 
FBA simulation. The CyFluxViz plugin[185] available for Cytoscape 2.8[148] is very useful in 
overlaying flux distributions on metabolic networks. However, the official tool to generate 
input files for CyFluxViz files is only compatible with the Matlab COBRA Toolbox. In order to 
use simulation results from COBRApy (the python alternative of the COBRA Toolbox) in 
Cytoscape 3, a different system was developed to incorporate flux distributions on the 
metabolic networks. Opacity of all blocked reactions (identified from FVA) and metabolites 
only associated with blocked reactions (inaccessible metabolites) were first set to 0. Next, a 
tab separated edge attribute file was generated with flux values and information on whether 
the metabolite was being produced or consumed according to the particular flux 
distribution. Edges were coloured green and red based on whether the metabolite was being 
produced or being consumed by the particular reaction respectively. Continuous mapping of 
edge width with respect to the flux values as described below was used to provide a better 
visualization of the fluxes. If y is the width of the edge and x is the flux value on the edge 
(and |x| is the absolute value of x), then the mapping was performed as follows, 
y = 0,    if x = 0 
y = (0.08)|x|,   if 0 < |x| ≤ 200 
y = (0.03)|x|+16,  if 200 < |x| ≤ 500 
y = (0.01)|x|+ 21,  if 500 < |x| ≤ 1000 
Figure 25 displays the continuous mapping of the edge width based on the fluxes in 
Cytoscape 3. 
Figure 25 – edge width with respect to the flux observed through the reaction 
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c) Simplifying flux distribution for better understanding 
Flux distributions generated from FBA analyses of genome-scale metabolic model can be 
difficult to interpret because of size and complexity of the metabolic network. Another 
factor for the complexity of the flux distribution are the thermodynamically-infeasible loops 
or flux cycles in FBA solutions. Thermodynamically-infeasible loops are cycles of reactions 
fluxes that are isolated in the system (making them thermodynamically infeasible). These 
flux cycles do not contribute to the objective and only add to the complexity of the flux 
distribution (see Figure 26). In iSS1077, the Palsson’s confidence scoring system[100] for 
reactions is being used to keep track of “confidence” the annotator has in each reaction. In 
order to simplify the flux distribution for better inference of the model solutions, an 
algorithm similar to the GIMME algorithm[128] was used to a) redirect the flux in the model 
through high confidence reactions while maintaining suboptimal values of the biomass flux 
(90% of maximum biomass flux) and b) avoid thermodynamically infeasible loops from the 
FBA. 
For a metabolic model of stoichiometric matrix Sorig where vorig is the vector of fluxes. FBA 
analyses assume Sorig.vorig = 0. 
The reversible reactions in the metabolic model were first converted to forward and reverse 
reactions. Let the new stoichiometric matrix and vector of fluxes be S and v respectively. 
S.v = 0 
Figure 26 – A thermodynamically infeasible loop in FBA solution 
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LP optimization of the biomass was then performed 
biomassmax = max(vT.c) 
where vT is the transpose of vorig and c is the vector of objective coefficients and biomassmax 
is maximum flux through the biomass equation 
Next the lower bound of the biomass flux (LBbiomass) was set to 90% of biomassmax 
LBbiomass = 
  
   
 biomassmax 
Next a reaction score, scorei for each reaction i in the model was set as follows 
   scorei =  
                          
 
 
                            
                             
 
where cscorei is the Palsson’s confidence score[100] through reaction i and SMindexi is the 
SBML merge index (see model reconstruction in article 2) through reaction i  
Finally LP optimization was performed for the following problem 
 min(∑(fluxi × scorei))  
where fluxi is the flux through reaction i and scorei is the score of reaction i 
=> min(vT.s)   
where s is the vector of scoreis when i ∈ n and n is the number of reactions. The flux 
distribution from this solution was visualized on Cytoscape 3 (as mentioned in the previous 
section). 
A normal FBA solution of the iSS1077 with flux forced through GPI sink, “R_lipidSINK_HYPO” 
(to represent VSG formation) and Dolichol-phosphate sink, “R_dolPSINK_HYPO” (to force 
flux through Dolichol phosphate biosynthesis) resulted in 551 reactions carrying non-zero 
flux values.  On calculating the FBA solution using the algorithm described here, the number 
of reactions with non-zero flux values was reduced to 365 giving us a more simplistic 
representation of the solution (See figure 27). 
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2B.2.7  Contribution of essential nutrients to biomass 
From reaction deletion studies, 14 essential nutrients required for biomass production were 
identified (see Article 2 Results). In order to understand why these nutrients were predicted 
to be essential we need to study their contribution to the biomass. This contribution of an 
essential nutrient can be identified by identifying the metabolite(s) in the biomass equation 
which are not available when the exchange reaction for the nutrient is blocked. This subset 
of biomass metabolites can be identified ideally by finding all possible subsets of the 
Figure 27 – Visualization of fluxes on the genome-scale metabolic model 
Flux distribution from FBA analysis is integrated with the manually laid-out iSS1077. The nodes are 
used to represent both reaction and metabolites. Green-coloured edges are used to represent 
metabolites consumed by the associated reactions and red-coloured edges are used to represent 
metabolites produced by the associated reactions. Transport reactions nodes are used to create 
virtual compartment boundaries. Each compartment is represented here by a coloured region.  
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biomass equation and then by comparing the biomass metabolite subsets that when 
removed from the biomass equation allows flux through biomass when the exchange 
reaction for the particular essential nutrient is blocked.  
The Algorithm to generate all subsets from a set of elements (S) has previously been devised 
and is described here.  
 
Now consider a set S ={A,B,C} and using this exhaustive algorithm all subsets will be 
generated as follows 
 
As we can observe from example, the number of subsets increases substantially with the 
increase in size of the original set.  
For a set of n elements, the solution set will have 1 + nC1 + 
nC2 +... + 
nCn subsets. 
If n = 1, solution is 1+1 = 2 subsets 
If n = 2, solution is 1+2+1 = 4 subsets 
 
solutions = {} 
 
Loop for element A  
temp_solutions = {} 
SE1 = {} ∪ {A} = {A} 
solutions = {{}} ∪ {{A}} = {{},{A}} 
 
Loop for element B 
temp_solutions = {{},{A}} 
SE1 = {} ∪ {B} = {B} 
SE2= {A} ∪ {B}={A,B} 
solutions = {{},{A}} ∪ {{B},{A,B}} = {{},{A},{B},{A,B}} 
 
Loop for element C 
temp_solutions = {{},{A},{B},{A,B}} 
SE1 = {} ∪ {C} = {C} 
SE2 = {A} ∪ {C} = {A,C} 
SE3 = {B} ∪ {C} = {B,C} 
SE4 = {A,B} ∪ {C} = {A,B,C} 
solutions = {{},{A},{B},{A,B}} ∪ {{C},{A,C},{B,C},{A,B,C}} = {{},{A},{B},{C},{A,B},{A,C},{B,C},{A,B,C}} 
final solutions = {{},{A},{B},{C},{A,B},{A,C},{B,C},{A,B,C}} 
 
solutions = {} 
For each element E in set S do, 
| temp_solutions = solutions 
|  For each set SE in solutions do, 
| | SE = SE ∪ {E} 
| endFor; 
| solutions= temp_solutions ∪ solutions 
endFor ; 
return solutions 
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If n = 3, solution is 1+3+3+1 = 8 subsets 
If n = 45, solution is 3.518 x 1013 subsets!!! 
In the case of the T. brucei genome-scale metabolic model, the biomass equation has 45 
substrates and the generation of all possible subsets failed on the python environment 
owing to memory issues. Hence it was concluded than an alternate algorithm is required. 
A non-exhaustive alternative algorithm was hence designed that was capable of identifying 
the contribution of essential nutrients to the biomass. For each nutrient, the respective 
exchange reaction was blocked and metabolites were iteratively removed from the biomass 
equation until the biomass equation can carry flux. The set of removed metabolites were 
then minimized to identify the biomass metabolite(s) affected by the lack of the nutrient. A 
detailed description of the algorithm is described below.  
For a network N and a biomass equation with a set substrates B.  
 
Er={}; 
Er=findEssentialExchangeReactions(N); 
 
Nutr is the metabolite involved in an exchange reaction r 
 
For each r in Er 
| result={} 
| remove r from N; 
| If B contains Nutr then    // check if Nutr is the reason for 0 biomass 
| | remove Nutr from B; 
| | result = {{Nutr}};  
| endIf; 
| 
| If FBA solution of N > 0 then 
| | return result;    // if Nutr was the reason for no biomass return {Nutr} 
| Else 
| | solutionMet={} 
| | For each metabolite M in B   // check if any single metabolite is the solution 
| | | Ncopy1 = N  
| | | Bcopy1 = biomass of Ncopy1 
| | | remove M from Bcopy1 
| | | If FBA solution of Ncopy1 > 0 then 
| | | | result=result U {M}; 
| | | | solutionMet = solutionMet U {M}; 
| | | endIf; 
| | endFor; 
| | removeSet={} 
| | For each metabolite MI in B, NOT in solutionMet // check if other subset of B is reason for 0 growth 
| | | removeSet = removeSet U {MI} 
| | | For each metabolite MJ in B, NOT in solutionMet AND Mj != Mi 
| | | | Ncopy2=N 
| | | | Bcopy2= biomass of Ncopy2; 
| | | | removeSet = removeSet U {MJ}; 
| | | | For each metabolite M in removeSet 
| | | | | remove M from Bcopy2; 
| | | | endFor; 
| | | | If FBA solution of Ncopy2 > 0 then 
| | | | | result = result U findSubsetResults(N,removeSet) 
| | | | | remove Mj from removeSet 
| | | | endIf; 
| | | endFor; 
| | endFor; 
| endIf; 
| 
| return result 
endFor; 
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findSubsetResults // Algorithm to reduce solution subset to find significant metabolites 
 
Input: N a network 
         removeSet a subset of biomass metabolites 
Output: solutionSets a set of sets of metabolite which when removed from the biomass solves the growth issue  
 
solutionSets={} 
For each metabolite MI in removeSet 
| removeSetCopy = removeSet 
| remove MI from removeSetCopy 
| For each metabolite MJ in removeSet 
| | If NOT (MI = MJ) then 
| | | remove MJ from removeSetCopy 
| | | Ncopy = N 
| | | Bcopy = set of biomass metabolites of Ncopy 
| | | For each metabolite M in removeSetCopy 
| | | | remove M from B 
| | | endFor; 
| | | If NOT FBA solution of N > 0 then 
| | | | add MJ to removeSetCopy 
| | | endIf; 
| | endIf; 
| endFor; 
| If removeSetCopy is NOT equal to {} then 
| | solutionSets = solutionSets U {removeSetCopy} 
| endIf; 
endFor; 
 
If solutionSets = {} then 
| solutionSets = {removeSet} 
endIf; 
 
return solutionSets 
 
findEssentialExchangeReactions //Algorithm to find essential exchange reactions in a network 
 
Input : N a network 
Output: Er a set of exchange reactions 
 
Er = {} 
Rex = {} 
For each reaction R in N 
| For each metabolite M in R 
| | If boundaryCondition of M = True AND compartment of M = “Extracellular” then 
| | | Rex = Rex U {R} 
| | endIf; 
| endFor; 
endFor; 
 
For each reaction R in Rex 
| Ncopy = N 
| remove R from Ncopy 
| If NOT FBA solution of Ncopy > 0 then 
| | Er = Er U {R} 
| endIf; 
endFor; 
 
return Er; 
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The algorithm was written in python using COBRApy and was applied the genome-scale 
metabolic model in order to identify essential nutrients and to understand why they were 
essential. 15 essential exchanges were identified; of which 14 reactions represented the 
influx of metabolites from the medium to the cell and the remaining reaction represents a 
sink reaction for ubiquinone-9 (flux was forced through the sink in order to create a demand 
for ubiquinol biosynthesis). Amino acids lysine, valine, tryptophan, isoleucine, histidine, 
leucine, arginine, phenylalanine from the medium were required for their direct use in 
protein biosynthesis. Ornithine from the medium was predicted to be required for 
putrescine, spermidine and trypanothione-disulphide required for the biomass equation. L-
cysteine was also found to be required for trypanothione synthesis. The contribution of 
 
Figure 28 – Contribution of essential nutrients in the iSS1077 model 
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ornithine and L-cysteine to Trypanothione biosynthesis has already been validated from 
previous studies[23, 186, 187]. Choline was required from the medium for sphingomyelin 
and phosphatidylcholine production which is also in accordance with published data[188]. 
Long chain alcohols were required for the alkyl dihydroxyacetone phosphate (alkyl DHAP) 
synthase step of ether-type phosphatidyl ethanolamine synthesis.  
One limitation of this algorithm is that it does not factor in the exchange reactions that have 
been forced to carry flux (as in the case of ubiquinol-9). Because of this, the algorithm was 
unable to find the contribution of O2 and tyrosine. This issue was dealt with by temporarily 
removing the demand reactions and adding the metabolites that were involved from the 
model into the biomass. On repeating the algorithm, it was capable of finding the 
contribution of O2 and tyrosine. O2 was found to be required for ubiquinol-9 biosynthesis 
and tyrosine was required for both ubiquinol-9 biosynthetic pathway and as a source of 
tyrosine required for protein synthesis. Figure 28 illustrates the final results of the algorithm 
on the genome-scale metabolic model 
2B.2.8  Optimizing iMAT BSF models 
In the Article 2, we have discussed the development of BSF models of T. brucei using the 
iMAT[127] algorithm. It was noticed that while iMAT tries to maximize the inclusion of 
expressed proteins into the active subnetwork, it does not takes into consideration that the 
protein being expressed does not necessarily mean that all the associated reactions are 
active. It is quite possible that only some substrates will be available and so only those 
reactions will take place. Consider “Hexokinase” for example, which can convert both alpha-
D-glucose and Beta-D-glucose into their respective monophosphates. The expression of 
Hexokinase does not necessarily mean that both α-D-glucose and β-D-glucose is converted 
to α-D-glucose-6-phosphate and β-D-glucose-6-phosphate respectively as only one of these 
reactions being active (based on availability of α-D-glucose or β-D-glucose) will do. To 
circumvent this, I propose an algorithm that optimizes the solutions generated by the iMAT 
algorithm.  
The idea is to remove reactions from a subnetwork derived from iMAT, if there exists other 
reactions catalyzed by the same genes, present on a more preferential path (a path with 
more reactions associated with expressed proteins), unless it blocks the flux through another 
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reactions associated with an expressed protein. This idea can be illustrated with the help of 
Figure 29. In order to reduce the iMAT network (Figure 29a), the path with the maximum 
number of reactions with expressed enzymes was identified and is considered as the 
reference network (Figure 29b). Next each reaction from the iMAT network not present in 
the reference network is removed unless it is a reaction catalyzed by an expressed gene 
which does not have another associated reaction in the reference subnetwork or its removal 
blocks the flux through another reaction of an expressed enzyme. Reaction A is removed as 
its enzyme is not known to be expressed. C is removed because another reaction with the 
same gene is present in the reference network (reaction D). H and J are not removed since it 
will prevent the flux through F, a reaction with an expressed gene that has no associated 
reaction in the reference network. Figure 29c represents the final optimized iMAT 
subnetwork. 
This algorithm works as follows: 
Figure 29 – Optimizing iMAT results 
A, B, C, D, E, F, G, H, I, J, K and L are the reactions in a context specific subnetwork generated using the iMAT 
algorithm (a). Dashed lines are used to indicate reactions that are catalyzed by the same enzymes. Reactions 
coloured ‘green’ represents the reactions associated with expressed enzymes. The reference network (b) was 
calculated by minimizing flux through reactions associated with enzymes which are not known to be 
expressed. The optimized iMAT model (c) was then generated by comparing the original iMAT model with the 
reference model as described in the algorithm. 
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1) Process the iMAT subnetwork 
Consider an iMAT solution metabolic model of stoichiometric matrix Sorig where vorig is the 
vector of fluxes. FBA analyses assume Sorig.vorig = 0. 
The reversible reactions in the metabolic network were first converted to forward and 
reverse reactions. Let the new stoichiometric matrix and vector of fluxes be S and v 
respectively. Then, 
S.v = 0 
The set of reactions associated with expressed enzymes is Rexpressed , ciMAT represents the 
coefficient of objective coefficients and NiMAT is defined as the set of all reactions in this 
network. If vT is the transpose of v, then the optimal flux distribution voptimal is identified by 
performing LP optimization of iMAT model (if         
  is the transpose of voptimal), 
        
 .ciMAT = max(v
T.ciMAT) 
2) Create the reference network 
The lower bound of the reaction(s) in the objective function in the iMAT network is set to 
90% of their corresponding value in voptimal. Next the objective coefficient of all reactions in 
the processed iMAT model are reset, 
ci = 0 for i ∈ NiMAT 
where ci is the objective coefficient of reaction i. Next the objective coefficient of all reaction 
are set based on the expressed state of their associated enzymes 
ci = 
                                                 
                                             
                                 
 
LP optimization was then performed to minimize the new objective to identify the flux 
distribution that restricts the flux to the pathways with more expressed enzymes. vreference is 
the desired flux distribution if, 
          
 .c = min(vT.c) 
(a) (b) (c) 
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where c is the vector of objective coefficients. All reactions for which the associated flux in  
vreference = 0 is removed to create the reference network where the set of all reactions in the 
network is Nreference 
3) Generating the optimized iMAT networks 
First, the lower bound of the reaction(s) in the objective function in the iMAT network is set 
to 90% of their corresponding value in voptimal. The optimized iMAT network can now be 
generated by removing all reactions i from the iMAT network, where i ∈ NiMAT and i ∉ 
Nreference , unless  
(i) i ∈ Rexpressed and there does not exist another reaction j ∈ Nreference catalyzed by 
the same enzyme 
(ii) there exists another reaction k ∈ Rexpressed such that the flux through k (vk) = 0 for 
all FBA solutions after i is removed from the network 
Blood stream form iMAT models were generated using the iMAT algorithm in COBRA toolbox 
as described in Article 2. Since iMAT does not necessarily force the flux through biomass, the 
iMAT models presented in the Article 2 were generated with the lower bound of the biomass 
flux set to 10% of maximum biomass flux (this model is referred to as iMAT10). Additional 
BSF models for the 3 datasets (3 experimental[168–170] , 1 TrypanoCyc annotation) were 
generated by setting lower bound of the biomass flux to 50% and 90% of the maximum 
biomass flux (these models are referred to as iMAT50 and iMAT90 respectively). 12 iMAT 
models were hence generated in total (3 each for the 3 experimental data sets and 
TrypanoCyc annotations). Using a COBRApy based python script, the algorithm described 
earlier was implemented on the 12 iMAT models. Data from gene knockout scenarios 
collected from 27 published studies (same data used in Article 2 Table 2) were used to 
compare the predictions of the optimized iMAT models with the original iMAT models 
(Tables 4 - 7 ). 
From Tables 4 - 7 it is evident that the optimized iMAT models show a higher compliance (if 
not the same), to the data collected from published literature. Interestingly, the optimized 
iMAT10 model based on the TrypanoCyc comments was noted as showing the highest 
prediction accuracy among the 12 models with 79.6 percent prediction accuracy.  
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Table 4 –prediction accuracy of iMAT and optimized iMAT models built from Urbaniak et al [168] 
   
Predicted lethality (green - predicted correct / black – prediction 
wrong) 
Enzyme Name Gene ID 
Deletion lethal 
according to 
published 
studies? 
iMAT10 
Optimized 
iMAT 10 
iMAT50 
Optimized 
iMAT 50 
iMAT90 
Optimized 
iMAT 90 
ELO1 Elongase 1 Tb927.7.4160 No (both) false false false false false false 
ELO2 Elongase 2 Tb927.7.4170 No (both) false false false false false false 
ELO3 Elongase 3 Tb927.7.4180 No (both) false false false false false false 
ASC5 Acyl-CoA synthetase 5 Tb927.10.3260 No (both) false false false false false false 
CK Choline kinase 2 Tb927.11.2090 Both true true true true true true 
ECT Ethanolamine-phosphate 
cytidylyltransferase 
Tb927.11.14140 Both true true true true true true 
EPT Ethanolamine 
phosphotransferase 
Tb927.10.13290 Both true true true true true true 
CTPS CTP synthase Tb927.1.1240 BSF false - - - - - 
PSS/PSS2 PS synthase/PS 
synthase-2 
Tb927.7.3760 Both true true true true true true 
PSD Phosphatidylserine 
decarboxylase 
Tb927.9.10080 BSF true true true true true true 
INO1 Inositol-3-phosphate 
synthase 
Tb927.10.7110 BSF true true true true true true 
PIS Phosphatidylinositol synthase Tb927.9.1610 Both true true true true true true 
GPI-PLC GPI phospholipase C Tb927.2.6000  No (BSF) false false false false false false 
SMase Neutral sphingomyelinase Tb927.5.3710 Both false false false false false false 
PLA1 Phospholipase A1 Tb927.1.4830 No (both) - - - - - - 
LPLA1 Lyso-phospholipase A1 Tb927.9.12700  No (both) - - - - - - 
ALG3 Dol-P-Man -1,3-
mannosyltransferase 
Tb927.10.6530  No (BSF) false false false false false false 
GDMPP GDP-Man 
pyrophosphorylase 
Tb927.8.2050 BSF true true true true true true 
DOLK Dolichol kinase Tb927.9.12790 Both true true true true true true 
DPMI Dol-P-Man synthase Tb927.10.4700 Both false false false false false false 
CHW8 Dol-PP phosphatase Tb927.6.1820 BSF true true true true true true 
(PIG-L) GlcNAc-PI de-N-acetylase Tb927.11.12080 BSF true true true true true true 
TbGUP1 GPI remodellase Tb927.10.15910 No (BSF) - - false false - - 
MDD Mevalonate-diphosphate 
decarboxylase 
Tb927.10.13560 BSF true true true true true true 
IDI Isopentenyl-diphosphate 
isomerase 
Tb927.9.9000 BSF true true true true true true 
FPS Farnesyl-pyrophosphate 
synthase 
Tb927.7.3360 BSF true true true true true true 
PFT Protein farnesyltransferase -
subunit 
Tb927.3.4490 BSF - - - - - - 
Trypanothione reducatase Tb927.10.10390 BSF true true true true true true 
Triose phosphate isomerase Tb927.11.5520 & Tb927.9.9820 BSF false false true true false false 
Phosphatidyl inositol 
phospholipase C 
Tb927.11.5970 No (both) false false false false false false 
Ornithine Decarboxylase Tb927.11.13730 BSF true true true true true true 
Spermidine Synthase Tb927.9.7770 BSF true true true true true true 
GS Glutathione sythetase Tb927.7.4000 BSF true true true true true true 
Arginine transport (a.a transport) Tb927.11.6680 Both true true true true true true 
Alternative oxidase & Glycerol 
kinase 
Tb927.10.7090 & Tb927.9.12550 
& Tb927.9.12570 & 
Tb927.9.12590 & Tb927.9.12610 
& Tb927.9.12630   
BSF false false false false false false 
dihydroorotate dehydrogenase, 
putative 
Tb927.5.3830 Both true true true true false false 
dihydrofolate reductase-
thymidylate synthase 
Tb927.7.5480 BSF true true true true true true 
Aldolase Tb927.10.5620 
 
false false false false false false 
Glyceraldehyde-3-phosphate 
dehydrogenase 
Tb927.10.6880 & Tb927.6.4280 
& Tb927.6.4300 & Tb927.9.9820  
false false false false true true 
PFK Phosphofructokinase Tb927.3.3270 BSF false false false false false false 
PyK Pyruvate Kinase Tb927.10.14140 
 
false false false false false false 
HK Hexokinase Tb927.10.2010 & Tb927.10.2020 BSF false false true true true true 
PMM Phosphomannomutase Tb927.10.6440 
 
true true true true true true 
GNA1 Glucosamine 6-phosphate 
N-acetyltransferase 
Tb927.11.11100   BSF false true true true false - 
UAP UDP-N-acetylglucosamine 
pyrophosphorylase 
Tb927.11.2520 BSF true true true true true true 
PEPCK Phosphoenol pyruvate 
carboxykinase 
Tb927.2.4210 
BSF, 
No(PRO) 
- - - - true true 
6PGDH 6-phosphogluconate 
dehydrogenase 
Tb927.9.12110 BSF true true true true false false 
PDH pyruvate dehydrogenase and 
TDH throenine dehydrogenase 
Tb927.10.12700 & Tb927.3.1790 
& Tb927.6.2790 
BSF true true false true - - 
HSK Homoserinekinase Tb927.6.4430 
no(BSF), no( 
in PRO in the 
presence of 
thr) 
- - - - - - 
SLS1+SLS2+SLS3+SLS4 
Tb927.9.9410 & Tb927.9.9400 & 
Tb927.9.9390 & Tb927.9.9380 
both true true true true true true 
Casiene Kinase Tb927.5.800 BSF false false false false false false 
galE UDP-galactose 4-epimerase Tb927.11.2730 BSF true true true true true true 
CDS CDP-DAG synthase Tb927.7.220 BSF true true true true true true 
ARD1 N-acetyltransferase subunit Tb927.11.4530 Both - - - - - - 
GMPS GMP synthase Tb927.7.2100 BSF - - - - - - 
PTR1 Pteridine reductase 1 Tb927.8.2210 BSF - - - - - - 
Prediction Accuracy 
  
72.2 % 74.1 % 75.9 % 77.8 % 72.2 % 72.2 % 
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Table 5 Prediction accuracy of iMAT and optimized iMAT models built from Gunasekara et al [169] 
   
Predicted lethality (green - predicted correct / black – prediction wrong) 
Enzyme Name Gene ID 
Deletion lethal 
according to 
published 
studies? 
iMAT10 
Optimized 
iMAT10 
iMAT50 
Optimized 
iMAT 50 
iMAT90 
Optimized 
iMAT 90 
ELO1 Elongase 1 Tb927.7.4160 No (both) false - false false true true 
ELO2 Elongase 2 Tb927.7.4170 No (both) false - false false false - 
ELO3 Elongase 3 Tb927.7.4180 No (both) false - false false false - 
ASC5 Acyl-CoA synthetase 5 Tb927.10.3260 No (both) false false false false false false 
CK Choline kinase 2 Tb927.11.2090 Both true true true true true true 
ECT Ethanolamine-phosphate 
cytidylyltransferase 
Tb927.11.14140 Both true true true true true true 
EPT Ethanolamine 
phosphotransferase 
Tb927.10.13290 Both true true true true true true 
CTPS CTP synthase Tb927.1.1240 BSF - - - - - - 
PSS/PSS2 PS synthase/PS 
synthase-2 
Tb927.7.3760 Both true true true true true true 
PSD Phosphatidylserine 
decarboxylase 
Tb927.9.10080 BSF true true true true true true 
INO1 Inositol-3-phosphate 
synthase 
Tb927.10.7110 BSF true true true true true true 
PIS Phosphatidylinositol synthase Tb927.9.1610 Both true true true true true true 
GPI-PLC GPI phospholipase C Tb927.2.6000  No (BSF) false false false false false false 
SMase Neutral sphingomyelinase Tb927.5.3710 Both - - - - - - 
PLA1 Phospholipase A1 Tb927.1.4830 No (both) - - - - - - 
LPLA1 Lyso-phospholipase A1 Tb927.9.12700  No (both) - - - - - - 
ALG3 Dol-P-Man -1,3-
mannosyltransferase 
Tb927.10.6530  No (BSF) false - - - - - 
GDMPP GDP-Man 
pyrophosphorylase 
Tb927.8.2050 BSF true true true true true true 
DOLK Dolichol kinase Tb927.9.12790 Both true true true true true true 
DPMI Dol-P-Man synthase Tb927.10.4700 Both false false false false false false 
CHW8 Dol-PP phosphatase Tb927.6.1820 BSF true true true true true true 
(PIG-L) GlcNAc-PI de-N-acetylase Tb927.11.12080 BSF true true true true true true 
TbGUP1 GPI remodellase Tb927.10.15910 No (BSF) false false false - false - 
MDD Mevalonate-diphosphate 
decarboxylase 
Tb927.10.13560 BSF true true true true true true 
IDI Isopentenyl-diphosphate 
isomerase 
Tb927.9.9000 BSF true true true true true true 
FPS Farnesyl-pyrophosphate 
synthase 
Tb927.7.3360 BSF true true true true true true 
PFT Protein farnesyltransferase -
subunit 
Tb927.3.4490 BSF - - - - - - 
Trypanothione reducatase Tb927.10.10390 BSF true true true true true true 
Triose phosphate isomerase Tb927.11.5520 & Tb927.9.9820 BSF false false false false false false 
Phosphatidyl inositol 
phospholipase C 
Tb927.11.5970 No (both) false - false - false - 
Ornithine Decarboxylase Tb927.11.13730 BSF true true true true true true 
Spermidine Synthase Tb927.9.7770 BSF true true true true true true 
GS Glutathione sythetase Tb927.7.4000 BSF true true true true true true 
Arginine transport (a.a transport) Tb927.11.6680 Both true true true true true true 
Alternative oxidase & Glycerol 
kinase 
Tb927.10.7090 & Tb927.9.12550 
& Tb927.9.12570 & 
Tb927.9.12590 & Tb927.9.12610 
& Tb927.9.12630   
BSF false false false false false false 
dihydroorotate dehydrogenase, 
putative 
Tb927.5.3830 Both true true - - - - 
dihydrofolate reductase-
thymidylate synthase 
Tb927.7.5480 BSF true true true true true true 
Aldolase Tb927.10.5620 
 
false false false false false false 
Glyceraldehyde-3-phosphate 
dehydrogenase 
Tb927.10.6880 & Tb927.6.4280 
& Tb927.6.4300 & Tb927.9.9820  
false false false false false true 
PFK Phosphofructokinase Tb927.3.3270 BSF false false false false false false 
PyK Pyruvate Kinase Tb927.10.14140 
 
false false false false false false 
HK Hexokinase Tb927.10.2010 & Tb927.10.2020 BSF false false true true true true 
PMM Phosphomannomutase Tb927.10.6440 
 
true true true true true true 
GNA1 Glucosamine 6-phosphate 
N-acetyltransferase 
Tb927.11.11100   BSF - - - - true true 
UAP UDP-N-acetylglucosamine 
pyrophosphorylase 
Tb927.11.2520 BSF true true true true true true 
PEPCK Phosphoenol pyruvate 
carboxykinase 
Tb927.2.4210 
BSF, 
No(PRO) 
- - - - - - 
6PGDH 6-phosphogluconate 
dehydrogenase 
Tb927.9.12110 BSF false false false false false false 
PDH pyruvate dehydrogenase and 
TDH throenine dehydrogenase 
Tb927.10.12700 & Tb927.3.1790 
& Tb927.6.2790 
BSF false - false false true true 
HSK Homoserinekinase Tb927.6.4430 
no(BSF), no( 
in PRO in the 
presence of 
thr) 
- - - - - - 
SLS1+SLS2+SLS3+SLS4 
Tb927.9.9410 & Tb927.9.9400 & 
Tb927.9.9390 & Tb927.9.9380 
both true true true true true true 
Casiene Kinase Tb927.5.800 BSF false false false false false false 
galE UDP-galactose 4-epimerase Tb927.11.2730 BSF true true true true true true 
CDS CDP-DAG synthase Tb927.7.220 BSF true true true true true true 
ARD1 N-acetyltransferase subunit Tb927.11.4530 Both - - - - - - 
GMPS GMP synthase Tb927.7.2100 BSF - - - - - - 
PTR1 Pteridine reductase 1 Tb927.8.2210 BSF - - - - - - 
Prediction Accuracy 
  
68.5 % 68.5 % 68.5 % 68.5 % 70.4 % 72.2 % 
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Table 6 Comparison of prediction accuracy of iMAT and optimized iMAT models built from Vasquez et al [167] 
   
Predicted lethality (green - predicted correct / black – prediction wrong) 
Enzyme Name Gene ID 
Deletion lethal 
according to 
published 
studies? 
iMAT10 
Optimized 
iMAT 10 
iMAT50 
Optimized 
iMAT 50 
iMAT90 
Optimized 
iMAT 90 
ELO1 Elongase 1 Tb927.7.4160 No (both) false true false true false false 
ELO2 Elongase 2 Tb927.7.4170 No (both) false false false false false false 
ELO3 Elongase 3 Tb927.7.4180 No (both) false false false false false false 
ASC5 Acyl-CoA synthetase 5 Tb927.10.3260 No (both) false false false false false false 
CK Choline kinase 2 Tb927.11.2090 Both true true true true true true 
ECT Ethanolamine-phosphate 
cytidylyltransferase 
Tb927.11.14140 Both true true true true true true 
EPT Ethanolamine 
phosphotransferase 
Tb927.10.13290 Both true true true true true true 
CTPS CTP synthase Tb927.1.1240 BSF false false false false false false 
PSS/PSS2 PS synthase/PS 
synthase-2 
Tb927.7.3760 Both true true true true true true 
PSD Phosphatidylserine 
decarboxylase 
Tb927.9.10080 BSF true true true true true true 
INO1 Inositol-3-phosphate 
synthase 
Tb927.10.7110 BSF true true true true true true 
PIS Phosphatidylinositol synthase Tb927.9.1610 Both true true true true true true 
GPI-PLC GPI phospholipase C Tb927.2.6000  No (BSF) false false false false false false 
SMase Neutral sphingomyelinase Tb927.5.3710 Both false false false false false false 
PLA1 Phospholipase A1 Tb927.1.4830 No (both) - - - - - - 
LPLA1 Lyso-phospholipase A1 Tb927.9.12700  No (both) false false false false false false 
ALG3 Dol-P-Man -1,3-
mannosyltransferase 
Tb927.10.6530  No (BSF) false - false - false - 
GDMPP GDP-Man 
pyrophosphorylase 
Tb927.8.2050 BSF true true true true true true 
DOLK Dolichol kinase Tb927.9.12790 Both true true true true true true 
DPMI Dol-P-Man synthase Tb927.10.4700 Both false false false false false false 
CHW8 Dol-PP phosphatase Tb927.6.1820 BSF true true true true true true 
(PIG-L) GlcNAc-PI de-N-acetylase Tb927.11.12080 BSF true true true true true true 
TbGUP1 GPI remodellase Tb927.10.15910 No (BSF) false false false false false false 
MDD Mevalonate-diphosphate 
decarboxylase 
Tb927.10.13560 BSF true true true true true true 
IDI Isopentenyl-diphosphate 
isomerase 
Tb927.9.9000 BSF true true true true true true 
FPS Farnesyl-pyrophosphate 
synthase 
Tb927.7.3360 BSF true true true true true true 
PFT Protein farnesyltransferase -
subunit 
Tb927.3.4490 BSF - - - - - - 
Trypanothione reducatase Tb927.10.10390 BSF true true true true true true 
Triose phosphate isomerase Tb927.11.5520 & Tb927.9.9820 BSF false false false false false false 
Phosphatidyl inositol 
phospholipase C 
Tb927.11.5970 No (both) false false false false false false 
Ornithine Decarboxylase Tb927.11.13730 BSF true true true true true true 
Spermidine Synthase Tb927.9.7770 BSF true true true true true true 
GS Glutathione sythetase Tb927.7.4000 BSF true true true true true true 
Arginine transport (a.a transport) 
Tb927.11.6680 Both true true true true true true 
Alternative oxidase & Glycerol 
kinase 
Tb927.10.7090 & Tb927.9.12550 
& Tb927.9.12570 & 
Tb927.9.12590 & Tb927.9.12610 
& Tb927.9.12630   
BSF false false false false false false 
dihydroorotate dehydrogenase, 
putative 
Tb927.5.3830 Both false false true true false false 
dihydrofolate reductase-
thymidylate synthase 
Tb927.7.5480 BSF true true true true true true 
aldolase Tb927.10.5620 
 
false true false false true true 
Glyceraldehyde-3-phosphate 
dehydrogenase 
Tb927.10.6880 & Tb927.6.4280 
& Tb927.6.4300 & Tb927.9.9820  
false false false false false false 
PFK Phosphofructokinase Tb927.3.3270 BSF false true false false true true 
PyK Pyruvate Kinase Tb927.10.14140 
 
false false false false false false 
HK Hexokinase Tb927.10.2010 & Tb927.10.2020 BSF true true true true false false 
PMM Phosphomannomutase Tb927.10.6440 
 
true true true true true true 
GNA1 Glucosamine 6-phosphate 
N-acetyltransferase 
Tb927.11.11100   BSF true true true true true true 
UAP UDP-N-acetylglucosamine 
pyrophosphorylase 
Tb927.11.2520 BSF true true true true true true 
PEPCK Phosphoenol pyruvate 
carboxykinase 
Tb927.2.4210 
BSF, 
No(PRO) 
true true false true false false 
6PGDH 6-phosphogluconate 
dehydrogenase 
Tb927.9.12110 BSF false true false false false false 
PDH pyruvate dehydrogenase and 
TDH throenine dehydrogenase 
Tb927.10.12700 & Tb927.3.1790 
& Tb927.6.2790 
BSF false false false false false false 
HSK Homoserinekinase Tb927.6.4430 
no(BSF), no( 
in PRO in the 
presence of 
thr) 
false false false false false false 
SLS1+SLS2+SLS3+SLS4 
Tb927.9.9410 & Tb927.9.9400 & 
Tb927.9.9390 & Tb927.9.9380 
both true true true true true true 
Casiene Kinase Tb927.5.800 BSF false false false false false false 
galE UDP-galactose 4-epimerase Tb927.11.2730 BSF true true true true true true 
CDS CDP-DAG synthase Tb927.7.220 BSF true true true true true true 
ARD1 N-acetyltransferase subunit Tb927.11.4530 Both - - - - - - 
GMPS GMP synthase Tb927.7.2100 BSF - - - - - - 
PTR1 Pteridine reductase 1 Tb927.8.2210 BSF - - - - - - 
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Prediction Accuracy 
  
72.2 % 75.9 % 72.2 % 72.2 % 72.2 % 74.1 % 
Table 7 –Prediction accuracy of iMAT and optimized iMAT models built from TrypanoCyc comments 
   
Predicted lethality (green - predicted correct / black – prediction wrong) 
Enzyme Name Gene ID 
Deletion lethal 
according to 
published 
studies? 
iMAT10 
Optimized 
iMAT 10 
iMAT50 
Optimized 
iMAT 50 
iMAT90 
Optimized 
iMAT 90 
ELO1 Elongase 1 Tb927.7.4160 No (both) false false true true true true 
ELO2 Elongase 2 Tb927.7.4170 No (both) false false false false false - 
ELO3 Elongase 3 Tb927.7.4180 No (both) false false false false false - 
ASC5 Acyl-CoA synthetase 5 Tb927.10.3260 No (both) false false false false false false 
CK Choline kinase 2 Tb927.11.2090 Both true true true true true true 
ECT Ethanolamine-phosphate 
cytidylyltransferase 
Tb927.11.14140 Both true true true true true true 
EPT Ethanolamine 
phosphotransferase 
Tb927.10.13290 Both true true true true true true 
CTPS CTP synthase Tb927.1.1240 BSF false false false false false false 
PSS/PSS2 PS synthase/PS 
synthase-2 
Tb927.7.3760 Both true true true true true true 
PSD Phosphatidylserine 
decarboxylase 
Tb927.9.10080 BSF true true true true true true 
INO1 Inositol-3-phosphate 
synthase 
Tb927.10.7110 BSF true true true true true true 
PIS Phosphatidylinositol synthase Tb927.9.1610 Both true true true true true true 
GPI-PLC GPI phospholipase C Tb927.2.6000  No (BSF) - - - - - - 
SMase Neutral sphingomyelinase Tb927.5.3710 Both - - - - - - 
PLA1 Phospholipase A1 Tb927.1.4830 No (both) - - - - - - 
LPLA1 Lyso-phospholipase A1 Tb927.9.12700  No (both) - - false false - - 
ALG3 Dol-P-Man -1,3-
mannosyltransferase 
Tb927.10.6530  No (BSF) false false false false false false 
GDMPP GDP-Man 
pyrophosphorylase 
Tb927.8.2050 BSF true true true true true true 
DOLK Dolichol kinase Tb927.9.12790 Both true true true true true true 
DPMI Dol-P-Man synthase Tb927.10.4700 Both false false false false false false 
CHW8 Dol-PP phosphatase Tb927.6.1820 BSF true true true true true true 
(PIG-L) GlcNAc-PI de-N-acetylase Tb927.11.12080 BSF true true true true true true 
TbGUP1 GPI remodellase Tb927.10.15910 No (BSF) false false - - - - 
MDD Mevalonate-diphosphate 
decarboxylase 
Tb927.10.13560 BSF true true true true true true 
IDI Isopentenyl-diphosphate 
isomerase 
Tb927.9.9000 BSF true true true true true true 
FPS Farnesyl-pyrophosphate 
synthase 
Tb927.7.3360 BSF true true true true true true 
PFT Protein farnesyltransferase -
subunit 
Tb927.3.4490 BSF - - - - - - 
Trypanothione reducatase Tb927.10.10390 BSF true true true true true true 
Triose phosphate isomerase Tb927.11.5520 & Tb927.9.9820 BSF false true false false false false 
Phosphatidyl inositol 
phospholipase C 
Tb927.11.5970 No (both) false false false false false false 
Ornithine Decarboxylase Tb927.11.13730 BSF true true true true true true 
Spermidine Synthase Tb927.9.7770 BSF true true true true true true 
GS Glutathione sythetase Tb927.7.4000 BSF true true true true true true 
Arginine transport (a.a transport) 
Tb927.11.6680 Both true true true true true true 
Alternative oxidase & Glycerol 
kinase 
Tb927.10.7090 & Tb927.9.12550 
& Tb927.9.12570 & 
Tb927.9.12590 & Tb927.9.12610 
& Tb927.9.12630   
BSF true true false true false false 
dihydroorotate dehydrogenase, 
putative 
Tb927.5.3830 Both true true false false false true 
dihydrofolate reductase-
thymidylate synthase 
Tb927.7.5480 BSF true true true true true true 
aldolase Tb927.10.5620 BSF false true false false false false 
Glyceraldehyde-3-phosphate 
dehydrogenase 
Tb927.10.6880 & Tb927.6.4280 
& Tb927.6.4300 & Tb927.9.9820 
BSF false false false false false true 
PFK Phosphofructokinase Tb927.3.3270 BSF - - - - false false 
PyK Pyruvate Kinase Tb927.10.14140 BOTH false false false false false false 
HK Hexokinase Tb927.10.2010 & Tb927.10.2020 BSF true true true true true true 
PMM Phosphomannomutase Tb927.10.6440 BSF true true true true true true 
GNA1 Glucosamine 6-phosphate 
N-acetyltransferase 
Tb927.11.11100   BSF false - false true false - 
UAP UDP-N-acetylglucosamine 
pyrophosphorylase 
Tb927.11.2520 BSF true true true true true true 
PEPCK Phosphoenol pyruvate 
carboxykinase 
Tb927.2.4210 
BSF, 
No(PRO) 
true true true true true true 
6PGDH 6-phosphogluconate 
dehydrogenase 
Tb927.9.12110 BSF true true false false false false 
PDH pyruvate dehydrogenase and 
TDH throenine dehydrogenase 
Tb927.10.12700 & Tb927.3.1790 
& Tb927.6.2790 
BSF false false false false false false 
HSK Homoserinekinase Tb927.6.4430 
no(BSF), no( 
in PRO in the 
presence of 
thr) 
- - - - - - 
SLS1+SLS2+SLS3+SLS4 
Tb927.9.9410 & Tb927.9.9400 & 
Tb927.9.9390 & Tb927.9.9380 
both true true true true true true 
Casiene Kinase Tb927.5.800 BSF - - - - - - 
galE UDP-galactose 4-epimerase Tb927.11.2730 BSF true true true true true true 
CDS CDP-DAG synthase Tb927.7.220 BSF true true true true true true 
ARD1 N-acetyltransferase subunit Tb927.11.4530 Both - - - - - - 
GMPS GMP synthase Tb927.7.2100 BSF - - - - - - 
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PTR1 Pteridine reductase 1 Tb927.8.2210 BSF - - - - - - 
Prediction Accuracy 
  
75.9 % 79.6 % 68.5 % 72.2 % 68.5 %  74.1 % 
 
2B.3  ADDITIONAL DISCUSSION 
Currently many tools and algorithms for genome-scale reconstruction, simulation and 
visualization of metabolic networks have been built, tested and released. The SEED [189] 
server’s ModelSEED is a very powerful tool which can be used to generate prokaryotic (and 
more recently plant [190]) genome-scale models. It uses the RAST [191] server to annotate 
genes before building the model. However RAST currently does not support the annotation 
of eukaryotic genomes. Nevertheless there is an annotated T. brucei genome in SEED which 
can be accessed through the Seed Viewer portal (http://rast.nmpdr.org/seedviewer.cgi). 
This annotated genome however does not use T. brucei standard gene identifiers which 
makes comparison of annotated genes and integrating published data very difficult. The 
SEED server was hence not used in this reconstruction project. Genome-scale models can 
also be generated via the KEGG [83] web service by compiling all known T. brucei reactions 
from the KEGG database. This feature has been implemented in many tools like MetExplore 
[149]. However since the secondary objective of this project (see Objectives) also required 
setting up a database on T. brucei metabolism, Pathway Tools [137] was the obvious tool of 
choice for genome-scale reconstruction. The COBRA package [159] with its multitude of 
algorithms and active user forums was selected as the tool for performing simulation and 
analyzing the genome-scale metabolic model. COBRApy [144] was chosen as the primary 
simulation tool since unlike its MATLAB counterpart it did not depend on a proprietary 
environment. Both Cytoscape [148] version 2 and  version 3 were used for visualization and 
analysis because of their respective strengths. Cytoscape version 2 although being the older 
version was still used in this project since it had more community-developed-plugins 
available than its counterpart. It also had a better import feature for SBML files and 
attributes. Cytoscape 3 also lacked some basic functions in its library such as “degree of 
node” function which can be very useful in topology based analysis of the metabolic model.  
Standardizing the metabolite and reaction identifiers of the TrypanoCyc-based model was 
one the most time consuming stage of the reconstruction pipeline (second only to manual 
curation). Although, programming script were used to identify BiGG identifiers based on 
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various attributes in the model such as ID, common name, formula, etc; the results had to be 
manually validated as mistakes in this step could lead to a bad model and hence incorrect 
predictions during simulations. Since the release of Pathway Tools 18.0 in March 2014, this 
issue has been solved for future researchers. This version incorporates the conversion of 
MetaCyc IDs to BiGG IDs into the “export reactions to sbml” function used to generate the 
TrypanoCyc-based model. 
To improve the reusability of metabolic model, the MIRIAM guidelines[101] encourages the 
use of database identifiers to link metabolites and reactions in the model to objects in 
standard databases as explained earlier (see standardization and model format in Section 
1.4.3). This system is quite popular among model repositories such as BioModels[109]. 
However, the same metabolite can be described by two or more different databases in 
different models. As an example, consider the metabolite water in three models - model1 , 
model 2 and model 3. If model 1, model 2 and model 3 associates the metabolite with 
MetaCyc (ID = WATER), KEGG (ID = C00001) and ChEBI (ID= CHEBI:15377) respectively, in 
order to compare these models, a web service performing conversion of IDs between these 
3 databases need to be used. In addition to this, the same databases can have multiple IDs 
for the same metabolite (ex: 11 IDs in ChEBI point to H2O). To overcome this issue in the T. 
brucei model, InChI values of the metabolites (which are unique for each metabolite) were 
considered as the primary ID/attribute to compare metabolites and map experimental data.  
Visualization of metabolic networks and flux distributions are useful in understanding the 
overall structure of the metabolic network. Genome-scale metabolic networks such as the 
iSS1077 comprise of hundreds of metabolites and reactions. Visualizing very large networks 
is not useful unless the network layout is simple and intuitive. Many tools provide algorithms 
for automated layout of metabolic networks. The organic layout in Cytoscape[148] uses 
metabolic network topology attributes to perform the automated layout. Other tools such as 
MetDraw[192] uses pathway (or subsystem) annotations on the reactions in the model to 
develop a more intuitive layout of the metabolic network. However the results of the organic 
layout are still too complex for visual inference and pathway based approaches (such as 
MetDraw) is unable to associate transport reactions resulting in a layout of subnetworks. 
The T. brucei iSS1077 model hence was “laid out” manually during manual curation of the 
various pathways. The addition of flux and hiding blocked reactions on the manual layout 
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provides a much simpler illustration of the FBA solution. Using this visualization, the flow of 
metabolites can be easily traced from the extracellular, through various pathways into the 
biomass to inspect the solutions of the FBA analysis when required. 
Being parasites, T. brucei have evolved to become auxotrophic to precursors of many 
metabolic processes (i.e. they are unable to synthesize these compounds). Nutritional 
requirements for T. brucei had been explored in order to understand the robustness of the 
parasite metabolism. This information is essential to determine efficient T. brucei culture 
media [193]. Knowledge of why the nutrients essential for T. brucei growth are essential 
helps to understand the implications of perturbing nutrient transport and metabolism. The 
algorithm used in this study to explore the contribution of essential nutrients to the biomass 
has proven quite useful in understanding this information. However, the algorithm is not 
exhaustive and could miss some solutions in the case of complicated scenarios. Consider a 
scenario where an essential nutrient (N) could contribute to the synthesis of 4 metabolites 
(A, B, C and D) but only 3 of them at once. In other words, if based on one FBA solution, N 
contributes to A, B and C; then it is not involved in the synthesis of D in that solution. If in 
another FBA solution, N contributes to A, B and D; then it is not involved in synthesis of C in 
that solution and so on. The contribution of N to the biomass in the model is hence A.B.C or 
A.B.D or A.C.D or B.C.D. The algorithm used in this project is capable of finding the solutions 
A.B.C, A.B.D and A.C.D but will not be able to predict B.C.D as a solution. A detailed analysis 
need to be done to evaluate the efficiency of this algorithm and to understand its 
limitations. This is the reason why this algorithm was not included in Article 2. Nevertheless, 
the algorithm is capable of returning at least one solution for each essential nutrient and is 
computationally feasible.  
From the study evaluating the need for stage-specific model we concluded that blood-
stream-form (BSF) models are required to accurately study BSF parasites (See Article 2 
Results). The iMAT algorithm was used to develop BSF models of T. brucei from the genome-
scale metabolic model. However from our results we can see that there remain some errors 
in the essentiality predictions (See Article 2 table 2). The algorithm designed to optimize the 
iMAT results and to overcome the errors caused by the underlying assumptions used by 
iMAT worked in 7 of the 12 tests (see Table 4-7) and prediction results were more consistent 
with published data. Nevertheless, more work need to be done to evaluate the efficiency of 
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this algorithm. The measure of true positives, true negatives, false positives and false 
negatives in gene essentiality predictions is one way to determine the quality of the 
algorithm. Another interesting point to note is that all optimized iMAT models have smaller 
number of reactions than the original iMAT models. Gene essentiality is directly related to 
the availability of alternate pathways and so smaller number of reactions is likely to improve 
the essentiality of genes. Validation techniques other than essential gene studies have to be 
employed to determine if the optimized iMAT models are better in representing BSF 
behaviour than the original iMAT models. The limitation of iMAT algorithm discussed in this 
study, can also be overcome with help of more information such as metabolomic data. The 
GIM3E algorithm[194] uses metabolomics and expression data gathered from the same 
culture to develop stage specific models. A comparison of the iMAT models, optimized iMAT 
models and respective GIM3E models should help in understanding the strengths and 
weaknesses of the different algorithms. 
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3. GENERAL DISCUSSION 
  
134 
 
The importance of organism specific databases – the  
T. brucei perspective  
The availability of vast amounts of data in biology led to the development of many biological 
databases handling different types of data (GenBank[195] handles nucleotide data, PDB[196] 
handles experimentally determined protein structures, UniProtKB[158] handles protein data 
and so on). These databases hold all available biological data of a particular type from all 
organisms and report interesting features in this data. Since these databases deal with data 
from many different organisms, the curation of this data is limited. This led to the rise of 
organism specific databases such as FlyBase [197] (a Drosophila database), Mouse Genome 
Informatics [198] (which has a mouse genome database) and Reactome [199] (a database of 
core pathways and reactions in humans). TrypanoCyc is a similar organism specific 
biochemical database on T. brucei metabolism. TrypanoCyc employs a team of experts from 
all areas of trypanosomatid research to help curate and maintain the database with the 
current knowledge on T. brucei metabolism. Because of this, databases such as TrypanoCyc 
will be involved in performing organism specific curation along with (or even more than) the 
addition of new features and tools for analyses. Let us consider the following issue to 
illustrate this point. By the end of 2011, new versions of chromosome 9 (December) and 
chromosome 11 (November) were released by GeneDB[43]. The identifiers of gene in these 
chromosomes were updated to follow the same structure as the systematic IDs previously 
used for chromosomes 1-8 and 10. For example previously the T. brucei triosephosphate 
isomerase gene was named Tb11.02.3210. Based on the new ID structure, this ID was 
changed to Tb927.11.5520. Searches using the old id Tb11.02.3210 on popular non-T. brucei 
specific databases such as GenBank, European Nucleotide Archive (from EMBL) and KEGG 
returned results pointing to the T. brucei triosephosphate isomerase as expected. However, 
at time of writing, searches on these databases using the new gene ID (Tb927.11.5520) 
returns no results (See Figures 30 a-c). Hence users are unable to use the latest gene IDs and 
have to revert using the old gene IDs to find information on their gene of interest in these 
most popular of databases. However, the fact that these generic databases do not have the 
updated information is understandable. Because these databases have to deal with 
information on every single organism, efforts are directed to improving the technical and 
analytical aspects as they will improve the quality of information on all sequences in the 
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database and not only those from one species. Organism-specific databases such as 
TrypanoCyc on the other hand, focus their attention on the curation of only one organism 
and hence are capable of providing more updated information on the organism to the user 
much faster than the generic databases. For example, known to possess an arginase gene 
Figure 30 – Search result for triosephosphate isomerise using new gene ID in popular databases 
a) Search result for Tb927.11.5520 in GenBank c) Search result for Tb927.11.5520 in ENA 
b) search result for Tb927.11.5520 in KEGG  d) Search results for Tb927.11.5520 in TrypanoCyc 
(a) 
(b) 
(c) 
(d) 
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Figure 31– T.brucei arginase activity in KEGG and TrypanoCyc 
(a) Arginase activity of T. brucei reported in KEGG 
(b) Arginase gene and gene-product are not associated with any reaction in TrypanoCyc 
(c) TrypanoCyc update report shows the database has been updated based on the lack of arginase 
activity in T. brucei  
(Tb927.8.2020) T. brucei was thought to have been capable of converting arginine to 
ornithine (EC: 3.5.3.1) [200, 201]. Ornithine is a precursor in polyamine biosynthesis an 
essential pathway in the parasite [23]. Recent studies have shown that although the gene-
product is generated [186], it is not catalytically active [50, 202] unlike in other 
trypanosomatids. This meant that the parasite needed ornithine from the medium and a lack 
(a) 
(b) 
(c) 
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of this nutrient could be fatal to the parasite. Information such as this can be extremely 
valuable to researchers aiming to develop new measures to control T.brucei growth. Generic 
databases such as KEGG still associate the gene product with arginase activity (see Figure 
31(a)) while organism specific databases such as TrypanoCyc manages to keep up-to-date 
thanks to its community of annotators (see Figure 31(b-c)). Additionally, organism-specific 
databases also hold information specific to the organism such as developmental stage 
specific activity of enzymes. Since these properties are specific to few organisms, generic 
databases do not maintain this information. Finally, organism specific databases such as 
TrypanoCyc are constantly under curation, based on the latest information, with the help of 
annotation teams comprising of experts actively involved in research are hence extremely 
important in propagating up-to-date information on the organism to the public.  
Apart from being the more reliable sources of organism-specific information for the public, 
the fact that these databases provide this information in an organized and parsable form, 
make them ideal resources for generic databases to collect information from. The generic 
databases could take advantage of the heavy curation efforts taken up by the annotation 
teams of the organism-specific databases allowing them to focus more on the addition of 
bioinformatics analyses and other functionalities that would benefit their entire database. 
However, although organism-specific databases provide more updated information on the 
organism, they lack the impressive array of tools and analyses which are available in generic 
databases making them a perfect complement to one another. 
Redundancy in annotation efforts – a waste of effort or a 
necessity in science 
Currently both TriTrypDB and TrypanoCyc are involved in collecting annotations on T. brucei 
metabolism. Although TrypanoCyc focuses on reactions and pathways; and TriTrypDB 
focuses on genes and their products, both the databases collect annotations from experts on 
enzyme activity. This brings forward the question, ‘should both databases combine their 
efforts to reduce duplication of effort or should they carry on collecting information 
separately?’. The two approaches have their own advantages and disadvantages. From the 
perspective of the databases, collecting annotations together involves sharing resources 
such as data storage and manpower and so it would be favourable. It also simplifies 
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information search for users as they only have to visit one database (since both databases 
will contain the same expert annotations). It also reduces annotation work for experts as 
they do not have to submit their annotations twice. However by collecting annotations on T. 
brucei metabolism separately, a much more reliable information (similar to using biological 
replicates in experiments) is available to the public. Collecting annotations independently 
also increases the number of annotators involved in annotating the metabolism and hence 
providing more information and perspectives on enzyme activity to the public. As for the 
experts/annotators, they can submit their annotations to either TrypanoCyc or TriTrypDB as 
the primary objective is to make the information available to the public. The choice of 
database to submit their annotations can be determined by comparing how the annotation 
will be presented to the public. TrypanoCyc presents user annotations relating to known 
developmental stage specific enzyme activity much better than TriTrypDB and could be the 
choice for such annotations. On the other hand TriTrypDB is capable of handling 
experimental data very efficiently and should be the go-to choice for annotators wanting to 
share their data with the rest of the scientific community.  
Another point to discuss with regards to annotations in TriTrypDB and TrypanoCyc is “should 
the data in the two databases be synchronized”. Although synchronization of databases is a 
smart idea to maximize the information available in a database, it could also lead to 
transmission of incorrect information across multiple databases. Such incidences have 
already been observed in biological databases[203]. One approach to deal with this issue is 
to make sure the user is informed when the information displayed was obtained from 
another database and to separate it from same information determined locally or from a 
different source. This approach could also help identify conflicts in annotation from different 
sources allowing users to determine the reliability of the information more accurately . An 
example of this approach can be seen in the Gene Ontology (GO) associated with the 
Figure 32– Gene Ontology information on TriTrypDB 
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proteins section of TriTrypDB pages (See Figure 32). These suggested measures may add 
additional effort into collecting information and annotations but in the long run will provide 
more reliable data to the scientific community. 
The SBML ‘notes’ and its importance in an otherwise 
standard format 
The Systems Biology Markup Language (SBML) is the XML based standard format used to 
facilitate easy exchange of systems biology models across different tools. It is capable of 
representing compartments, metabolites, proteins, genes and reactions. In the case of 
genome-scale metabolic models, the SBML file is also capable of handling flux constraints on 
reactions (flux upper bounds and lower bounds) as well. Meta data on the metabolites can 
be provided in more recent versions of SBML in the form of resource description frameworks 
(or RDFs). However the SBML format is still unable to represent important information on 
the metabolism such as pathways (or subsystems) associated with reactions. This 
information can be provided in the annotation attribute of SBML elements as RDFs. 
However, the MIRIAM [101] registry is still unable to deal with information such as the 
confidence score used to denote the confidence the curator has in a particular reaction. 
Information such as these are primary provided in the ‘notes’ attribute of SBML elements 
(SBase). Chemical formula for metabolites (species) and gene association for reactions are 
some of the data that used be present primarily in SBML notes. SBML level 3 with the fbc 
package (http://tinyurl.com/j8cgzyb) can now hold chemical formula as an attribute of 
metabolites and Gene association can be used to build species representing proteins (or 
protein complexes) which can then be associated with reactions using the ‘listOfModifiers’ 
attributes. SBML notes hence provide a much needed place for many attributes until new 
versions of SBML capable of holding this information is released.  
In the case of T. brucei, we have discussed the importance of the developmental stage 
specific behaviour of the metabolism (Article1, Article 2, Result 2 Additional Discussions). 
There is no standard manner to represent this information in the SBML files. SEDML or 
Simulation Experimental Description Markup Language has been used to describe kinetic 
simulation conditions in order to improve the reproducibility of SBML model based kinetic 
simulations. However no such standard for storing FBA simulation conditions is currently 
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available. Since the purpose of the ‘notes’ attribute for SBML elements is to handle 
information that cannot be provided in the standard format elsewhere, in iSS1077 the 
“notes” attribute of reactions were used to describe whether a particular reaction was active 
or not in the various developmental stages (as annotated on TrypanoCyc) in order to 
successfully convey this information. When studying a particular developmental stage (e.g. 
procyclic forms), a simple script can be used to look for the developmental stage of interest 
(ex: PROCYCLIC) and its value (TRUE or FALSE or UNKNOWN) in the reaction notes and 
remove reactions that have been identified to be absent in the developmental stage of 
interest. Simple blood stream form (LONG SLENDER) or procyclic insect form (PROCYCLIC) 
models can hence be developed using these attributes. With the rising popularity of context 
specific metabolic modelling, it might be worthwhile to set up standards to include multiple 
simulation conditions for the same model in the SBML file. One manner this could be done 
Figure 33 – Suggestion to include context specific constraints in sbml model 
Context specific information such as developmental stage specific activity of reactions can currently 
only be stored in SBML notes (a). By allowing SBML reactions to have multiple “kinetic law” nodes, 
this information could be handled without SBML notes (b). 
<reaction id="..." name="..." reversible="false" > 
        <notes> 
          <body xmlns="http://www.w3.org/1999/xhtml"> 
           ... 
           <p>SLENDER: FALSE</p> 
           <p>PROCYCLIC: TRUE</p> 
          </body> 
        </notes> 
        <listOfReactants> 
 ... 
        </listOfReactants> 
        <listOfProducts> 
 ... 
        </listOfProducts> 
        <listOfModifiers> 
 ... 
        </listOfModifiers> 
        <kineticLaw> 
... 
           <listOfParameters> 
            <parameter id="LOWER_BOUND" value="0" 
units="mmol_per_gDW_per_hr"/> 
            <parameter id="UPPER_BOUND" value="1000" 
units="mmol_per_gDW_per_hr"/> 
          </listOfParameters> 
        </kineticLaw> 
      </reaction> 
 
 
 
 
 
 
 
(a) 
<reaction id="..." name="..." reversible="false" > 
        <notes> 
          <body xmlns="http://www.w3.org/1999/xhtml"> 
           ... 
          </body> 
        </notes> 
        <listOfReactants> 
 ... 
        </listOfReactants> 
        <listOfProducts> 
 ... 
        </listOfProducts> 
        <listOfModifiers> 
 ... 
        </listOfModifiers> 
        <kineticLaw id=“SLENDER”> 
... 
           <listOfParameters> 
            <parameter id="LOWER_BOUND" value="0" 
units="mmol_per_gDW_per_hr"/> 
            <parameter id="UPPER_BOUND" value="0" 
units="mmol_per_gDW_per_hr"/> 
          </listOfParameters> 
        </kineticLaw> 
        <kineticLaw id=“PROCYCLIC”> 
... 
           <listOfParameters> 
            <parameter id="LOWER_BOUND" value="0" 
units="mmol_per_gDW_per_hr"/> 
            <parameter id="UPPER_BOUND" value="1000" 
units="mmol_per_gDW_per_hr"/> 
          </listOfParameters> 
        </kineticLaw> 
</reaction> 
(b) 
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would be to add multiple “kinetic law” nodes for the same reaction with an id attribute 
which can be used to identify the condition which the constraint represents (see Figure 33). 
Manual curation – the essentially unending stage of 
genome-scale metabolic reconstruction 
The manual curation stage of genome-scale metabolic reconstruction is a continuous 
process and involves the validation of all metabolic reactions, their localizations, 
metabolites, GPR associations and transport reactions (both extracellular and intracellular) 
in the model based on experimental observations. This curation, simulation and validation 
loop stage of genome-scale metabolic reconstruction is only limited by time or the amount 
of information available. There has always been a steady increase in the interest of T. brucei 
research (See Figure 34). The release of the T. brucei genome in 2005, the rise in popularity 
of analytical techniques at the genomic, proteomic and metabolomic level, development of 
mutant strains and efficiency of RNAi techniques all led to an increase in the understanding 
of T. brucei metabolism. There is hence a rich resource of published studies on T. brucei 
metabolism to be used in the validation of the metabolic model. Ribosome profiling can be 
used to predict proteins not expressed in a particular developmental stage of T. brucei. 
Proteomics data can be used to predict the expression of a protein during various 
developmental stages (comparative SILAC studies[168, 204]) and predict the localization of 
enzymes (glycosomal[205] and mitochondrial[206] proteomics). RNAi and KO studies[22, 
178, 207] can be used to evaluate the quality of the model. Flux can be forced through 
pathways which have been validated[208–210] to check if the model can support the 
observed behaviour. Results from metabolomics studies[50] can be used to identify missing 
regions in the metabolic network. Labelled nutrient studies[211, 212] can be used to 
indentify pathways and reaction missing or wrongly present in the metabolic model. Studies 
observing the behaviour of T. brucei grown in normal and nutrient depleted media[213] can 
be used to validate prediction of the model simulating the same scenario. Studies analyzing 
the difference in metabolomics profile of the fresh and spent media[177] can be used 
identify metabolite produced and consumed by the parasites and this information can be 
used to check if the model can simulate growth under constraints representing the same 
nutrient consumption-secretion behaviour. In this manner, many of the available 
information can hence be used in manual curation of the metabolic model. And so, the 
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limiting factor in manual curation is very often time. One approach to improve the efficiency 
of manual curation would be to create validation pipelines classified based on the type of 
study. All published data of the same data types can be classified together along with 
information on culture medium used (such as what was the carbon source used or if any 
medium was deficient in any nutrient) and then common protocols to validate them can 
formulated. Similarly protocols to identify problems in the case of failed simulations can also 
be generated. For example, in the case of adding growth medium constraints based on 
experimental data, if the model fails to support flux through biomass, the algorithm used in 
this project to identify contribution of essential nutrients (see Result 2: Additional results - 7) 
can be tweaked to identify biomass metabolites responsible for the failure of the simulation. 
By removing these metabolites and adding sink reactions for them (which will be blocked 
since flux to biomass from these metabolites was also not possible), the algorithm used in 
this project to identify parts of the model that required curation to unblock a reaction (see 
Article 2: Methods - FVA) can be used. This approach could potentially increase the efficiency 
in validating the model by saving time and might prove interesting for other users as well.  
The growth medium – a challenge in the simulation of 
genome-scale metabolic models. 
Performing simulations using metabolic models helps to study the metabolism under various 
conditions and scenarios (ex: a gene knockout or knockin). However an important question 
when performing simulations is “What medium am I simulating?”. The in silico growth 
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Figure 34 – Trend in published studies containing the term “brucei” from Pubmed 
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medium can be set by adjusting flux constraints on reactions responsible for the exchange of 
metabolites between the model and the extracellular space (exchange reactions) and has 
important implications on the simulation. Genome-scale metabolic networks represent the 
full metabolic capabilities of an organism and so they would contain reactions representing 
all known transport mechanisms in the organism. And so unless these transport reactions 
are constrained, the simulation assumes that all metabolites are available in the in silico 
medium. However this may not be true for the environmental conditions available for the 
parasites in in vivo or in vitro experiments. A simple example of this in T. brucei is the carbon 
source available in the mammalian host and insect vector. Glucose is the preferred carbon 
source in T. brucei[209, 213] and is readily available from the blood of the mammalian host. 
The Tsetse fly gut lacks high concentration of glucose and so the parasite is forced to use L-
proline as its carbon source[214]. This change in medium conditions have to be incorporated 
into the model while simulating the growth of the model in mammalian host and insect 
vector respectively to provide a more accurate representation of T. brucei metabolism. 
Metabolomics studies have been successful in generating a metabolomics profile 
representing the composition of metabolites in the blood[215]. This information can be used 
to set the in silico medium when trying to simulate growth of the parasites in mammalian 
blood. Similarly a Tsetse fly gut metabolite profile could be used to set the in silico medium 
to simulate parasite growth in the insect vector. Most studies on T. brucei metabolism are 
performed on in vitro cultures of the parasite. The HMI-11 [170, 216], HMI-9 [204, 207], 
CMM [193] culture media have been used to grow T. brucei in in vitro studies. All these 
culture mediums contain foetal bovine serum (FBS). Since the exact composition of FBS is 
unknown, the exact composition of the metabolites available in the culture medium cannot 
be determined. Hence we are unable to constrain the exchange reactions of the model. 
Errors because of this issue can be reduced by using information on metabolites consumed 
or produced during culture of the parasites. Comparison of fresh and spent culture media as 
performed by Kim et al [177] can be used to identify metabolites having higher and lower 
metabolite concentration in the spent media, suggesting these metabolites were secreted 
and consumed by the parasites respectively. Using this information we can constrain some 
of the many exchange reactions in the model and hence partially set the in silico culture 
medium including important parameters such as the major carbon source, major secreted 
144 
 
by-product, etc. Such approaches should be used to update as many constraints as possible 
in order to improve the accuracy of the simulation.  
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4. CONCLUSION 
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Summary of the results 
The TrypanoCyc database has been online since 2012 and was published in November 2014 
[172]. The TrypanoCyc annotation team presently consists of 36 experts from 19 institutions. 
So far a total of 233 confidence scores and 653 annotations has been presented on 464 
reactions. During November 2013 - 2015, the database has had over 4200 users from across 
107 countries. 
The iSS1077 model is the first manually curated genome-scale metabolic model on 
Trypanosoma brucei. It consists of 8 compartments, 1689 reactions, 1677 metabolites and 
1077 genes. Of the 43 essential genes predicted by the model, 26 have already been 
validated and 11 genes are associated with essential pathways. Gene deletion scenarios 
from 27 published studies were used to show that blood stream form specific models were 
capable of predicting blood stream form behaviour much better than the genome-scale 
model.  
During the project algorithms to simplify flux distribution for visualization, to identify the 
contributions of essential nutrients to the biomass and to optimize iMAT generated context 
specific models were proposed. Although they have yet to be tested on other models to 
determine their limitations, precision and accuracy, the results on the iSS1077 model is 
positive. Algorithm used to simplify flux distribution has been successful in eliminating flux 
cycles in FBA solutions. Contribution of all 15 essential nutrients have been determined and 
is in accordance with published information in the case of ornithine[23, 186], L-cysteine[187] 
and choline[188]. Gene essentially data shows that the optimized iMAT subnetworks display 
better prediction accuracy in 7 of the 12 cases when compared to the prediction accuracy of 
the original iMAT solutions. 
Future work in studying T. brucei metabolism using Systems 
Biology  
Curation of Genome-scale reconstruction is a continuous process and updates to both 
TrypanoCyc and iSS1077 need to be made based on the availability of new information and 
expert annotations. The priority of the TrypanoCyc database and the annotation team will be 
to maintain this continuous updation of the information on enzymes, reactions and 
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pathways in the T. brucei along with the addition of more published studies to support the 
annotations. Pathway summaries need to be collected systematically from the annotation 
team. More experts also need to be recruited into the annotation team in order to reduce 
the annotation workload on existing members. Reactions from the iSS1077 need to be 
compared against the TrypanoCyc in order to identify additional reactions for the database. 
Reactions in iSS1077 absent from TrypanoCyc also need to be validated with the help of the 
corresponding expert form the annotation team in order to add missing information in 
TrypanoCyc. Reactions in the iMAT derived blood stream form (BSF) models need to be 
validated for their developmental stage specific activity with the help of the annotation team 
and this information need to be added to TrypanoCyc. Because of the obvious interest in BSF 
parasites owing to the drug design perspective, mostly BSF data was used to curate the 
model. Data from procyclic forms hence need to be used to curate the model so that the 
procyclic metabolism is represented accurately by the iSS1077.  
In the case of algorithms used in this project, both the iMAT optimization algorithm and the 
algorithm used to find the contribution of essential nutrients to the biomass needs to be 
further tested in order to identify all of their limitations. The iMAT optimization algorithm 
also needs to be evaluated on multiple genome-scale models (such as the H. sapiens Recon 2 
model[72] and the E. coli iJO1366[71] model) in order determine if the errors are caused 
because of the quality of the model or because of the algorithm. Additionally new algorithms 
can also be used help in vitro research. Recently studies have successfully identified 
threonine as the major source of acetyl-CoA (used in lipid metabolism) in T. brucei [217]. 
Glucose was also found to be an alternate source for acetyl-CoA [217]. An FBA based 
algorithm can be designed to predict all potential sources for such important metabolites 
and can facilitate this type of research.  
One of the most important uses of genome-scale metabolic models is the generation of 
hypothesis. Results from gene and reaction deletion studies in this project have helped in 
the identification of potential vulnerabilities of the T. brucei metabolism. In vitro 
experiments using techniques such as RNAi can be used to validate these results. Combining 
this information with other bioinformatics techniques can also be used to identify potential 
drugs against T. brucei. Chavali et al in 2012 used genome-scale metabolic model with 
sequence similarity searches of drug targets to identify potential anti-Leishmanial activity of 
148 
 
FDA approved drugs [112]. In that case the structure of the target enzyme has been 
determined, pharmacophore and docking based virtual screening can be used to identify 
potential drugs against T. brucei [218–220]. These in silico techniques can be used to 
shortlist drug molecules for high throughput screening (HTS) saving both time and money 
[221]. Apart from drug designing, genome-scale metabolic models can be used to generate 
hypothesis for basic research in biology such as metabolite permeability/transport across 
membranes. T. brucei is one of the model organisms used to study eukaryotic 
behaviour[222] and hence hypothesis on the properties of T. brucei could be prove useful in 
studying other organism. Pathways extending across multiple membranes in T. brucei can be 
identified by annotating enzyme localization in genome-scale models using data from sub-
cellular proteome analyses [205, 206]; which can be used to identify metabolites that would 
need to cross organelle membranes. This information can be used generate hypotheses on 
intracellular transporters and permeability of organelle membranes. Such information on the 
permeability of organelle membranes can be proven useful in studying the metabolism of 
other eukaryotic organism as well. 
Another interesting avenue in the computational modelling of T. brucei metabolism would 
be to study the metabolic interactions of the procyclic parasites with the Tsetse gut 
microbiota using a systems biology approach. Procyclic T. brucei has been proposed to 
depend on homoserine produced by the insect gut microbiota for threonine [223]. Since T. 
brucei procyclic forms cannot survive without homoserine (or quorum-sensing acyl 
homoserine lactones) or threonine in vitro, depletion of these nutrients from the insect gut 
could cause the T. brucei death. Such metabolic interaction of the parasites and the insect 
gut microbiota may hence prove as an alternate method in controlling T. brucei growth. A 
metabolic network of the Tsetse gut microbiota including the procyclic T. brucei can be 
generated using protocols used in developing reconstructions of metabolic communities 
[224] and the iSS1077 model. This metabolic network can then be used to study the effects 
of perturbations in the gut endosymbiotic metabolism that can effect T. brucei growth. Such 
studies could lead to the development of faster means to control T. brucei growth since the 
perturbation used to control the parasite will be made inside the tsetse fly and not the 
human host.  
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Abstract: 
The last two decades saw a monumental advancement in genome sequencing and high-throughput 
“omics” techniques. For the first time, more data was generated than that could be analyzed. The 
availability of data and the increasing popularity of a systems level approach in the study of 
metabolism led to the development of computational techniques capable of modelling, simulating 
and studying whole cells. In this chapter we provide an introduction to the approach of genome-scale 
metabolic network reconstruction and flux balance analysis in the study of parasitic metabolism. We 
also summarize upon the various tools and databases popularly used in this approach. Lastly, we also 
discuss the application of this approach in parasitology and the current limitations. 
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Understanding Protozoan Parasite Metabolism and 
Identifying Drug Targets through Constraint-Based Modeling 
Francis Isidore Totanes, Sanu Shameer, David R. Westhead, Fabien Jourdan, and 
Glenn A. McConkey 
 
 
21.1 
Introduction 
 
21.1.1 
Genome-Scale Models 
 
Systems biology is the study of multiple molecular components and of their 
interactions at the cellular and organism levels. It involves using large datasets 
from high-throughput measurements, reconstruction of cellular systems, math- ❦               
ematical modeling, and in silico simulations  [1]. The main objective of systems                                                
❦
 
biology is to provide an understanding of complex biological systems, and to 
attain this, development of mathematical  models is required. These models 
attempt to closely replicate wet lab experiments with the goal of computationally 
generating hypotheses that can be experimentally  validated at the organism 
scale (also called  genome scale) [2]. Genome  sequencing  data, gene–protein 
reaction knowledge, and biochemical and enzymatic data on the metabolism of 
an organism are combined to create a genome-scale model. This genome-scale 
model is formatted following a deﬁned and standard structure compatible with 
various software suites. Computation  based on these models then allows calcu- 
lation of possible phenotypic  states of the model organism [3]. Genome-scale 
models can also be used to predict the function of previously uncharacterized 
genes and rectify incorrectly  annotated genes. Gene deletions and gene over 
or underexpression strategies are applied to genome-scale models to predict 
genes and pathways that may be altered for bioengineering the production of 
therapeutically or industrially important compounds [4]. These models  can also 
be used to predict genes and enzymes that are essential for the survival of an 
organism. These predicted essential genes and enzymes may be potential drug 
targets and therefore important in drug discovery and development [5]. 
Genome sequence and gene annotation data are used to identify speciﬁc roles 
of individual  proteins within the system. A metabolic  network  (i.e., a network 
of metabolites interconnected  via reactions involving  the said metabolites) is 
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First Edition. Edited by Sylke Müller, Rachel Cerdan, Ovidiu Radulescu, and Ewelina Guca. 
© 2016  Wiley-VCH Verlag GmbH & Co. KGaA. Published 2016 by Wiley-VCH Verlag GmbH & Co. KGaA. 
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developed utilizing  published data on elucidated protein function and cellular 
location, enzyme thermodynamics, and reaction stoichiometry. Data from closely 
Q1 related organisms, for example, orthologous  gene data, are sometimes used in 
the absence of reported information on the organism of interest  [6]. Reactions 
and corresponding  metabolites are tabulated into a matrix that accounts for 
the number of metabolites consumed and produced within the given reactions. 
Additional  constraints on the ﬂuxes through  the reactions  (often expressed 
in metabolite amount per dry weight of the parasite per hour with upper and 
lower boundaries) are incorporated to control the ﬂux values and represent the 
reversibility or irreversibility of reactions [7]. 
 
21.1.2 
Constraint-Based Modeling 
 
Constraint-based modeling is an important in silico approach  as it takes into 
account  the diﬀerent  biochemical  processes (i.e., reactions) and the ﬂow of 
metabolites (i.e., species) in order to closely represent the metabolic network of 
an organism without the necessity for individual enzyme kinetics. It models the 
possible steady states of the metabolic network (metabolite concentrations do not 
change with time), thus enzyme kinetic parameters (e.g., Michaelis–Menten) that 
would need to be derived from recombinant expression and biochemical assays 
for all enzymes are not required. This is an important advantage for genome-scale 
modeling since these are seldom known for every enzyme encoded in a genome. ❦                    
Moreover, these enzyme parameters are strongly dependent on environmental                                  
❦
 
conditions  (pH, for instance). Even with the steady-state assumption, too many 
ﬂuxes will need to be computationally  predicted. In order to focus on more 
relevant ﬂux distributions, speciﬁc constraints, often based on experimental 
data, are entered into the system to represent limits of enzymatic ﬂuxes as well 
as available  metabolites. The steady-state assumption allows the use of linear 
programming (i.e., a mathematical technique that computes the optimal output 
of a model whose constraints are given by a set of linear equations) to solve for the 
maximum or minimum ﬂux values [8]. Finally, the growth of the organism is pre- 
dicted based on the production of essential components for increasing biomass 
[3]. This  set of constraints in terms of metabolite consumption  and biomass 
component production is the reason why this approach is called constraint-based 
modeling. 
The genome-scale metabolic network is assigned an objective, most often the 
production of metabolites such as proteins, lipids, nucleic acids, and carbohy- 
drates representing the biomass components that are essential for the survival 
of the organisms. ATP production  can also be assigned as the objective function 
of the network  [9]. The production of these components is then correlated with 
the growth of the organism in the given system. The ﬂux values for all the reac- 
tions in the network are calculated as those values that maximize the objective 
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function. The utilization of biomass components to satisfy the objective function 
is represented by the drain of these metabolites out of the system. Since in ﬂux bal- 
ance analysis (FBA), biochemical reactions are assumed to occur rapidly, steady 
state is achieved instantaneously and hence is assumed in all reactions. Linear 
programming is used to incorporate the constraints in the model to identify ﬂux 
values that will result in the maximized production of biomass components at 
steady state. This process deﬁnes FBA. Flux variability analysis (FVA), on the other 
hand, aims to identify the minimum and maximum ﬂux values on reactions that 
correspond to similar optimal values for the objective function. This identiﬁes 
alternate pathways that contribute to achieving the objective function. It also gives 
an idea of the ﬂexibility of the organism metabolism. For instance, this may help 
in identifying essential pathways where only small changes in ﬂuxes through reac- 
tions are allowed. One of the major drawbacks of this technique is that since it does 
not take into consideration the reaction kinetics and the initial concentration of 
each metabolite, it will be unable to predict the concentration of these metabo- 
lites over time as in kinetic modeling [3]. There has, however, been a release of 
algorithms  such as dynamic FBA, which tries to address the issue of varying con- 
centration of medium components [10, 11]. 
Constraint-based modeling has been used to predict the cellular response of 
an organism in diﬀerent conditions. This allows a more in-depth comprehension 
of the complex metabolic networks in organisms [12]. As a result, functional 
annotations for hypothetical proteins and correction of erroneous annotations 
are possible [7]. By restricting  the amount of speciﬁc metabolites, changes in ❦               
the production of biomass components are noted to predict the growth rate                                             
❦
 
of the organism  [9]. Altering the entry of metabolites into the system can also 
simulate the presence or absence of speciﬁc components in the media, and thus, 
components that are essential for the growth of the organism can be identiﬁed. 
Gene knockout can also be simulated in the FBA model in order to identify 
essential  genes. A gene knockout is represented in the model by forcing a zero 
ﬂux through speciﬁc enzymatic reaction/s associated with the gene. Single gene 
knockouts have been used to pinpoint possible drug targets against pathogenic 
organisms [7]. 
Double gene knockouts have also been simulated and outcomes predicted using 
FBA. There are two types of lethal double-gene knockouts that have been deﬁned 
in the recent literature [7]. Trivial knockouts are lethal gene pairs where one of 
the two genes is lethal when deleted individually. On the other hand, nontrivial or 
synthetic lethal genes are gene pairs that are lethal when inhibited together, but 
are nonessential when taken singly [7, 13]. Cell-scale networks have been utilized 
in order to identify drug targets in cancer cells [14]. This technique can also be uti- 
lized in the development of bacterial strains used for the production of metabolites 
of nutritional or pharmaceutical interests. Gene knockouts that will redirect the 
consumption of precursor metabolites to allow the overproduction of metabolites 
of interest can be identiﬁed using FBA [13].
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21.1.3 
 
 Existing Metabolic Models 
  
21.1.3.1   Leishmania major 
 Chavali et al. [7] developed a reconstruction of the Leishmania major metabolic 
 network utilizing  published literature and gene/enzyme databases. The network 
 takes into account a total of 560 genes, 1112 reactions, and 1101 metabolites. Stoi- 
 chiometric equations of metabolic reactions were atom- and charge-balanced, and 
 thermodynamic properties of these equations were also considered. Biomass pro- 
 duction was assigned as the overall objective of the metabolic network. Biomass 
 components include amino acids, fatty acids, and DNA. The estimated amount 
 of amino acid per gram of dry weight was computed based on the open reading 
 frames in the genome of the organism, while the DNA component was computed 
 by taking into account the G-C content of L. major DNA. Fatty acid components 
 were based on previously published literature. For the computation of ﬂuxes, sub- 
 cellular locations of the diﬀerent reactions were also considered. Linear program- 
 ming was used to compute the ﬂux distribution for the entire network at maxi- 
 mum biomass production. 
 To identify essential genes, single- and double-gene deletions were simulated by 
 forcing zero ﬂux through reaction/s associated with particular gene/s. The eﬀect 
 of the deletion on the growth of the organism was then categorized as lethal (0% 
 growth), growth-reducing (between 0% and 90% growth), and no eﬀect (>90% 
 growth). Lethal double-gene deletions were further classiﬁed as either trivial or 
nontrivial. A total of 69 lethal single-gene deletions were identiﬁed, while 19 285 
❦ 
 and 56 trivial and nontrivial double-gene deletions were identiﬁed, respectively  
 [7]. Furthermore, using the sequences of the enzymes involved in the predicted set  
 of essential reactions, inhibitors (e.g., antipsychotics and antibiotics) were identi-  
 ﬁed from existing drug databases and were tested experimentally for target vali-  
 dation [15].  
 
 
21.1.3.2   Plasmodium falciparum 
 
 A metabolic network reconstruction of Plasmodium  falciparum involving 1001  
 reactions and 616 metabolites in four distinct intracellular compartments was  
 developed by Plata et al. [16]. The biomass objective function was based on that  
 used in the iND750 yeast metabolic model [17] with the individual compositions  
 modiﬁed for Plasmodium. FBA was done and the production  of biomass compo-  
 nents was used as the objective function of the network. A total of 55 lethal single-  
 gene deletions and 16 nontrivial double-gene deletions were identiﬁed using this  
 model. Published materials on metabolic gene knockouts in P. falciparum  and  
 Plasmodium berghei were used to validate the results obtained from this model.  
 All 14 published essential and nonessential metabolic gene knockouts were con-  
 sistent with knockouts identiﬁed by FBA. On the other hand, 17 previously pub-  
 lished drug inhibition  studies coincided with those obtained from the FBA of the  
 metabolic network.  
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Gene expression data from published microarray studies were also incorporated 
into the FBA model of Plata et al. Gene expression data at diﬀerent stages (i.e., ring, 
late trophozoite, and schizont) were used to calculate proportional  constraints in 
relation to the level of gene expression. In order to validate the results, trends 
in metabolite production, in terms of changes in metabolite concentration (i.e., 
increase or decrease, as opposed to actual concentrations)  from ring to tropho- 
zoite and from trophozoite to schizont stages, were compared against experimen- 
tally obtained shifts in metabolite concentrations in the media. Calculated shifts in 
ﬂux values of exchange reactions (i.e., reactions involved in transporting metabo- 
lites into or out of the given network) were interpreted  as change in metabo- 
lite concentration. Thus, a negative or positive shift in ﬂux represents a decrease 
or increase in concentration, respectively. This comparison revealed consistent 
results in 46 out of 66 shifts in concentrations of 33 identiﬁed metabolites. More- 
over, the magnitudes of change in concentration observed in the FBA model cor- 
related signiﬁcantly with the experimental values [16]. 
An extensive in silico model of P. falciparum  by Huthmacher et al. [18] was 
developed through the compilation  of metabolic networks from a number of 
databases available online. The authors also integrated the parasite metabolic 
networks with that of the erythrocyte model. Data were obtained from published 
literature and online resources to take into account the exchange of metabolites 
between the host and the intraerythrocytic  parasite. In this merged metabolic 
network, limits in the uptake of metabolites were based on the existing data on 
the proportions of these metabolites in the plasma, while the parasite is allowed ❦               
to consume glucose and hemoglobin from the red blood cells.                                                              
❦
 
Stage-speciﬁc gene expression data from ﬁve published data sets on P. falci- 
parum and Plasmodium yoelii were used to compute binary variables to represent 
gene expression, where 1 is assigned to a gene that is expressed, while a value of 
0 is assigned to a gene that is not expressed. A reaction related to a gene that is 
not expressed is forced to have a null ﬂux while a reaction that is expressed is 
allowed a nonzero ﬂux. In addition, constraints on biomass components impor- 
tant in speciﬁc stages were taken into consideration. Similar to the previously 
presented metabolic networks, Huthmacher et al. simulated gene knockouts by 
ﬁxing zero ﬂux into individual reactions while maintaining an objective of pro- 
ducing metabolites that are essential to the survival of the parasite at a speciﬁc 
stage. It is important to note that essential metabolites diﬀer between parasite 
stages since each stage has its own survival objectives (e.g., replication, invasion, 
etc.). Through  this technique,  307 essential reactions  were identiﬁed, 35 of which 
were reported in published literature to be essential to parasite growth or survival 
(out of a list of 57 essential reactions reported in literature). By blocking reactions 
associated with the same gene product, they were able to identify two more reac- 
tions in the list of essential reactions reported in the literature. Finally, in order to 
identify potential drug targets, sequences of essential parasite proteins were used 
to screen for human orthologs and those found were excluded, thus resulting in 
a total of 30 potential drug targets. Additionally, identiﬁed drug targets that were 
not in the list of 57 previously reported essential reactions were scored based on 
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(i) nonhomology of the corresponding gene to human genes, (ii) if the function of 
the parasite enzyme is targeted in any organism (using the SuperTarget database) 
[19], and (iii) essentiality  of the reaction  in all stages of the parasite. The top 30 
targets were then presented as essential reactions [18]. 
Forth [20] developed a malaria metabolic network that focused on 247 reactions 
representing important high-ﬂux reactions. The reconstruction was built manu- 
ally and utilized a Cytoscape session for easy visualization and inspection of the 
network. Metabolite concentrations  of 10 carbon compounds that were obtained 
through  proton  nuclear magnetic  resonance assay of media samples from in vitro 
P. falciparum 3D7 culture were used as a basis for the FBA constraints. The net- 
work objectives were also based on laboratory-measured biomass components 
(i.e., DNA, RNA, and protein) extracted from P. falciparum culture. The model 
predicted 117 essential reactions associated with 79 lethal and 19 growth-reducing 
gene deletions. Only 22 of these identiﬁed essential genes were also predicted in 
the Plata et al. model; however, among the genes predicted to be nonessential, 
eight were predicted to be essential by the Plata et al. model. 
 
21.1.3.3   Trypanosoma brucei 
The TrypanoCyc  Pathway/Genome  Database (PGDB)  [21] is a  community- 
annotated metabolic database on Trypanosoma  brucei metabolism. The initial 
reconstruction  was developed in Pathway Tools using the genome of the T. 
brucei 927 strain sequenced at the Wellcome  Trust Sanger Institute. The draft 
has since then been curated by a team of 37 experts, each specialized in his/her 
❦                    
area  of trypanosome  metabolism.  The TrypanoCyc PGDB currently  has  9                                    
❦
 
compartments, 227 pathways, 1008 enzymatic reactions, and 835 metabolites. 
The unique feature of the TrypanoCyc  database is the presence of reaction 
annotations.  These annotations  were submitted  though  the  semiautomated 
TrypAnnot  pipeline and includes the localization of enzyme(s) catalyzing the 
reaction and the life-cycle stage(s) where it is known to be active. Annotators are 
provided with additional space to submit comments and publications to support 
their statement. TrypanoCyc also employs a modiﬁed version of the conﬁdence 
scoring system proposed by Thiele and Palsson [22] to represent conﬁdence of 
each reaction based on the annotations. The TrypanoCyc PGDB can be converted 
to the more popular SBML  (systems biology markup language) format using 
the Pathway Tools suite. The TrypanoCyc  community is also growing and is 
expected to continue collecting annotations on the Trypanosoma  metabolism, 
continuously  improving  the quality and accuracy of the TrypanoCyc  model. 
Work on the model generated from this database is currently ongoing. 
 
21.1.3.4   Trypanosoma cruzi 
The iSR215 is a metabolic network reconstruction of Trypanosoma cruzi strain CL 
Q2       Brenner core metabolism developed by Roberts et al. [23]. In this study, two mod- 
els were created for T. cruzi. The full model was based on direct genetic and bio- 
chemical data involving T. cruzi as well as data on other related species obtained 
from published literature. It takes into account 215 genes and 162 reactions in 
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four subcellular compartments. Another model simulated the metabolic network 
of the epimastigote form of the parasite. Proteomic data from epimastigote cul- 
tures was obtained to identify speciﬁc proteins that are present in this stage of 
the parasite. Proteins absent in the epimastigote are removed from the full model 
by forcing a null ﬂux into the involved reactions. Redirections of metabolic ﬂuxes 
through certain pathways in the epimastigote model were observed as a result of 
the absence of trypomastigote and amastigote stage-speciﬁc reactions. The model 
was validated by comparing the predicted metabolic by-products under aerobic 
and anaerobic conditions with the data presented in the published literature. By- 
products observed in the model were found to be mostly consistent with the data 
reported in the literature. 
Single reaction knockouts were predicted for each reaction in the full and the 
epimastigote models. A greater number of lethal reaction knockouts (40 reac- 
tions) were observed in the epimastigote model compared with that of the full 
model (26 reactions). This has been associated with the limitations imposed by 
the redirection of pathways in the absence of a number of reactions in the epi- 
mastigote model. Double reaction knockouts were also simulated in both models. 
Similarly, the epimastigote model yielded greater number of trivial and nontrivial 
deletions, 2880 and 183, respectively, as compared with the full model (1872 and 
96, respectively). The predicted essential reactions were then compared with pub- 
lished experimental data on the species related to T. cruzi to further validate the 
results of the metabolic model. In total, 46 out of the 58 published gene targets 
available were consistent with the results of the metabolic network. All nonlethal ❦               
reactions in the published literature were consistent with the results of the net-                                             
❦
 
work [23]. 
 
21.2 
Genome-Scale Reconstruction 
 
21.2.1 
Automated Genome-Scale Metabolic Network Reconstruction 
 
A genome-scale metabolic reconstruction  is a representation of a cell as a network 
of all the metabolic reactions that have been identiﬁed to occur within the given 
cell. As it is time-consuming to manually add every single reaction one after the 
other, many automated tools [24–26] and algorithms have been developed to help 
generate a draft, which can then be manually curated to better describe the cellular 
network. 
Automated genome-scale draft reconstruction  tools use an annotated genome 
of the organism of interest to mine biochemical  databases (or reactions pools) 
in order to identify  a set of reactions associated with the enzymes encoded in 
the genome. Some of these tools also predict the cellular localization  of the 
enzymes in order to develop multicompartment models. This subset of chemical 
reactions along with their gene–protein reaction relationship forms the draft 
of the metabolic  reconstruction  [8]. Some automated genome-scale metabolic 
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reconstruction  tools such as the SEED  server is even capable of annotating 
the genome of interest and have proved to be quite eﬃcient with prokaryotic 
reconstructions  [24]. All automated draft reconstruction tools have their own 
reaction pools from which reactions are selected for the draft. PathoLogic, the 
automated draft reconstruction tool employed in Pathway Tools, for instance, 
uses the MetaCyc database as its pool [25]. The AUTOGRAPH pipeline is well 
known for implementing the use of a user-deﬁned manually curated metabolic 
model as the reaction pool for generating the initial draft [26]. More details on 
these tools are discussed further along in this chapter. 
Most draft reconstruction tools and servers use nonorganism speciﬁc reaction 
pools to enable their application on diverse species. These drafts are hence prone 
to false-positive and false-negative hits that result in the draft containing reac- 
tions known to be absent in the organism of interest and not containing reactions 
that are known to be present in the organism of interest, respectively. Organism- 
speciﬁc reactions, which are absent in the reaction pool, are also missed in these 
automated reconstructions. Many automated genome-scale reconstructions also 
fail to identify and incorporate transport reactions into the model that are neces- 
sary for successful simulation of these models. Manual curation is hence necessary 
to ﬁx these issues and create a more realistic representation of the genome-scale 
metabolism of interest. 
 
21.2.2 
Manual Reﬁnement of Genome-Scale Model ❦                                                                                                 ❦ 
 
The manual curation step in genome-scale reconstruction  involves modifying the 
model draft so that it better represents the organism in real life. It involves 
adding reactions missing in the draft and removing reactions known not to 
exist in the organism of interest. The manual curation stage involves re-evaluation 
and reﬁne- ment based on literature and experimental observations. The 
manual curation stage is in essence a never-ending  process. It is usually 
coupled with validation of the model with experimental data in order to 
identify how well the model is able to represent the actual metabolism. Another 
important part of manual cura- tion is the addition of metadata to the model 
such as InChI and SMILES  iden- tiﬁers to the metabolites and Enzyme 
Commission  (EC) number, and pathway and enzyme localization information 
to the reactions. With the recent increase in genome-scale metabolic 
reconstructions, many detailed protocols for manual 
Q3       curation have been published [22] (Figure 21.1). 
A simpliﬁed representation of the steps involved in genome-scale metabolic 
Q4       reconstruction, model validation, and model prediction. 
 
21.2.3 
Standardization and Model Formats 
 
In 2005, Le Novère et al. reported that “most of the published quantitative models 
in biology are lost for the community because they are either not made available
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Color Fig.: 21.1 
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 Model Predictions  
 
❦ ❦  Figure 21.1  Steps in genome-scale metabolic  model  reconstruction and prediction. 
  or they are insuﬃciently characterized to allow them to be reused” [27]. With the 
  increasing importance of metabolic models in research, standard formats were 
  established to improve exchange and reusability. Currently, metabolic models 
  are accepted in the scientiﬁc community in the form of standardized machine 
  readable formats such as SBML  [28], CellML [29], and BioPax  [30]. Additionally, 
 Q5 speciﬁc standards were developed to encode systems biology graphics notations 
(SBGNs [31]) and simulation descriptions (SedML [32]). 
 
One of the major issues that aﬀect the understanding and reusability of exist- 
ing metabolic models is the lack of a single identiﬁer system for metabolites and 
reactions. This leads modelers to generate their own identiﬁers or borrow iden- 
tiﬁers from popular biochemical databases such as Kyoto Encyclopedia of Genes 
and Genomes (KEGG) [32], Biochemical Genetic and Genomic (BiGG) [33], and 
BioCyc [34]. Since genome-scale reconstructions tend to have more than a thou- 
sand reactions and metabolites, the use of diﬀerent systems makes comparison of 
models or mapping experimental data diﬃcult and time-consuming. As a result, 
the scientiﬁc community  stresses on the inclusion of metadata along with the 
model elements in the form of annotations. Some modelers also provide additional 
information on model components in the form of InChI, SMILES, EC numbers, 
and so on. The Minimum  Information Required In the Annotation of Models 
(MIRIAM) guidelines published in 2005 [27] describe an eﬃcient solution to this 
problem. According to the MIRIAM guidelines, the model should clearly provide
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a description of all model elements, relate to a publication, and list its authors and 
contact information along with the simulation conditions. In the case of model 
elements’ annotations, the MIRIAM guidelines advice authors to link those to 
external databases using an annotation triplet: “data type,” “identiﬁer,” and “qual- 
iﬁer.” Here, the “data type” refers to the general part of the link to a database 
resource and the “identiﬁer” refers to the speciﬁc ID in the particular database. The 
qualiﬁer is a term (selected from a predeﬁned namespace) used to represent the 
relationship to the resource. According to the Biomodels database [35], there are 
two types of qualiﬁers: (i) model qualiﬁer that represents the relationship between 
a modeling object and its annotation and (ii) biological qualiﬁer that represents the 
relationship between a biological object represented by a model element and its 
annotation [36]. The implementation of the MIRIAM guidelines can thus improve 
the reusability of metabolic models. However, since diﬀerent modelers can use 
references to diﬀerent database resources, comparison of diﬀerent models imple- 
menting diﬀerent identiﬁer  systems is still not straightforward. The InChI system 
[37] developed by International  Union of Pure and Applied Chemistry (IUPAC) 
provides a unique identiﬁer for a chemical entity (i.e., metabolite), and hence, this 
can be used to determine identical metabolites and reactions between two diﬀer- 
ent models. With the implementation of these standardizations, metabolic models 
developed can be easily read, understood, integrated with experimental data, and 
even combined to generate larger metabolic models. 
 
21.2.4 ❦                    
Tools and Databases                                                                                                                                                
❦
 
 
21.2.4.1   Automated Draft Reconstruction Tools and Servers 
Pathway Tools is a genome-scale reconstruction  software suite developed by SRI 
International and was ﬁrst introduced to the scientiﬁc community in 1996 [38]. 
Pathway Tools is capable of generating automated genome-scale reconstruction 
based on an annotated genome using PathoLogic [25]. PathoLogic not only rec- 
ognizes reactions associated with a given enzyme, but also intuitively identiﬁes 
potential pathways to which the reaction belongs, with the assumption that the 
predicted pathway plausibly exists in the organism of interest. The model gener- 
ated by Pathway Tools is stored in a database called PGDB. A Pathway/Genome 
Editor helps users in curating the PGDB  generated by PathoLogic. Besides reac- 
tions, metabolites, and pathways, users can add/modify experimental evidence, 
publications, summary/description, information on curators and aﬃliations, and 
so on, using the PGDB  editor. Another important component of Pathway Tools is 
the Pathway/Genome navigator. This component lets the user browse through the 
PGDB, query, and visualize the diﬀerent components of the model. The navigator 
also allows the user to enable an independent web server mode, which generates 
browsable web pages of the PGDB. The TrypanoCyc and LeishCyc [21, 39] are 
examples of web resources generated by the Pathway/Genome navigator. With the 
introduction of MetaFlux [9], Pathway Tools is also now capable of developing ﬂux 
balance models.
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The SEED server  [24] is  another  important   resource  in genome-scale 
reconstruction. The ModelSEED  component of this  server implements  an 
eﬃcient pipeline, which can be used to generate good-quality metabolic model 
drafts. The genome of interest is ﬁrst annotated using the RAST  server [40] 
to generate a preliminary  model draft. The pipeline  then generates a biomass 
equation for the draft and performs an autocompletion step so that the model is 
capable of producing the biomass components. This model can then be “ﬁtted” 
to experimental data through FBA. The ModelSEED pipeline also contains a 
modiﬁed version of the GrowMatch  algorithm, which helps in model optimiza- 
tion by identifying missing transport reactions, conﬂicts between GPRs and gene 
essentiality data, gaps in the metabolic network, and extra reactions in the model 
[41]. ModelSEED is also a repository of genome-scale models with about 236 
public models and 247 pathways, as of February 2015. 
Most automated draft reconstruction tools are based on organism-nonspeciﬁc 
databases to generate the primary metabolic  draft. In 2006, Notebaart  et al. 
published  the  AUTOGRAPH pipeline in which existing,  manually  curated 
genome-scale model of a taxonomically  related organism was used to generate 
metabolic  draft [26]. In this pipeline, orthologous  genes between the template 
(for which there exists a manually curated model) and the target genomes were 
identiﬁed  using bioinformatics  tools such as INPARANOID [42]. The  list of 
orthologs was then used to select components of the manually curated model to 
build the target organism metabolic draft. Selecting the right template organism 
and model is an important step in this pipeline and determines the quality of ❦               
the resulting metabolic draft. This method has been proved to generate more                                              
❦
 
accurate metabolic drafts. 
 
21.2.4.2   Databases 
Manually curated metabolic models take a considerable amount of eﬀort and time 
to build. They are rich in information such as gene–protein reaction relationships 
and metabolic capabilities of the organism. BioModels  is one of the most popular 
model databases for both metabolic and nonmetabolic  models [35]. At the time 
of writing, it has 562 curated models and 696 noncurated models published in 
peer-reviewed literature. BioModels  also hosts automatically generated 112 898 
metabolic,  27 531  nonmetabolic,  and  2641 genome-scale  metabolic  models 
[43]. An important feature of BioModels  is that it allows users to query not just 
the model components but even the annotation and metadata provided in the 
model, making it a very important  resource. The BioCyc  database collection 
(www.biocyc.org) is a huge set of PGDBs  generated by Pathway Tools. As of 
7 November  2014, BioCyc  contains  5500 databases in three categories: Tier 
1, Tier 2, and  Tier 3. Tier 1 databases are literature-based  manually  curated 
databases while  Tier 2 and Tier 3 databases were computationally  predicted 
using the PathwayTools software and lack intense manual curation [34]. BioCyc 
is hence a very rich biochemical  resource providing easy-to-browse metabolic 
models. The BiGG database [33] is another database of 10 extensively curated 
published genome-scale metabolic models. These models provide a good source 
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of biochemical information for speciﬁc organisms and also provide cross-links to 
other databases. Another example of a metabolic model repository is the JWS 
online  [44], the browser-based simulation tool, which maintains kinetic models. 
Biochemical information in databases provides an excellent resource on the 
metabolic capabilities of an organism. One of the most popular databases among 
them is the KEGG [32]. The  KEGG database collects information  on genes, 
enzymes, metabolites, biochemical reactions, and biological  pathways among 
many other types of information. KEGG also has a popular web service, allowing 
other tools and databases to quickly mine them for information. As of April 2014, 
the KEGG web service was reported to have 400,000–500,000 unique users per 
month. KEGG pathway maps are also frequently used by many to map omics 
datasets. These maps are generated by merging all known biological pathways 
and are well maintained. MetaCyc [34], one of the most important PGDBs in the 
BioCyc collection, is another important biochemical database. It is a collection 
of all pathways, reactions, and metabolites generated from all the BioCyc PGDBs 
that provides a good biochemical reaction pool during gap ﬁlling. PathoLogic, 
the draft reconstruction tool in Pathway Tools, completely relies on MetaCyc to 
generate the draft PGDBs. Enzyme databases such as BRaunschweig  ENzyme 
DAtabase (BRENDA) [45], ExplorEnz [46], and (Expert Protein Analysis System) 
ExPASy  [47] enzyme databases are quite useful resources for thermodynamic 
information of reactions in systems biology. In addition, BRENDA allows users to 
submit biochemical reactions identiﬁed in various species, providing other users 
with substrates speciﬁc to the reaction in a particular species. Gene and protein ❦                    
databases such as NCBI and UniProt [48] (formerly, EMBL and SwissProt) carry                                   
❦
 
many useful annotations on gene/protein functions. GeneDB  [49] is another 
such  database that stands out for providing  up-to-date annotated sequence 
information on protozoan parasites. Chemical  Databases such as ChEBI  [50] 
and ChemSpider  [51] provide  a good resource on the metabolites for model 
reconstructions. These databases report chemical  formula, InChIs, alternative 
names, and chemical properties for chemical entities. 
Transport  reactions are very important  in generating functional  metabolic 
models. Transport Databases such as TransportDB [52] provide  a good resource 
on these reactions. TransportDB  also allows users to BLAST  search protein 
sequences to identify transporters. 
The EuPathDB  [53] collection  of databases provides  sequence information 
along with related protein information  and experimental data on Eukaryotic 
pathogens.  Users  are also  allowed  to submit comments on genes/proteins, 
improving the value of these data. EuPathDB maintains well-curated databases 
for Trypanosomatidae and Plasmodium  through TritrypDB [54] and PlasmoDB 
[55], respectively. PlasmoDB and TritrypDB  contain genomic data (sequence 
and/or annotation) of 8 Plasmodium  species  (i.e., P. falciparum, Plasmodium 
vivax, P. yoelii, P. berghei, Plasmodium  chabaudi, Plasmodium  knowlesi, Plas- 
modium  reichenowi, and Plasmodium  gallinaceum) and 14 Trypanosomatidae 
species (Crithidia  fasciculata, Leishmania  braziliensis, Leishmania  donovani, 
Leishmania  infantum, L. major, Leishmania  mexicana, Leishmania  tarentolae, 
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T. brucei, Trypanosoma congolense, T. cruzi, Trypanosoma evansi, Trypanosoma 
grayi, Trypanosoma  rangeli, and Trypanosoma  vivax), respectively. Apart from 
genomic data, these databases also include functional  data on RNA and protein 
expression, putative functions, protein interactions, localization  and features, 
as well as gene polymorphisms, orthology, and homology. Users Queries can be 
done by performing a keyword search using gene names or gene IDs. Initial search 
results can be combined with succeeding search parameters using Boolean oper- 
ations  (i.e., “and,” “or,” “not”) and are presented in a workﬂow showing the total 
number of hits at each step. Users are required to register in order to store search 
strategies, save and download  data, and add comments on gene sequences [53]. 
The Malaria Genome Exploration Tool or MaGnET utilizes a MySQL database 
storage and Java for the user interface. Queries can be done to display the location 
of a given open reading frame and to visualize protein–protein  interaction and 
3D motifs. Gene ontology annotation is also included in the results page when 
available [56]. 
The Malaria Parasite Metabolic Pathway (MPMP) is a web-based resource that 
aims to collate and synthesize biological, physiological, and biochemical data on 
P. falciparum  genes to provide a more profound understanding of these genes 
[57]. MPMP focuses on metabolic pathways that are involved in the erythrocytic 
stage of the parasite. It shows pertinent metabolic pathways from KEGG, with 
some pathways developed as a result of the consolidation  of diﬀerent metabolic 
maps. A pathway is considered to exist if at least three to four enzymes in 
sequence for the pathway are encoded in the P. falciparum genome; however, if ❦               
there is biochemical data that supports the functionality of a given pathway, then                                     
❦
 
it is also considered relevant. In addition to the pathways, “Transcription Clocks” 
are included beside each enzyme providing transcription data corresponding to 
the speciﬁc enzyme. EC numbers in the pathways have external links to other 
resources for further information, including  description, cellular localization, 
and references  [57, 58]. 
MetaTIGER  is a tool that provides phylogenetic information on the metabolic 
proﬁles of over 500 organisms. Apart from the use of existing genomic sequence 
data, expressed tag sequences, PSI-BLAST  searches through SHARKhunt, and 
hidden Markov models were utilized to further enrich the MetaTIGER database. 
Comparison of diﬀerent organisms can be done using this tool and results can be 
presented as phylogenetic  trees, KEGG metabolic maps, or table formats along 
with their corresponding E-values [59]. Information from this tool can be used to 
ﬁll gaps in pathways in a metabolic network by comparing the pathway with that 
of closely related organisms in conjunction with the likelihood of the involved 
enzyme/s existing in the organism in question. 
With more than 250  public databases,  MetExplore   [60] is a  web  server 
developed to study experimental data in the context of metabolic networks. 
MetExplore supports mapping of metabolites using standard identiﬁers such as 
InChI and molecular mass. Users registered on MetExplore can import their own 
metabolic networks into the server, visualize, curate, and share them. Analysis of 
metabolic pathways using experimental data through MetExplore, which does 
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not rely on predrawn pathways, contributes to better understanding the changes 
 
Q6 in the metabolism of an organism of interest (Table 21.1). 
  
21.3 
 Metabolic Model Simulation 
  
21.3.1 
 Flux Balance Analysis 
 
The initial step to FBA is the creation of a mathematical representation  of the 
 metabolic reactions in a given metabolic network. Reactions and corresponding 
 metabolites involved in speciﬁc reactions are tabulated into a matrix (i.e., Stoichio- 
 metric matrix or S-matrix) that accounts for the number of metabolites consumed 
 and produced within the given reactions. Columns of the matrix represent the 
 reactions while rows represent the metabolites. The number of metabolites pro- 
 duced or consumed in a given reaction is represented in the matrix as a positive 
 or negative number, respectively. The stoichiometry of each reaction provides a 
 constraint onto the resulting network. In addition, each reaction is assigned a 
 ﬂux boundary  (i.e., upper  and lower  bounds),  which  represents  the permissible 
 ﬂuxes for the said reaction. These constraints therefore deﬁne the allowable rates 
Q7 at which metabolites are produced or consumed within the system [3]. 
 Following the creation of the S-matrix and the assignment of ﬂux boundaries for 
the reactions, an objective function is assigned. A reaction representing the said 
❦ 
 function (e.g., production of biomass components from precursors) is included  
 into the matrix. Biomass reactions, for example, are based either on experimen-  
 tally obtained data [3, 20] or on the data obtained from closely related organisms  
 [6, 16, 18]. Simulation tools that utilize linear programming software are then used  
 to calculate the permissible solution space and can identify the optimal solution  
 for the given objective reaction through FBA. FVA [62] can be performed to iden-  
 tify alternative solutions that will still satisfy a given condition. An example of such  
 condition is the production of at least 90% of the biomass. The ﬂuxes of individual  
 reactions (within the assigned limits) are maximized and minimized in order to  
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ﬁnd alternative solutions [3] (Figure 21.2). 
This ﬁgure describes the summary of FBA process. Here, we have considered a 
simple metabolic model (i) with six metabolites (A, B, C, D, E, and F) and four reac- 
tions (R1, R2, R3, and R4) (ii), summarized in the stoichiometric matrix (S-matrix) 
(iii). Flux values (f 1, f 2, f 3, f 4) for the reactions have maximum and minimum 
constraints, [ f 1max, f 1min], [ f 2max, f 2min], [ f 3max, f 3min], and [ f 4max, f 4min], 
respectively  (iv). As for the objective function, we have considered the maximiza- 
tion of the production of metabolite E. Using this S-matrix, linear equations of the 
ﬂuxes are determined (v). Linear equations and constraints are used to determine 
the solution space. The optimum solution (vi), in this case, is the solution with 
maximum permissible ﬂux through the objective function f 2. 
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Table 21.1   Summary of databases useful in model reconstruction. 
 
Database Biochemical 
data 
Pathways Proteins Gene Experimental 
data 
Metabolic 
models 
Metabolite Organism 
speciﬁc 
References 
 
BiGG 
     ✓  ✓ 
 
[33] 
BioModels      ✓  ✓ [35] 
BRENDA ✓    ✓  ✓ ✓ [45] 
ExPASy ✓        [47] 
ExploreEnz ✓        [46] 
ChEBI ✓      ✓  [50] 
ChemSpider       ✓  [51] 
EuPathDB ✓ ✓ ✓ ✓ ✓   ✓ [53] 
GeneDB   ✓ ✓    ✓ [51] 
KEGG ✓ ✓ ✓ ✓   ✓ ✓ [32] 
LAMPa) 
MaGnETa) 
✓ ✓ ✓ 
✓ 
✓ 
✓ 
 
✓ 
 ✓ ✓ 
✓ 
[61] 
[56] 
MetaCyc ✓ ✓ ✓ ✓   ✓  [34] 
MetaTIGER  ✓ ✓     ✓ [59] 
MPMPa)  ✓ ✓ ✓ ✓   ✓ [57, 58] 
TrypanoCycb) ✓ ✓ ✓ ✓   ✓ ✓ [21] 
UniProt   ✓ ✓    ✓ [48] 
 
a)    Plasmodium only. 
         
b)    Trypanosoma only.          
This table summarizes information that can be retrieved  from some of the commonly utilized databases that are useful in genome-scale  reconstruction of 
Plasmodium 
falciparum and Trypanosoma brucei. 
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Figure 21.2  Constraint-based modeling. 
 
21.3.2 
 
Simulation Tools 
The constraint-based reconstruction  and analysis (COBRA) Toolbox  is a col- 
lection of methods for the development, analysis, and simulation of metabolic 
networks. These methods are based on an approach that utilizes physicochemical, 
❦ 
biological, and data-driven constraints to identify phenotypic states of a given  
metabolic network under a given condition [63]. Version 1.0 of the toolbox was  
initially released in 2007 and was then updated  to version 2.0 in 2011. Apart from  
the COBRA archive, installation of this toolbox requires MATLAB [64], libSBML  
and the SBML Toolbox (www.sbml.org), and linear programming software (e.g.,  
GLPK, Gurobi, CPLEX). Currently, it oﬀers a wide range of functionalities as  
shown in Table 21.2 [65]. COBRAPy is a version of the COBRA Toolbox that runs  
using Python instead of MATLAB, which is a proprietary software. Furthermore,  
COBRAPy is based on Python programming language, increasing its ﬂexibility  
[66]. In terms of user interface,  the COBRA Toolbox requires the users to provide  
a ﬂat ﬁle, which contains all the species (i.e., molecules),  reactions, and the reac-  
tion equations via MATLAB or Python interface. The MATLAB COBRA Toolbox  
accepts models in MATLAB, SBML, and Microsoft excel formats, and its Python  
implementation accepts SBML, JSON, and COBRA model object. Although the  
toolbox has functions to evaluate model correctness, error detection may not  
 be as good compared with other applications. One example of such an issue  
is that if a reaction  in the input ﬁle contains an undeclared metabolite, the 
function,  instead of returning  an error message, proceeds to add the reaction  to 
the cobra model object without the undeclared metabolite leading to an incorrect 
and unbalanced reaction. However, the COBRA Toolbox  provides a number of 
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Table 21.2   Features of 
21.3   Metabolic Model Simulation 
 
COBRA toolbox  (version 2.0) [65]. 
493 
 
Feature 
 
Details  
 
Flux balance analysis 
 
Flux variability, gene deletion studies, geometric  FBA, 
 
 growth-rate optimization, loop law, MOMA, robustness analysis  
Fluxomics C13 data ﬁtting and ﬂux estimation, experimental design  
Gap ﬁlling DetectDeadEnds, gapFind, growthExpMatch  
Input/output Read/write  SBML (level 2, version 4)  
Metabolic engineering GDLS, OptGene,  OptKnock  
Reconstruction Create submodels  using omics data, model curation tools  
Sampling Artiﬁcial centering hit and run (ACHR) sampling, updated  ACHR  
 sampling (parallel/multipoint)  
Test suite Examples are provided for testing, verify installations  
Visualization Display maps, overlay data (ﬂux distributions, ﬂux variability)  
 
 
advanced features that are not present in most FBA applications/software as 
shown in Table 21.2. Finally, it is important to note that the COBRA  Toolbox is 
well maintained, and it is constantly being improved using methods and programs 
contributed by active community members [67]. 
SurreyFBA is a free stand-alone command line tool that is written in the C++ 
programming  language. It uses the GLPK software for linear programming. 
Alongside the main application is the JyMet, which is a graphical user interface 
❦               that is implemented  in the Python  programming  language written  in Java                                                 ❦ 
(Jython). JyMet  has a menu-based  interface  in order to access the diﬀerent 
simulation commands easily and displays the model in a spreadsheet format. The 
features of SurreyFBA include FBA, FVA, robustness analysis, phenotypical phase 
planes, elementary mode analysis, essentiality scans and prediction of reaction, 
and gene/enzyme knockout results, as well as model  validation  that includes 
the detection of live reactions, orphan metabolites, nonconserved metabolites, 
and connected components. After applying the optional matrix reduction algo- 
rithm, FVA on the iND750 model (Saccharomyces cerevisiae) using SurreyFBA 
was 41% faster compared  to conducting  the same analysis using the COBRA 
Toolbox [68]. 
OptFlux is a free software application  that uses GLPK software for linear pro- 
gramming and LibSBML  to read and handle metabolic models in SBML format, 
although other formats can also be loaded (e.g., Metatool  or ﬂat ﬁles). FBA simu- 
lations can be performed alongside adjustments in environmental conditions. The 
software also uses the BioVisualizer plug-in to visualize pathways and networks in 
the form of nodes and edges. OptFlux has a user-friendly graphical user interface 
with a menu bar that is easy to navigate. Similarly to the COBRA Toolbox, OptFlux 
can also perform FVA and Minimization of Metabolic Adjustment (MOMA) [69]. 
Acorn is a web-based application with a desktop-based graphical editor that has 
been designed to handle large genome-scale metabolic model. Users are required 
to install Acorn and set up an account in order to utilize the application. Models 
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in SBML format can be imported into the application for analysis. FBA as well as 
FVA can be conducted with objective parameters and nutritional conditions set by 
the user. Essential genes and reactions can also be identiﬁed by the software. Path- 
ways can be visualized using the desktop editor showing the corresponding ﬂux 
values calculated for each reaction. Selected models and results of perturbations 
can also be shared using the application [70]. Table 21.3 summarizes the diﬀerent 
FBA application software . 
 
 
 
21.4 
Applications of Flux Balance Analysis in Identifying Potential Drug Targets 
 
Potential drug targets in pathogens should meet several important criteria. Pri- 
marily, the protein or enzyme must be necessary for the survival of the pathogenic 
organism. In relation to the metabolic network, the protein is often involved in 
pathways ultimately leading to the production of biomass components. Enzymes 
involved in carbon, lipid, nucleotide, or protein metabolism are potential targets 
[7]. Moreover, the druggability of a protein target, which is deﬁned as the likeli- 
hood of altering the function of the target upon exposure to a given compound, 
is assessed through  a number of ways. An important characteristic of a druggable 
target is the presence of potential binding sites in the three-dimensional struc- 
ture of the protein. These binding  sites can further be assessed based on their 
shape, surface lipophilicity, and predicted aﬃnity for drug compounds [72]. Sim- ❦                    
ilarities in protein structures with known drug targets, also referred to as guilt                                        
❦
 
by association, have also been utilized in determining the druggability of a tar- 
get [73]. Comparison with homologous targets in other pathogens has also been 
used to identify potential targets with similar binding sites and possible ligand 
interactions, particularly with antibiotics [74]. Lastly, high homology to the bind- 
ing pockets of important human enzymes makes the protein in the pathogen an 
unlikely drug target, owing to an increased likelihood  of side eﬀects [13]. 
Enzymes that are essential for the survival of a pathogen can be identiﬁed using 
FBA by simulating individual  gene or reaction knockouts and observing its eﬀect 
on the objective function.  In this case, it is important to accurately deﬁne the spe- 
ciﬁc gene–protein reaction association [75]. It is crucial that targets identiﬁed are 
Q8       involved in primary metabolic pathways, rather than in secondary metabolism 
that are often nonessential to the growth of organism. Additionally, the objective 
function can be adjusted to represent the production of the minimum component 
requirements of an organism. This may result in an accurate prediction of the 
essentiality  of certain  reactions  or genes [76]. Genes that encode isozymes may 
be considered nonessential since the organism is capable of producing another 
enzyme with a similar function. On the other hand, a gene that contributes to a 
protein complex that is essential to an organism is considered essential [13]. 
Potentially, double-gene knockouts can be targeted by a drug combination  that 
can slow down, if not prevent, the development of drug resistance. In addition, 
the use of drug combinations  may have synergistic eﬀects. In vitro testing has 
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demonstrated that some drug combinations exhibited greater inhibitory  eﬀect 
when compared to the sum of the eﬀect of individual drugs when given separately. 
Yet little is known of the ﬂux restrictions that produce the synergy [15]. 
Apart from focusing on enzymes in a metabolic network, a metabolite-centered 
approach can be applied toward identifying potential drug targets. Metabolic 
choke points, or reactions that solely produce or consume one or a few metabo- 
lites, are presumed to be essential if an inhibition at this point will result in the 
deprivation of an essential by-product or the accumulation of a possibly toxic 
metabolite  [18]. Molecules similar to the metabolites involved in choke point 
reactions  (i.e., single reaction connected to a number of important reactions or 
pathways) may be used as a competitive inhibitor  for the given reaction and may 
be able to target more than one enzyme [77]. 
Drug repositioning or repurposing involves the use of a currently available drug 
in addressing a diﬀerent disease pathology. Repurposing of drugs that have been 
approved for another purpose beneﬁts from the fact that these drugs have already 
been tested on humans and thus toxicity  and adverse eﬀect information  are 
already available [6, 14]. This shortens the time frame for drug development and 
reduces the developmental costs [78]. Available resources, such as the DrugBank, 
provide an extensive database of drugs and their corresponding  drug targets [79]. 
A number of studies have utilized the DrugBank to identify potential drugs that 
can target essential proteins to inhibit the growth of pathogenic organisms and 
cancer  cells [6, 14, 80]. 
In a study by Chavali et al. [15], data on identiﬁed essential genes obtained from ❦                    
a previously developed L. major model were used to screen FDA-approved drugs                                  
❦
 
that can potentially be used as antileishmanials. The protein sequences of L. major 
genes included in the metabolic network reconstruction were aligned against the 
sequences of drug targets in the DrugBank and STITCH databases. Inclusion and 
exclusion criteria such as FDA approval status, druggability, and drug toxicity 
were also incorporated in the drug screening. As a result, 15 genes representing 
potential  drug targets for a total of 240 FDA-approved drugs were identiﬁed. Pro- 
tein sequences of eight genes involved in nontrivial deletions were also identiﬁed 
as potential drug targets for a total of 37 FDA-approved drugs. Among the com- 
bined list of potential drugs targeting essential genes (single genes or gene pairs), 
9 have been reported in literature to exhibit antileishmanial activity, while 71 
have been shown to exhibit activity against L. major in previous high-throughput 
in vitro drug screenings. It is important to note that through this screening, halo- 
fantrine, an antimalarial drug, has been identiﬁed and tested in vitro to exhibit 
antileishmanial  activity  at concentrations  of 3 μM and higher.  Furthermore, 
drug combinations with disulﬁram, a drug used to treat chronic alcoholism, and 
antibiotics/antipsychotics  have also been demonstrated to show antileishmanial 
activity in  vitro.  These drug  combinations  have also produced  signiﬁcantly 
greater inhibition  when compared with the sum of the inhibitory eﬀects of the 
individual drugs. 
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21.5 
Conclusion 
 
Recently, the number of genome-scale metabolic reconstructions has increased 
greatly. With the rapid increase in the number of sequenced genomes, simplic- 
ity of tools, better predictive algorithms, and intuition of automated metabolic 
reconstruction tools, genome-scale metabolic draft reconstruction has been made 
much easier. Although manual curation is still time-consuming and requires the 
dedication of one or more individuals, the improvement in the quality of auto- 
mated drafts makes the process faster. Model simulation tools are also constantly 
being improved with better, faster algorithms, and new features are added regu- 
larly. Discussion forums such as the COBRApy and sbml.org google groups pro- 
vide a perfect opportunity  for systems biologists and computer programmers to 
discuss issues and drawbacks of existing tools and in turn facilitate the develop- 
ment process [81–84]. 
Genome-scale reconstruction and simulations aim to combine all known infor- 
mation on a particular organism to further understand their biology and predict 
their metabolic behavior under diﬀerent environmental conditions. With the dis- 
covery of new information on their metabolism, metabolic models need to be 
updated in order to take into account these details. Recon 2 (Homo sapiens) [85] 
and iJO1366 (Escherichia coli) [86] are the best examples where existing models 
have been improved to provide better representation of known metabolism. 
Finally, it is important to remember that the accuracy of the model highly ❦               
depends on the accuracy of existing knowledge on the metabolic pathways in the                                              
❦
 
organism. In addition, constraints in the model are mainly limited to available 
information on reaction stoichiometry and ﬂux boundaries and may not take 
into consideration other enzyme reaction parameters. Thus, it is important to 
take this into consideration when interpreting and evaluating simulation results. 
The objective of performing simulations of genome-scale metabolic models is 
never to replace experimental work but to generate hypotheses and help direct 
experiments saving both time and resources in the process. 
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APPENDIX 2 : ESSENTIAL GENES IDENTIFIED FROM SINGLE 
GENE DELETION STUDIES 
Gene Product Pathway involved 
Validated 
as essential 
Study 
Tb927.2.4370 trypanothione synthetase (TRYS) 
Trypanothione 
biosynthesis 
Yes PMID:22162199 
Tb927.4.3160 
dihydroxyacetone phosphate 
acyltransferase, putative (DAT) 
ether-type PE 
biosynthesis 
* PMID:20382188 
Tb927.4.4070 mevalonate kinase, putative (MK) 
isoprenoid 
biosynthetic 
pathway 
* PMID:18848949 
Tb927.5.1140 ethanolamine/choline kinase (C/EK) 
PC biosynthsis, PE 
biosynthesis 
*  
Tb927.6.1500 
alkyl-dihydroxyacetone phosphate 
synthase (ADS) 
ether-type PE 
biosynthesis 
* PMID:20382188 
Tb927.6.4410 
S-adenosylmethionine decarboxylase 
(AdoMetDC) 
Polyamine 
biosynthesis 
Yes PMID:17485680 
Tb927.6.4460 
S-adenosylmethionine decarboxylase 
(AdoMetDC) 
Polyamine 
biosynthesis 
Yes PMID:17485680 
Tb927.6.4470 
prozyme, S-adenosylmethionine 
decarboxylaseregulator (AdoMetDC) 
Polyamine 
biosynthesis 
Yes PMID:17485680 
Tb927.6.4540 
3-hydroxy-3-methylglutaryl-CoA 
reductase, putative (HMR) 
mevalonate 
pathway 
*  
Tb927.7.220 CDP-DAG synthase (CDS)  Yes PMID:20382188 
Tb927.7.3360 
farnesyl pyrophosphate synthase 
(FPPS) 
 Yes PMID:20382188 
Tb927.7.3760 
phosphatidylserine synthase, putative 
(PSS) 
PS synthesis Yes PMID:20382188 
Tb927.7.4000 glutathione synthetase, putative (GS) 
Trypanothione 
biosynthesis 
Yes PMID:24610661 
Tb927.7.5480 
dihydrofolate reductase-thymidylate 
synthase (DHFR-TS) 
 Yes PMID:18557814 
Tb927.8.1720 
phosphatidylglycerolphosphate 
synthase, mitochondrial (PGPS) 
Cardiolipin 
biosynthesis 
Yes PMID:23190171 
Tb927.9.10080 
phosphatidylserine decarboxylase, 
putative (PSD) 
 Yes PMID:20382188 
Tb927.9.10340 amino acid transporter, putative 
Amino acid 
transport 
Yes??  
Tb927.9.10580 
3-demethylubiquinone-9 3-
methyltransferase, putative 
Ubioquinol 
biosynthesis 
Yes??  
Tb927.9.1610 Phosphatidylinositol synthase (PIS) PI biosynthesis Yes PMID:20382188 
Tb927.9.5170 
phosphomevalonate kinase protein, 
putative (PMK) 
isoprenoids 
pathway 
*  
Tb927.9.5890 
solanesyl-diphosphate synthase, 
putative (SPPS) 
solanesyl 
disphosphate 
biosynthesis( for 
Ubiquinol) 
Yes PMID:24376001 
Tb927.9.7770 spermidine synthase (SpSyn)  Yes PMID:17916066 
Tb927.9.9000 
isopentenyl-diphosphate delta-
isomerase (IDI) 
 Yes PMID:20382188 
Tb927.9.9390 
sphingomyelin/ceramide 
phosphorylethanolamine synthase, 
bifunctional (SLS) – IPC producing 
IPC biosynthesis Yes PMID:19545591 
Tb927.10.10390 trypanothione reductase (TryR) 
Trypanothione 
recycling 
Yes PMID:10672177 
Tb927.10.11700 guanylate kinase, putative Purine salvage NO  
Tb927.10.12370 
gamma-glutamylcysteine synthetase 
(GCS) 
 Yes PMID:8663359 
Tb927.10.12810 
cholinephosphate cytidylyltransferase A 
(CCT) 
PC biosynthsis, PE 
biosynthesis 
Yes(PRO 
validated) 
 
Tb927.10.13290 
ethanolamine phosphotransferase 
(EPT) 
 Yes PMID:20382188 
Tb927.10.13560 
mevalonate-diphosphate 
decarboxylase (MDD) 
 Yes PMID:20382188 
Tb927.10.13930 
phosphatidic acid phosphatase, 
putative (PAP) 
DAG/CDP-DAG 
biosynthesis, ether-
type PE 
biosynthesis 
*  
Tb927.10.3660 aspartate aminotransferase (AspAT) 
Ubiquinol 
biosynthesis, 
Amino acid 
?  
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metabolism 
Tb927.10.8900 
Choline/ethanolaminephosphotransferase 
(CEPT) 
PC biosynthsis, PE 
biosynthesis 
Yes(PRO 
validated) 
PMID:26577437,PMID
:20382188 
Tb927.11.10510 
ubiquinone biosynthesis 
methyltransferase, putative (UbiE) 
Ubiquinol 
biosynthesis 
*  
Tb927.11.11250 
cytosolic malate dehydrogenase 
(cMDH) 
Ubioquinol 
biosynthesis, other 
Probably not  
Tb927.11.13220 
phospholipid:diacylglycerol 
acyltransferase-like protein 
Triglyceride 
biosynthesis 
  
Tb927.11.13730 ornithine decarboxylase (ODC) 
Trypanothione 
pathway 
Yes PMID:19304951 
Tb927.11.14140 
Ethanolamine-phosphate 
cytidylyltransferase (ECT) 
 Yes PMID:20382188 
Tb927.11.15150 
1-acyl-sn-glycerol-3-phosphate 
acyltransferase, putative (GAT2) 
ether-type PE 
biosynthesis 
*  
Tb927.11.2090 choline kinase (CK) 
PC biosynthsis, PE 
biosynthesis 
Yes PMID:20382188 
Tb927.11.6680 
amino acid permease/transporter, 
putative 
Amino acid 
transport 
----  
Tb927.11.9360 prenyltransferase 
Ubiquinol 
biosynthesis 
*  
Tb927.11.9590 
S-adenosylhomocysteine hydrolase, 
putative 
Methionine 
degradation (to 
homocysteine) 
Yes PMID:16539398 
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APPENDIX 3: ESSENTIAL GENE PAIRS IDENTIFIED FROM 
DOUBLE GENE DELETION STUDIES 
Gene 1 Product 1 Gene 2 Product 2 
Tb927.4.3930 amino acid transporter, putative Tb927.8.7670 amino acid transporter, putative 
Tb927.5.3810 
orotidine-5-phosphate 
decarboxylase/orotate 
phosphoribosyltransferase, putative, 
OMPDCase-OPRTase, p... 
Tb927.4.3320 uracil phosphoribosyltransferase, putative 
Tb927.4.4360 monoglyceride lipase, putative Tb927.2.5210 3-oxoacyl-ACP reductase, putative 
Tb927.4.4360 monoglyceride lipase, putative Tb927.8.7100 acetyl-CoA carboxylase 
Tb927.4.4360 monoglyceride lipase, putative Tb927.7.7410 oxidoreductase, putative 
Tb927.4.4360 monoglyceride lipase, putative Tb927.2.3910 
beta-ketoacyl synthase family protein, 
putative 
Tb927.5.3820 aspartate carbamoyltransferase, putative Tb927.4.3320 uracil phosphoribosyltransferase, putative 
Tb927.9.9400 
ceramide phosphorylethanolamine 
synthase 
Tb927.9.9410 
inositol phosphorylceramide synthase 
(SLS1) 
Tb927.5.3830 dihydroorotate oxidase Tb927.4.3320 uracil phosphoribosyltransferase, putative 
Tb927.8.5630 dihydroorotase, putative Tb927.4.3320 uracil phosphoribosyltransferase, putative 
Tb927.11.1540 isovaleryl-coA dehydrogenase, putative Tb927.4.2700 
Hydroxymethylglutaryl-CoA lyase, 
mitochondrial, putative 
Tb927.11.1540 isovaleryl-coA dehydrogenase, putative Tb927.8.2540 3-ketoacyl-CoA thiolase, putative 
Tb927.10.8530 glucose transporter 2A (THT2A) Tb927.1.3830 
glucose-6-phosphate isomerase, 
glycosomal (PGI) 
Tb927.8.7440 lipase, putative Tb927.2.5210 3-oxoacyl-ACP reductase, putative 
Tb927.8.7440 lipase, putative Tb927.8.7100 acetyl-CoA carboxylase 
Tb927.8.7440 lipase, putative Tb927.7.7410 oxidoreductase, putative 
Tb927.8.7440 lipase, putative Tb927.2.3910 
beta-ketoacyl synthase family protein, 
putative 
Tb927.10.3100 
glycerol-3-phosphate acyltransferase, 
putative 
Tb927.2.5210 3-oxoacyl-ACP reductase, putative 
Tb927.10.3100 
glycerol-3-phosphate acyltransferase, 
putative 
Tb927.8.7100 acetyl-CoA carboxylase 
Tb927.10.3100 
glycerol-3-phosphate acyltransferase, 
putative 
Tb927.7.7410 oxidoreductase, putative 
Tb927.10.3100 
glycerol-3-phosphate acyltransferase, 
putative 
Tb927.2.3910 
beta-ketoacyl synthase family protein, 
putative 
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APPENDIX 4: ESSENTIAL REACTIONS IDENTIFIED FROM 
SINGLE REACTION DELETION STUDIES 
Reaction ID Reaction Name 
EC 
number 
GPR 
Valid
ated? 
Publication Comment 
R_AKG3PO_LM 
R_acylglycerone-
phosphate 
reductase 
1.1.1.101   PMID:6562019 
Involved in AAG 
biosynthesis, TbEPT 
has been validated as 
essential , AAG is 
required by TbEPT for 
ether-PE biosynthesis 
R_HYDROXYPHENY
LPYRUVATE__45__
REDUCTASE__45__
RXN 
HYDROXYPHENYL
PYRUVATE-
REDUCTASE-RXN 
1.1.1.237 ( Tb927.11.11250 )   
Required in 4 hydroxy 
benzoate biosynthesis 
pathway for Ubiquinol 
R_RXN__45__9243 RXN-9243 1.14.-.-    Ubiquinol biosynthesis 
R_RXN__45__9278 RXN-9278 1.14.13    Ubiquinol biosynthesis 
R_RXN__45__9241 RXN-9241 1.14.3    Ubiquinol biosynthesis 
R_1__46__8__46__1
__46__12__45__RXN 
1.8.1.12-RXN 1.8.1.12 ( Tb927.10.10390 ) Yes PMID:10672177  
R_RXN__45__9281 RXN-9281 2.1.1.114 ( Tb927.9.10580 )   Ubiquinol biosynthesis 
R_METS 
HOMOCYSMETB12
-RXN 
2.1.1.13  No  
essentiality was found 
to be associated with 
homocysteine 
accumulation which 
was due to missing 
homoycysteine--> 
cystathione 
R_RXN__45__9242 RXN-9242 2.1.1.201 ( Tb927.11.10510 )   Ubiquinol biosynthesis 
R_TMDS 
THYMIDYLATESYN
-RXN[c]-
DUMP/METHYLEN
E-
THF//TMP/DIHYDR
OFOLATE/PROTON
.58. 
2.1.1.45 ( Tb927.7.5480 ) Yes PMID:18557814  
R_2__46__1__46__1
__46__64__45__RXN 
2.1.1.64-RXN 2.1.1.64 ( Tb927.9.10580 )   Ubiquinol biosynthesis 
R_DAGAT_LM 
R_Phospholipid:1,2-
diacyl-sn-glycerol O-
acyltransferase 
2.3.1.158 ( Tb927.11.13220 )   
Triglyceride 
biosynthesis 
R_2__46__3__46__1
__46__42__45__RXN 
2.3.1.42-RXN 2.3.1.42 ( Tb927.4.3160 ) * PMID:20382188 
DHAP → AAG → 
ether type PE, 
CDPethanolamine + 
AAG → PE + CMP is 
catalyzed by TbEPT 
which is a known 
essential gene , 
R_1akg3pacyltransf
erase 
RXN1V8-25 2.3.1.51 ( Tb927.11.15150 )   
catalyzes 1akgp → 
ak2gp, ak2gp → AAG 
→ PE,  
CDPethanolamine + 
AAG → PE + CMP is 
catalyzed by TbEPT 
which is a known 
essential gene 
R_GUAPRT 
GUANPRIBOSYLTR
AN-RXN[c]-
GUANINE/PRPP//G
MP/PPI.35. 
2.4.2.8 
( Tb927.10.1470 ) or 
( Tb927.10.1400 ) or 
( Tb927.10.1390 ) 
NO PMID:9088991 
purine salvage 
pathway, Double KO 
with TbXPRTis lethal 
R_DMATTx 
R_dimethylallyltranst
ransferase 
2.5.1.1 ( Tb927.7.3360 ) Yes PMID:20382188  
R_SPMS 
SPERMIDINESYN-
RXN 
2.5.1.16 ( Tb927.9.7770 ) Yes PMID:17916066  
R_ALKYLGLYCERO
NE__45__PHOSPHA
TE__45__SYNTHAS
E__45__RXN 
ALKYLGLYCERON
E-PHOSPHATE-
SYNTHASE-RXN 
2.5.1.26 ( Tb927.6.1500 ) * PMID:20382188 
DHAP → AAG → 
ether type PE, 
CDPethanolamine + 
AAG → PE + CMP is 
catalyzed by TbEPT 
which is a known 
essential gene / 
R_2__46__5__46__1 2.5.1.39-RXN 2.5.1.39 ( Tb927.11.9360 )   Ubiquinol biosynthesis 
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__46__39__45__RXN 
R_METAT 
S-ADENMETSYN-
RXN 
2.5.1.6 
( Tb927.6.4890 ) or ( 
Tb927.6.4920 ) or ( 
Tb927.6.4880 ) or ( 
Tb927.6.4860 ) or ( 
Tb927.6.4910 ) or ( 
Tb927.6.4870 ) or ( 
Tb927.6.4900 ) or ( 
Tb927.6.4840 ) or ( 
Tb927.6.4850 ) 
 NO  PMID:8457607 
No, (since adoMet 
transport should be 
present, but otherwise 
yes) 
R_TRANS__45__OC
TAPRENYLTRANST
RANSFERASE__45_
_RXN 
TRANS-
OCTAPRENYLTRA
NSTRANSFERASE-
RXN 
2.5.1.84 ( Tb927.9.5890 ) Yes PMID:24376001  
R_TYROSINE__45__
AMINOTRANSFERA
SE__45__RXN 
TYROSINE-
AMINOTRANSFER
ASE-RXN 
2.6.1.57 ( Tb927.10.3660 ) ??   
R_CHOLK 
CHOLINE-KINASE-
RXN 
2.7.1.32 ( Tb927.5.1140 )  PMID:20382188  
R_ETHAK 
ETHANOLAMINE-
KINASE-RXN 
2.7.1.82 ( Tb927.11.2090 ) Yes PMID:20382188  
R_PMEVKx 
R_phosphomevalon
ate kinase 
2.7.4.2 ( Tb927.9.5170 )    
R_NUCLEOSIDE__4
5__DIP__45__KIN__
45__RXN_1 
NUCLEOSIDE-DIP-
KIN-RXN 
2.7.4.6 
( Tb927.4.1720 ) or ( 
Tb927.9.11260 ) or ( 
Tb927.11.16130 ) 
   
R_ETAPCT 
R_ethanolamine-
phosphate 
cytidylyltransferase 
2.7.7.14 ( Tb927.11.14140 ) Yes PMID:20382188  
R_CHLPCTD 2.7.7.15-RXN 2.7.7.15 ( Tb927.10.12810 ) Yes PMID:20382188 (PRO validated) 
R_PHCYT_LM 
R_phosphatidate 
cytidylyltransferase 
(L. major) 
2.7.7.41 ( Tb927.7.220 ) Yes PMID:20382188 
(A. Lilley and T.K. 
Smith, unpublished 
data) 
R_RXN1V8__45__22 RXN1V8-22 2.7.8 ( Tb927.9.9390 ) Yes PMID:19545591  
R_EAPT_LM 
R_alkyl acylglycerol 
phosphoethanolami
ne transferase 
2.7.8.1 ( Tb927.10.13290 ) Yes PMID:20382188  
R_2__46__7__46__8
__46__11__45__RXN
__91__g__93____45
__CDPDIACYLGLYC
EROL__47__MYO__
45__INOSITOL__47_
___47__L__45__1__
45__phosphatidyl__
45__inositols__47__
CMP__47__PROTON
__46__85__46__ 
2.7.8.11-RXN[g]-
CDPDIACYLGLYCE
ROL/MYO-
INOSITOL//L-1-
phosphatidyl-
inositols/CMP/PROT
ON.85. 
2.7.8.11 ( Tb927.9.1610 ) Yes PMID:20382188  
R_PINOS_LM 
R_phosphatidylinosit
ol synthase (L. 
major) 
2.7.8.11 ( Tb927.9.1610 ) Yes PMID:20382188  
R_RXN1V8__45__23 RXN1V8-23 2.7.8.27 
( Tb927.9.9400 ) or ( 
Tb927.9.9410 ) 
  SLS1/SLS2 
R_RXN__45__1382 RXN-1382 2.7.8.29 ( Tb927.7.3760 ) Yes PMID:20382188  
R_3__46__1__46__2
__46__23__45__RXN 
3.1.2.23-RXN 3.1.2.23    
Ubiquinol biosynthesis 
(4hydroxy benzoate) 
R_4coumarylCoAde
acetylase 
4-coumarylCoA 
deacetylase 
3.1.2.23    
Ubiquinol biosynthesis 
(4hydroxy benzoate) 
R_AKAGPP_LM 
R_alkyl glycerol 
phosphate 
hydrolase 
3.1.3.4 ( Tb927.10.13930 ) *  
AAG formation –
>ether PE,  
CDPethanolamine + 
AAG → PE + CMP is 
catalyzed by TbEPT 
which is a known 
essential gene 
R_AHC 
ADENOSYLHOMOC
YSTEINASE-RXN 
3.3.1.1 ( Tb927.11.9590 ) Yes PMID:16539398  
R_RXN__45__9284 RXN-9284 4.1.1    Ubiquinol biosynthesis 
R_ORNDC 
ORNDECARBOX-
RXN 
4.1.1.17 ( Tb927.11.13730 ) Yes PMID:19304951  
R_DPMVDx 
R_diphosphomevalo
nate decarboxylase 
4.1.1.33 ( Tb927.10.13560 ) Yes PMID:20382188  
R_ADMDC SAMDECARB-RXN 4.1.1.50 
( Tb927.6.4470 and 
Tb927.6.4410 and 
Tb927.6.4460 ) 
Yes 
PMID:18949025, 
PMID:17485680 
(BSF) 
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R_4__45__COUMARAT
E__45____45__COA__4
5__LIGASE__45__RXN 
4-COUMARATE--
COA-LIGASE-RXN 
6.2.1.12 
( Tb927.9.4230 ) or ( 
Tb927.9.4210 ) or ( 
Tb927.9.4200 ) 
 
 
Ubiquinol biosynthesis 
(4hydroxy benzoate) 
R_FACOAL140 
R_fatty-acid--CoA 
ligase 
(tetradecanoate) 
6.2.1.3 
( Tb927.10.3260 ) or 
( Tb927.9.4200 ) or ( 
Tb927.9.4210 ) or ( 
Tb927.9.4190 ) or ( 
Tb927.11.4490 ) 
   
R_FACOAL1 
R_fatty-acid--CoA 
ligase (gamla) 
6.2.1.3 
( Tb927.10.3260 ) or 
( Tb927.9.4200 ) or ( 
Tb927.9.4210 ) or ( 
Tb927.9.4190 ) or ( 
Tb927.11.4490 ) 
   
R_FACOAL2 
R_fatty-acid--CoA 
ligase (alpla) 
6.2.1.3 
( Tb927.10.3260 ) or 
( Tb927.9.4200 ) or ( 
Tb927.9.4210 ) or ( 
Tb927.9.4190 ) or ( 
Tb927.11.4490 ) 
   
R_TRYS 6.3.1.9-RXN 6.3.1.9 
( Tb927.2.4370 ) or ( 
Tb927.8.2410 ) 
Yes PMID:22162199  
R_GSS GSPSYN-RXN 6.3.1.9 ( Tb927.2.4370 ) Yes PMID:22162199  
R_GLUCYSL GLUTCYSLIG-RXN 6.3.2.2 ( Tb927.10.12370 ) Yes PMID:8663359  
R_GTHS 
GLUTATHIONE-
SYN-RXN 
6.3.2.3 ( Tb927.7.4000 ) Yes PMID:24610661  
R_dADPth 
dADP_flagellar_tran
sport 
NA  
INTR
ACEL
LULA
R 
  
R_solanesylppTg 
Solanesyl-
pyrophosphate 
glycosomal transport 
NA  
INTR
ACEL
LULA
R 
  
R_QH2tm R_qh2 transport NA  
INTR
ACEL
LULA
R 
  
R_Ornsink Ornithine_sink NA  
Yes-
excha
nge 
PMID:25536859  
R_O2trm 
R_O2 transport 
(diffusion) 
NA  Yes ------------  
R_acoatx HYPO NA  
INTR
ACEL
LULA
R 
  
R_34hydroxyphenyll
actate 
3-(4-
hydroxyphenyl)lactat
e 
NA    
Ubiquinol biosynthesis 
(4hydroxy benzoate) 
R_EX_cys__45__L__
40__e__41__ 
R_L-Cysteine 
exchange 
NA  
Yes-
excha
nge 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_EX_his__45__L__
40__e__41__ 
R_L-Histidine 
exchange 
NA  
Yes-
excha
nge 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_EX_leu__45__L__
40__e__41__ 
R_L-Leucine 
exchange 
NA  
Yes-
excha
nge 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_LYSt6 
R_L-lysine transport 
in/out via proton 
symport 
NA ( Tb927.11.6680 ) Yes 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_PItg PI_golgi_transport NA  
INTR
ACEL
LULA
R 
  
R_ATPth 
ATP_flagellar_trans
port 
NA  Yes PMID:24931043  
R_ADPth 
ADP_flagellar_trans
port 
NA  
INTR
ACEL
LULA
R 
  
R_EX_lys__45__L__
40__e__41__ 
R_L-Lysine 
exchange 
NA  
Yes-
excha
nge 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_HISt6 
R_L-histidine 
transport in via 
NA ( Tb927.11.6680 ) Yes 
http://eprints.lanc
s.ac.uk/9639/ 
 
185 
 
proton symport 
R_EX_o2__40__e__4
1__ 
R_O2 exchange NA  Yes   
R_LongChainCarbox
ylateTx 
HYPO NA  
INTR
ACEL
LULA
R 
  
R_CDPdagTg 
CDPdag golgi 
transport 
NA  
INTR
ACEL
LULA
R 
  
R_EX_ile__45__L__4
0__e__41__ 
R_L-Isoleucine 
exchange 
NA  
Yes-
excha
nge 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_TYRabc 
R_L-tyrosine 
transport via ABC 
system 
NA 
( Tb927.4.3930 ) or ( 
Tb927.8.7670 ) 
Yes 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_LongChainAlchoh
olTx 
HYPO NA  
INTR
ACEL
LULA
R 
  
R_IPCS_LM R_IPC Synthase NA ( Tb927.9.9390 ) Yes PMID:19545591  
R_12DGRter 
R_12dgr_LM 
transport 
NA  
INTR
ACEL
LULA
R 
  
R_EX_trp__45__L__
40__e__41__ 
R_L-Tryptophan 
exchange 
NA  
Yes-
excha
nge 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_COAtg R_CoA transporter NA  
INTR
ACEL
LULA
R 
  
R_EX_arg__45__L__
40__e__41__ 
R_L-Arginine 
exchange 
NA  
Yes-
excha
nge 
  
R_VALt6 
R_L-valine transport 
in/out via proton 
symport 
NA ( Tb927.9.10340 ) Yes 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_O2t 
R_O2 transport in 
via diffusion 
NA  Yes   
R_CHLt6 
R_choline transport 
in/out via proton 
symport 
NA  Yes PMID:23747277  
R_ipcHYPOtr HYPO NA  
INTR
ACEL
LULA
R 
  
R_dAMPth 
dAMP_flagellar_tran
sport 
NA  
INTR
ACEL
LULA
R 
  
R_longChainAlchoh
olsSINKHYPO 
HYPO NA  
EXCH
ANGE 
  
R_cmptg CMP golgi transport NA  
INTR
ACEL
LULA
R 
  
R_Htg 
hydrogen golgi 
transport 
NA     
R_LEUt6 
R_L-leucine 
transport in/out via 
proton symport 
NA ( Tb927.9.10340 ) Yes 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_PTD1INOter 
R_phosphatidyl-1D-
myo-insoitol 
transport 
NA  
INTR
ACEL
LULA
R 
  
R_EX_phe__45__L_
_40__e__41__ 
R_L-Phenylalanine 
exchange 
NA  
Yes-
excha
nge 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_TRPabc 
R_L-tryptophan 
transport via ABC 
system 
NA 
( Tb927.4.3930 ) or ( 
Tb927.8.7670 ) 
Yes 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_ILEt6 
R_L-isoeucine 
transport in/out via 
NA ( Tb927.9.10340 ) Yes 
http://eprints.lanc
s.ac.uk/9639/ 
 
186 
 
proton symport 
R_PHEt6 
R_L-phenylalanine 
transport in/out via 
proton symport 
NA ( Tb927.11.6680 ) Yes 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_EX_val__45__L__
40__e__41__ 
R_L-Valine 
exchange 
NA  
Yes-
excha
nge 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_Ornt Ornithine_transport NA  Yes PMID:25536859  
R_EX_chol__40__e_
_41__ 
R_Choline 
exchange 
NA  
Yes-
excha
nge 
PMID:23747277 
No other choline 
source 
R_1akgpsinkt 
1-Alkyl-sn-glycerol 
3-phosphate 
transport 
NA  
EXCH
ANGE 
  
R_EX_tyr__45__L__
40__e__41__ 
R_L-Tyrosine 
exchange 
NA  Yes 
http://eprints.lanc
s.ac.uk/9639/ 
 
R_ARGt 
R_L-arginine 
transport in via 
proton symport 
NA ( Tb927.11.6680 ) YES   
R_INSTtg 
R_inositol transport 
in via proton 
symport 
NA  
INTR
ACEL
LULA
R 
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